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Autotransporters represent a diverse family of virulence effectors that are secreted from 
Gram-negative bacteria by the Type V Secretion System. Their initial description coined the 
term „Autotransporter‟ to embody the notion that their three-part architecture governs their 
navigation through the bacterial cell envelope. The Pet cytotoxic autotransporter is secreted 
by the diarrhoeal pathogen, Enteroaggregative Escherichia coli (EAEC) and was used as a 
model to study autotransporter biogenesis. Following a global transposon mutagenesis of 
EAEC, novel accessory factors were identified that are required for Pet biogenesis, including 
the transcription factors CRP and Fis, periplasmic chaperones and components of the β-barrel 
assembly machinery (BAM) complex. Using both in vivo and in vitro techniques, we show 
that the pet promoter is co-dependent on CRP and Fis. We present a novel co-activation 
mechanism whereby CRP is placed at a non-optimal position for transcription initiation, 
creating dependence on Fis for full activation and show that this co-activation mechanism 
extends to functionally similar autotransporters. Furthermore, we highlight novel components 
of the BAM complex required for AT secretion. This work builds on previous studies that, in 
recent years, have challenged the „auto‟ nature of this secretion process causing a paradigm 
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Secreted virulence determinants are essential to both colonisation and pathogenesis of Gram-
negative bacteria. The biogenesis of virulence determinants is a multi-stage process, which 
has to be tightly controlled in order to ensure optimal protein expression in the correct growth 
phase or niche. The journey of a typical secreted protein, from its initial transcription to its 
final destination outside the cell will be outlined below, detailing the mechanism of each 
major process, whilst also describing specialised systems that have evolved to circumvent 
obstacles associated with the secretion of virulence factors through the bacterial cell envelope.  
1.2 Transcription in Escherichia coli  
The ability of a bacterium to survive in a range of hosts and environments largely depends on 
its capacity to sense and respond to a repertoire of environmental cues. These environmental 
signals can be integrated into a variety of different pathways that affect gene expression and 
hence, protein synthesis. Escherichia coli uses multiple strategies to modulate protein 
synthesis, however the most economic choice for the bacterium is to regulate protein 
synthesis at the principal stage of its biogenesis; transcription initiation. The bacterial RNA 
polymerase (RNAp) holoenzyme is responsible for all the transcription in the cell and its 
distribution on the chromosome is subject to regulation by transcription factors (TFs). It is 
these TFs that mediate responses to environmental cues and translate them into modulation of 
the transcription machinery.  
1.2.1 Bacterial RNA polymerase  
Synthesis of all RNA in bacterial cells is dependent on the multi-subunit enzyme, RNAp. The 
dynamic activities of RNAp determine the ability of pathogens to successfully transit from 
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one niche to another. Bacterial RNAp exists in two forms, which are functionally distinct 
from each other; the RNA polymerase core enzyme and the RNA polymerase holoenzyme. 
The core enzyme comprises 5 subunits; α2, β, β‟ and ω (Zhang et al., 1999), which forms the 
catalytically active, elongation-competent complex (Fig. 1.1). This core composition is 
conserved in sequence, structure and function, from bacteria to humans, with archaeal and 
eukaryotic polymerases differing only by the presence of additional subunits (Ebright, 2000; 
Minakhin et al., 2001). Structural studies, elucidating the organisation of the multi-subunit 
RNAp, observed a structure reminiscent of a „crab‟ claw with two „pinchers‟ (the β and β‟ 
subunits) shaping the central, active site cavity (Zhang et al., 1999), which is occupied by the 
DNA template during transcription elongation (Naryshkin et al., 2000). The identical α 
subunits contain two domains; an N-terminal domain (α-NTD) and a C-terminal domain (α-
CTD), which are connected via a flexible linker (Blatter et al., 1994). They form a homodimer 
in the RNAp structure, with the strongest dimerisation determinants located in the α-NTD 
(Ebright and Busby, 1995). The flexible linker is instrumental in permitting the interaction of 
α-CTD with upstream regulatory elements and/or proteins, whilst tethering the α-NTD to the 
rest of RNAp (Fig. 1.1) (Ebright and Busby, 1995). The ω subunit is non-essential for 
transcription but plays a role in the assembly of the α2β subunits (Minakhin et al., 2001).  
Although the core enzyme is proficient in transcription elongation, association with a σ 
subunit to create the holoenzyme is necessary for specific, promoter-mediated transcription 
initiation (Burgess et al., 1969; Typas et al., 2007). Most bacteria have a range of σ subunits 
that can be divided into two classes; one of which has only a single member σ
54
 and the other 
sigma factors belonging to the σ
70
 class. Each σ subunit is thought to recognise different 





























Figure 1.1. Schematic representation of the interactions between the RNA 
polymerase holoenzyme and promoter DNA. This figure illustrates the interactions 
between the different subunits of the RNA polymerase holoenzyme with the core 
promoter elements. The interactions shown include; the α-CTD subunits with the UP 
element („UP‟); σ domain 4 with the -35 hexamer element; σ domain 3 with the 
extended -10 motif („ext -10‟); and σ domain 2 with the -10 hexamer element. Both the 
-35 and -10 elements are aligned with consensus binding hexamer sequences, shown in 




σ is critical for the correct orientation of RNAp at promoters and facilitates subsequent 
unwinding of duplex DNA, close to the transcript start site (Browning and Busby, 2004; 
Wosten, 1998). All bacteria contain a major essential σ factor (in the case of E. coli, this is 
σ
70
), which is responsible for initiating transcription of the housekeeping genes. Other σ 
subunits are required to co-ordinate gene expression in response to specific environmental 
stimuli or growth phases. For example, σ
S
 is induced during stationary phase or stress (Typas 
et al., 2007), whilst σ
E 
responds to extracytoplasmic signals (Helmann, 2002). Furthermore, 
some σ subunits have now been associated with a specific up-regulation of genes encoding 
virulence determinants (Kazmierczak et al., 2005) and are therefore indispensable for certain 
bacterial pathogens such as Bacillus anthracis and Mycobacterium tuberculosis, to cause 
disease (Fouet et al., 2000; Geiman et al., 2004). For example, mice infected with a strain of 
M. tuberculosis lacking its alternative σ
F 
sub-unit were attenuated for late-stage disease in 
comparison to mice infected with the wild type strain (Fouet et al., 2000). Genetic and 
biochemical analysis of the σ
70
 subunit family revealed four regions of sequence conservation 
and highlighted the importance of regions 2 and 4 in recognition and binding of the -10 and -
35 promoter elements, respectively (Fig. 1.1) (Barne et al., 1997; Fenton et al., 2000). High 
resolution structural studies confirmed that the σ subunit is comprised of four predominant 
domains, which assume an entirely α-helical structure; N-terminal domain 1, N-terminal 
domain 2, 'linker' domain and C-terminal domain (Murakami et al., 2002; Vassylyev et al., 
2002).   
1.2.2 Transcription initiation  
Transcription occurs in three major steps; initiation, elongation and termination. Transcription 
initiation is further divided into three key stages, involving many structural and 
conformational changes of RNAp, promoter DNA and regulatory proteins. Firstly, RNAp 
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holoenzyme binds to the promoter and forms what is referred to as the closed complex (RPc) 
(Murakami and Darst, 2003). RPc then undergoes a conformational change to form the open 
complex (RPo), whereby the DNA template is unwound around the transcript start site and 
brought into close proximity of the active site of RNAp, ready for interaction with the 
initiating nucleoside triphosphate (NTP) (deHaseth et al., 1998; Murakami et al., 2002). A 
short, nascent transcript is synthesised by the initial RNAp-promoter transcribing complex, 
through a scrunching mechanism (Kapanidis et al., 2006). Once the initial transcript reaches 
the threshold of 8-15 nucleotides (nts) in length, the sigma subunit dissociates from core 
RNAp (promoter escape) and the core RNAp enters the processive stage of transcription in an 
RNAp-DNA elongation complex, which is the first irreversible stage of transcription 
initiation (Browning and Busby, 2004). However, the transition of the initial RNAp-promoter 
transcribing complex into the RNAp-DNA elongation complex is not a fluent process, as 
RNAp can go through tens or hundreds of cycles of synthesising an 8-15 nt RNA transcript 
without successful transition to the elongation complex. This process is known as abortive 
initiation and has been well characterised as an RNAp phenomenon in vitro (Murakami and 
Darst, 2003) and in vivo (Goldman et al., 2009), at many promoters. A role for the aborted 8-
15 nt transcripts remains elusive, with theories alluding to its function as a primer for the 
initiation of RNA synthesis (Goldman et al., 2009; Nickels and Dove, 2011).  
1.2.3 Regulation of transcription initiation 
Extensive studies on the regulation of transcription initiation have elucidated the many 
strategies that bacteria employ to modulate initiation of transcription. These include the 
regulation of chromatin structure (Browning et al., 2010), use of small ligands, such as ppGpp 
(Srivatsan and Wang, 2008), the exchange of particular σ factors, as described above, 
promoter DNA sequences and TFs (Browning and Busby, 2004). Whilst all these factors 
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contribute to the dynamics of gene expression, the latter two have been the subject of most 
interest and are the most relevant to my work.   
1.2.3.1 Promoter DNA sequences 
Studies on promoter recognition by RNAp holoenzyme have identified the promoter-specific 
sequence elements that orchestrate promoter recognition and transcription initiation (Busby 
and Ebright, 1994; deHaseth et al., 1998; Murakami et al., 2002). Aside from the σ
54
-
dependent promoters, which solely depend on the presence of specific enhancer binding 
proteins for transcription (Buck et al., 2000), all promoters share a conserved architecture 
with respect to two predominant features; the -10 and -35 hexamer elements, located 10 and 
35 base pairs (bps) upstream of the transcription start site, respectively (Browning and Busby, 
2004; Busby and Ebright, 1994). A canonical hexamer binding sequence has been defined for 
both of these regulatory elements (Fig. 1.1), yet the conservation of each base at each 
promoter differs, thereby permitting promoter differentiation whilst preventing tight, 
unfavourable RNAp-promoter interactions. Two other sequence elements that contribute to 
specific RNAp-promoter interactions are the UP element and the extended -10 motif. The UP 
element is usually an AT-rich, 20 bp sequence situated upstream of the -35 element and acts 
as a docking site for the α-CTDs of RNAp (Fig. 1.1) (Ross et al., 2001). The extended -10 
element is a 3-4 bp motif located immediately upstream of the -10 element and interacts with 
domain 3 of the RNAp σ subunit (Fig. 1.1) (Sanderson et al., 2003). All these promoter 
elements contribute to the specificity and variability of RNAp promoter binding. 
1.2.3.2 Transcription factors  
The distribution of RNAp at promoters is largely dependent on the activities of TFs, which 
fluctuate according to external signals or internal metabolic states (Ishihama, 2010). Precise 
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control of TF activities, in response to such signals, can be achieved in a variety of ways. For 
example, in the case of the well characterised TF, LacI repressor, the intracellular 
concentration of a small ligand (allolactose) alters in response to nutrient availability (lactose) 
and consequently reduces the DNA-binding affinity of LacI, such that the presence of lactose 
removes LacI-mediated repression, thereby promoting expression of structural genes required 
for lactose metabolism (Jacob and Monod, 1961; Wilson et al., 2007). Additionally, TF 
activity can be subject to control via covalent modifications, such as phosphorylation. 
Phosphorylation of TFs plays an important role in the efficacy of two component systems. 
Phosphorylation events link the sensing of extracellular stimuli, predominantly by membrane 
bound sensor-kinases, to a switch that governs the expression of a subset of genes, through 
phosphorylation of their associated TF (Casino et al., 2010).  
The E. coli genome contains approximately 300 TFs (Perez-Rueda and Collado-Vides, 2000), 
which function by binding DNA to activate or repress transcription. Some of these TFs bind 
and regulate hundreds of genes, whereas others are exclusive to just one or two promoters. In 
E. coli, seven TFs have been identified as „global‟ regulators, given that they contribute to the 
regulation of over 50% of all genes (Grainger and Busby, 2008). One aspect of my work 
studies the regulation of transcription initiation by two of these global regulators; the cyclic 
AMP receptor protein (CRP) and the factor for inversion stimulation (Fis), and these are 
discussed in detail below. It is important to note that the regulation of many pathogen-specific 
virulence determinants is controlled by dedicated TFs, which have been dubbed „Master 
virulence regulators‟. For example, in Enteroaggregative E. coli 042, the TF AggR is 
responsible for the up-regulation of key virulence factors, including fimbriae (Nataro et al., 
1994) and dispersin (Dudley et al., 2006; Sheikh et al., 2002). Another example is, VirF, the 
primary regulator of the large Shigella flexneri virulence plasmid and its activities are largely 
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responsible for its characteristic pathogenic attributes (Porter and Dorman, 2002). Global 
regulators are defined by the pleiotropic phenotype that results from their deletion, and as TFs 
that regulate a large number of functionally distinct operons (Gottesman, 1984). The seven E. 
coli global TFs identified are listed as CRP, FNR, IHF, Fis, ArcA, H-NS and Lrp (Martinez-
Antonio and Collado-Vides, 2003), however there are obvious ommisions from this list, such 
as HU that could be categorised as a „global‟ regulator. Three of these (IHF, Fis and H-NS) 
are „nucleoid associated proteins‟ (NAPs). Although NAPs function as classical TFs at some 
promoters, their main role is to alter chromosome structure, by bending, bridging or wrapping 
chromosomal DNA, (Browning et al., 2010; Dillon and Dorman, 2010).  
1.2.4 Cyclic AMP receptor protein 
The cyclic AMP receptor protein, which was originally identified as the TF essential for the 
activation of the E. coli lactose operon (Emmer et al., 1970; Zubay et al., 1970), can function 
either as an activator or repressor of transcription initiation. It functions as a homodimer that, 
when allosterically activated by the small ligand, cyclic adenosine 3',5'-monophosphate 
(cAMP), binds to specific DNA sequences (Won et al., 2009). DNA targets for CRP contain a 
16 bp sequence, consisting of two 8 bp elements organised as an inverted repeat that are each 
recognised by one of the two CRP monomers (Ebright et al., 1989). Each monomer in the 
homodimeric complex contains two functional domains connected by a flexible hinge. The 
smaller C-terminal domain binds to DNA via participation of a helix-turn-helix motif, whilst 
the larger N-terminal domain is responsible for cAMP binding and also serves as the 
dimerisation interface (McKay and Steitz, 1981; Weber and Steitz, 1987).  
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1.2.4.1 CRP-dependent activation  
At promoters where CRP activates transcription, it is well established that two surface-
exposed determinants, activating region 1 (AR1) and activating region 2 (AR2), mediate 
interaction with the αCTD and the αNTD of RNAp, respectively (Rhodius et al., 1997). The 
involvement of these activating regions largely depends on the location of the CRP binding 
site. There are two major classes of CRP-dependent promoters, known as Class I and Class II 
(Fig. 1.2). Class I CRP-dependent promoters carry a single CRP binding site positioned at 
various locations (positions -61.5, -71.5, -82.5 and -92.5) upstream of the -35 element, and 
CRP interacts with the αCTD of RNAp via AR1 (Fig. 1.2, A). For activation at these 
promoters CRP and RNAp must bind on the same side of the DNA helix (Gaston et al., 
1990). At class II CRP-dependent promoters, the DNA site for CRP binding overlaps the -35 
promoter element and is usually centred at position -41.5. At these promoters, both AR1 and 
AR2 of CRP interact with the αCTD and αNTD of RNAp, respectively (Fig. 1.2, B) (Rhodius 
et al., 1997).  
1.2.4.2 CRP in virulence 
CRP was originally identified as an activator of catabolite sensitive genes, in response to 
glucose starvation (Zubay et al., 1970), hence its alias as catabolite activator protein (CAP). 
However, it is now apparent that CRP regulates a diverse range of genes including virulence 
determinants in many Gram-negative pathogens such as M. tuberculosis, Yersinia pestis, 
Pseudomonas aeruginosa and enterotoxigenic E. coli (Espert et al., 2011; Fuchs et al., 2010; 
Stapleton et al., 2010; Zhan et al., 2008). As exemplified in the study of Y. pestis, a null 
deletion of the crp gene can lead to an overall attenuation in virulence (Zhan et al., 2008) or it 



















































Figure 1.2. Interactions at Class I and Class II CRP-dependent promoters. A. This 
figure illustrates the organisation of RNA polymerase and CRP at Class I activated 
promoters. In this situation, CRP binds to a site upstream of the core promoter and 
binds one α-CTD of RNA polymerase, via Activating region 1 (AR1), mediating its 
recruitment to the promoter. B. This figure illustrates the organisation of RNA 
polymerase and CRP at class II activated promoters. Here, CRP binds to a site that 
overlaps the -35 hexamer element which facilitates many CRP interactions with RNA 
polymerase; AR1 binds one of the α-CTDs, Activating region 2 (AR2) interacts with 
one of the α-NTDs. AR3 is a non-native region that binds to σ domain 4 (Bell et al., 
1990; Rhodius and Busby, 2000). Red asteriks represent the site of protein-protein 
interactions. All the above interactions mediate recruitment of RNA polymerase to the 
promoter. Figure adapted from (Busby and Ebright, 1999). 
: Class I 







such as the Type 1 Fimbriae of uropathogenic E. coli (Muller et al., 2009), which is 
essentially tailored to the expression pattern of CRP late in E. coli growth.   
1.2.5 Nucleoid associated proteins  
The compaction of DNA into confined subcellular compartments is seen in cells of all 
kingdoms of life (Luijsterburg et al., 2008). In eukaryotes, the well characterised histone 
proteins are responsible for forming higher order chromosome structures referred to as 
chromatin, which play a vital role in all DNA transactions, including transcription and 
replication (Li and Reinberg, 2011). In bacteria, investigations into functionally similar 
structures have revealed the presence of a diverse set of structurally unrelated proteins, named 
„nucleoid associated proteins‟ (NAPs) (Azam and Ishihama, 1999). Thus far, in E. coli 12 
NAPs have been identified (Dillon and Dorman, 2010), yet others are being found with 
further investigations (Teramoto et al., 2010). A common theme with all characterised NAPs 
is their ability to bind DNA, yet the subsequent compaction of DNA is mechanistically 
distinct. Using single-molecule techniques and high-resolution imaging of protein-DNA 
complexes, observations of H-NS mediated compaction shows the propensity of H-NS to 
„bridge‟ DNA (Dorman and Kane, 2009; Wiggins et al., 2009). In contrast, HU, a 
constitutively expressed NAP, exhibits dual activities by virtue of DNA bending and 
condensation (van Noort et al., 2004). Most relevant to my work is the expression and 
activities of the NAP, Fis (Fig. 1.3). Fis is the most promiscuous NAP in E. coli, given that it 
has the capacity to affect gene expression by at least six different mechanisms (Browning et 
























Figure 1.3. Fis-DNA interactions. This figure shows the residues important for 
mediating contact between an activation patch on Fis and the α-CTD of RNA 
polymerase. The residues highlighted in green are those that have been 
identified, through mutagenesis studies, to contact RNA polymerase and activate 
transcription at two independently tested promoters (rrnB1 and proP2) (Bokal et 
al., 1997; McLeod et al., 2002). The locations of these residues are physically 
and functionally distinct from the region of Fis necessary for its regulation of 
site-specific DNA inversion, labelled in the figure as „DNA inversion‟. The A-D 
helices, present in each monomer, are labelled in the figure as αA-αD. Figure 




1.2.6 Factor for inversion stimulation (Fis) 
Fis was originally discovered as an E. coli protein essential for the action of a bacteriophage-
encoded site specific recombinase and as a co-factor in flagellar phase variation in Salmonella 
(Johnson et al., 1986; Koch and Kahmann, 1986). However, Fis is now known to play many 
important phage-independent functions by binding and bending DNA (Kostrewa et al., 1991), 
organising local topology (Travers et al., 2001) and acting as a TF by activating or repressing 
transcription initiation (McLeod et al., 2002). Similarly to CRP, Fis functions as a homodimer 
that binds to 15 bp target sequences (Fig. 1.3). Crystallography studies revealed an α-helical 
core, with each monomer comprising of 4 α helices (A-D) with the latter two helices (C and 
D) forming the DNA binding helix-turn-helix motif. However, in contrast to CRP, where the 
DNA recognition sequence is highly specific, the degenerate nature of the DNA recognition 
sequence for Fis may be due to an unusually high number of positively charged residues in 
the D helix of the helix-turn-helix motif (Kostrewa et al., 1991). Recent crystallography 
studies revealed that Fis recognises DNA targets primarily through indirect mechanisms 
involving the shape of the minor groove, whilst interactions with the adjacent major groove is 
sequence-dependent (Stella et al., 2010). Additionally, specific residues (Q68, R71, G72 and 
Q74) have been identified in a surface-exposed loop adjacent to the helix-turn-helix motif of 
Fis that constitute an activation patch responsible for direct interactions with the α-CTD of 
RNA polymerase (Fig. 1.3) (Bokal et al., 1997). The activity of Fis is controlled by its 
concentration within the cell, and its growth-phase dependent regulation restricts its 
expression to the logarithmic phase of growth (Mallik et al., 2006), consistent with the 
observation that Fis governs control of rRNA promoters, essential for ribosome synthesis 
during rapid cell growth (Nilsson et al., 1990). Furthermore, fis is part of a bicistronic dusB-
fis operon, where both fis and the preceding gene, dusB, which encodes a tRNA 
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dihydrouridine synthase, are controlled by the integration of IHF, CRP and Fis activites at 
their promoter region (Nasser et al., 2002).  
1.2.6.1 Fis in virulence  
Similarly to CRP, the biological role of Fis in virulence has taken precedence over its initially 
established role as a factor that regulates the activity of a bacteriophage specific recombinase. 
Many studies have highlighted a role for Fis in the virulence of bacterial pathogens, however 
it is largely renowned for its prominent role in the pathogenesis of Salmonella enterica 
serovar Typhimurium (S. Typhimurium). Fis exerts its effects through the control of one of 
the major virulence loci, named Salmonella pathogenicity island 2 (SPI-2) (Fass and 
Groisman, 2009; Ó Cróinín et al., 2006). Fis mediates direct activation of the SPI-2 ssrAB 
encoded two-component system, which is responsible for regulating the SPI-2 encoded type 
III secretion system that delivers effector proteins directly into host cells (Fass and Groisman, 
2009).  
1.2.7 Models of transcriptional activation and repression 
TFs predominantly function as either activators or repressors of transcription, although at 
some target promoters, TFs can display both activities. Activators use various mechanisms to 
promote transcription and three functionally distinct classes have been described. In class I 
activation, activators bind upstream of the transcript start site and typically function by 
making direct protein-protein interactions with the α-CTD of RNAp, mediating recruitment of 
RNAp to the promoter (Fig. 1.4, A). In class II activation, activators bind to the promoter 
region adjacent to, or overlapping, the -35 element and make direct contact with domain 4 of 
σ
70
, again mediating recruitment of RNAp to the targeted promoter (Fig. 1.4, B) (Browning 









































C Class III activation
Figure 1.4. Models of transcriptional activation. This figure illustrates the organisation of 
RNA polymerase and activators at promoters that are activated in a class I, II and III fashion. 
In this diagram, activators are represented in green as dimeric proteins. RNA polymerase sub-
units are shown in blue. A. Class I activation; activator is bound upstream of the transcript 
start site and typically function by making direct protein-protein interactions with the α-CTD 
of RNAp, mediating recruitment of RNAp to the promoter. B. Class II activation; activators 
bind to the promoter region adjacent to the -35 element and make direct contact with domain 
4 of σ
70
, again mediating recruitment of RNAp to the target promoter. C. Class III activation; 
a combination of activators are involved, making both class I and class II interactions to 












































Figure 1.5. Models of transcriptional repression. This figure illustrates the typical mechanisms used to 
repress transcription at target promoters. A. Repression by steric hindrance; the repressor binds to a site that 
occludes the core promoter elements from RNA polymerase, thereby abrogating RNA polymerase binding. 
B. DNA looping; repressors bind to sites separate from the promoter and act by looping the DNA and 
blocking access of RNA polymerase to the promoter. C. Repression by blocking the activities of an activator; 
the repressor binds directly to an activator, thereby disrupting interactions with RNA polymerase such that 




class I and class II interactions to achieve full activation (Fig. 1.4, C) (Beatty et al., 2003). 
Other activators function by causing a conformational change of the DNA topology around 
the promoter, such that the -10 and -35 elements are more accessible to RNAp (Brown et al., 
2003).  
Repression, in the simplest form, occurs when a repressor is bound at or near the promoter 
such that RNAp is unable to bind to the target DNA (Fig. 1.5, A) (Wilson et al., 2007). More 
complex mechanisms exist whereby repressors cause looping of the DNA, thereby abrogating 
the ability of RNAp to initiate transcription (Fig. 1.5, B) (Choy and Adhya, 1992). Repressors 
have also been observed to act as „anti-activators‟, whereby interaction with a bound activator 
disrupts its activity, leading to an indirect repression (Fig. 1.5, C) (Shin et al., 2001). 
1.2.8 Co-dependence at promoters 
For bacterial pathogenesis, integration of a multitude of signals, specific to various niches 
within their infected host, is crucial to co-ordinating an appropriate gene expression response. 
In the case of S. Typhimurium infection, passage through the acidic stomach, survival of bile, 
attachment to intestinal lining, subsequent invasion into mammalian cells and evasion of the 
immune system all require differential expression of a wide array of virulence genes (Lucas 
and Lee, 2000). Intriguingly, S. Typhimurium crp mutants have proven to be effective in the 
preparation of a live oral vaccine (Curtiss et al., 1988). Thus, in contrast to the simple models 
of activation and repression outlined in section 1.2.7, the complexity of bacterial pathogenesis 
is reflected in the organization of TFs at certain promoters, where co-dependence on two or 
more TFs is often required for transcription initiation. The mechanistic details of co-
dependence can vary greatly between promoters (Barnard et al., 2004). TFs can often make 
independent contacts with RNAp and result in the dependence of two bound activators for full 
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activation of the promoter (McLeod et al., 2002). Co-dependence is occasionally observed in 
the initial binding of TFs to the promoter. For example, in Vibrio cholerae, co-operative 
binding is seen with the TFs AphA and AphB at the tcpPH promoter, which regulates the 
cholera toxin and toxin-co-regulated pilus (Kovacikova and Skorupski, 2001). Additionally, 
the integration of multiple transcription factors is required in scenarios whereby „anti-
repression‟ is used as a mechanism for activation at a given promoter. This occurs when a 
secondary activator inhibits the activities of a repressor, thereby allowing the primary 
activator to function (Browning and Busby, 2004).   
1.2.9 Post-transcriptional control of gene expression in E. coli 
Although transcription initiation is the favoured mode of regulation, it is important to note 
that many post-transcriptional regulatory processes have been observed in prokaryotes. These 
include small RNA (sRNA) mediated regulation of mRNA, mRNA secondary structure, 
mRNA decay, ribosome synthesis and activity, modulation of translation efficiency, protein 
stability and the recently characterised importance of mRNA leader sequences (Caron et al., 
2010; Park et al., 2010; Picard et al., 2009; Raghavan et al., 2011). Although all these 
processes play a vital role in the genetic output of the cell, the huge pleiotropic effects 
observed in an RNA chaperone (Hfq) mutant is a good example of the prolific post-
transcriptional regulation that is essential for the virulence of many pathogens, including V. 
cholerae, Listeria monocytogenes, P. aeruginosa and S. Typhimurium (Christiansen et al., 
2004; Ding et al., 2004; Sonnleitner et al., 2003).  
Once transcription has been activated and the barriers to post-transcriptional regulation have 
been overcome, the mRNA is translated and protein synthesis occurs. Inherent to all virulence 
effector proteins is the necessity to reach their surface-exposed or extracellular target. In the 
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case of Gram-negative pathogens, virulence factors must traverse both layers of the cell 
envelope. The ways in which virulence factors undergo such directive processes to overcome 
this additional obstacle are discussed below.  
1.3 Gram-negative cell envelope 
1.3.1 Inner membrane composition 
In contrast to Gram-positive bacteria, where a thick peptidoglycan layer coats a single plasma 
membrane, Gram-negative bacteria are enclosed by two physically distinct lipid bilayers; with 
an intervening peptidoglycan-containing periplasmic space. They are termed the inner and 
outer membrane (OM) and are characterised by distinctly different protein and lipid 
compositions (Fig. 1.6) (Silhavy et al., 2010). The inner membrane (IM) is a phospholipid 
bilayer, primarily consisting of phosphatidyl ethanolamine, phosphatidyl glycerol and 
cardiolipin with the protein composition being mainly α-helical in structure (Raetz and 
Dowhan, 1990; Silhavy et al., 2010). In comparison to the OM, the IM is structurally less 
complex, but, even so, it has remarkably diverse functions. It is also the site for the synthesis 
and assembly of structural wall components including lipopolysaccahrides (LPS), 
phospholipids and the basic chemical units of peptidoglycan (Costerton et al., 1974). The IM 
poses the first barrier to protein secretion. Two systems that permit translocation of proteins 
across the IM have been described. These are named the Sec and the Tat systems and are 
responsible for the translocation of unfolded and folded species, respectively (Cristobal et al., 
1999).   
1.3.2 The periplasm 
















Figure 1.6. Gram-negative cell envelope. Depicted in this figure is the organisation of 
the main components of the Gram-negative cell envelope; OMP, outer membrane 





a structural role providing the bacterium with its shape and rigidity (Fig. 1.6) (Silhavy et al., 
2010). The peptidoglycan is a complex structure which remains relatively invariant across 
most bacteria. The anchoring of the most abundant protein in E. coli, Lpp (or Braun 
lipoprotein), to peptidoglycan acts as the foundations for attachment of the OM (Braun, 
1975). The surrounding periplasmic space is an extremely viscous sub-cellular compartment, 
found to contain functionally diverse proteins (Mullineaux et al., 2006). One group of 
proteins exhibit protective functions, acting to modify toxic compounds such as heavy metals 
or antibiotics, for example, the degradation of β-lactam antibiotics by β-lactamase. Another 
group of periplasmic proteins comprise substrate binding proteins that are indispensable to 
two fundamental processes; chaperoning and folding (Kadokura and Beckwith, 2010; Sklar et 
al., 2007b). The latter of these processes has now been well characterised and is found to be 
under the control of the „Disulphide bond forming‟ proteins, DsbA-DsbD and DsbG. These 
proteins form a network of both periplasmically and IM located enzymes that catalyse the 
formation of disulphide bonds. DsbA is the primary oxidant of periplasmically located 
proteins and catalyses the formation of disulphide bonds between cysteine residues by virtue 
of donating its own disulphide bond to its substrate. DsbB-D and DsbG act in concert to 
stabilise the redox potential necessary to ensure optimal processivity of substrates (Kadokura 
and Beckwith, 2010).  
In Gram-negative bacteria, export of proteins outside the bacterial cell can be achieved using 
molecular architecture that spans their inherent double membrane, thus averting exposure of 
their secreted substrates to the periplasm (Henderson et al., 2004). However, many virulence 
determinants need to passage through the periplasm in order to reach their extracellular or 
membrane bound target. The chaperones that enable transit of proteins across the periplasm 
constitute three distinct groups; those that catalyse the formation of disulphide bonds, as 
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described above, peptidyl-prolyl cis/trans isomerases (PPIases) and those that display general 
chaperone activities (Sklar et al., 2007b). The latter group are periplasmic proteins that play a 
major role in the delivery of outer membrane proteins (OMPs) to the OM. Three main 
chaperones have been described for this purpose; DegP, Skp and SurA. Unique to DegP, is 
the ability to exhibit both protease and chaperone activities in a temperature-dependent 
manner (Spiess et al., 1999). Given that DegP chaperone activity is more efficient at lower 
temperatures, higher temperatures govern the switch to protease activity, which subsequently 
degrades misfolded protein species (Spiess et al., 1999). Skp was characterised as a chaperone 
with substrate specificity restricted to OMPs (Chen and Henning, 1996), whereby a skp null 
mutant has decreased levels of the OMPs LamB, OmpA, OmpC, and OmpF (Chen and 
Henning, 1996). SurA encompasses two of the periplasmic chaperone groups given that it 
displays both peptidyl-prolyl cis/trans isomerase activity and general chaperone activity 
(Behrens et al., 2001). Given its broad activities, a surA null mutant exhibits the most 
dramatic phenotype, with a compromised OM structure due to the absence of many OMPs 
(Rouviere and Gross, 1996). These three periplasmic proteins constitute the major chaperones 
involved in maintaining OM integrity. One particular study proposed that they form two 
parallel pathways with functional redundancy (Rizzitello et al., 2001). A subsequent study 
investigated this redundancy demonstrating that SurA forms the primary pathway responsible 
for the delivery of most OMPs to the OM, whereas DegP and Skp together form a parallel 
pathway that only plays a minor role in OMP delivery by rescuing proteins that have fallen 
off the SurA pathway (Sklar et al., 2007b).  
1.3.3 Outer membrane composition 
The OM, being the terminal layer of the Gram-negative cell envelope, possesses a more 
diverse range of components than its IM counterpart (Fig. 1.6). The more abundant 
24 
 
components of the OM include phospholipids, LPS, OMPs and lipoproteins (Silhavy et al., 
2010). Lipoproteins are involved in a wide range of cellular functions, from substrate 
transport to antibiotic resistance. More than 90 species of lipoproteins are found in E. coli, 
most of which are membrane attached via an N-terminal N-acyl-diacylglycerylcysteine and 
with only a few exceptions, such as SphB1 where the functional domain is surface localised, 
are orientated facing the periplasm (Bos and Tommassen, 2004). Localization of lipoproteins 
to the OM has been found to require a lipoprotein-specific sorting machinery, the Lol system, 
which is composed of five proteins, LolABCDE (Fig. 1.7). LolCDE is responsible for 
detachment of the lipoproteins from the IM allowing the association of the lipoprotein with 
the periplasmic chaperone LolA, which delivers the lipoprotein to LolB, the dedicated 
receptor in the OM (Narita and Tokuda, 2006). LPS is made up of a three-part architecture 
and is essential for most Gram-negative bacteria. This common structure protrudes from the 
bacterial cell surface consisting of a distal O-antigen, linked to an oligosaccharide core 
structure, which is then anchored to the membrane by lipid A. LPS is responsible for causing 
characteristic endotoxic shock associated with the septicaemia caused by Gram-negative 
bacteria (Raetz and Whitfield, 2002). Analogous to the Lol system for lipoprotein sorting, 
delivery of LPS to the OM involves a similar network of IM, periplasmic and OMPs named 
LptA-F (Fig. 1.7). After synthesis of LPS in the inner leaflet of the IM followed by flipping of 
LPS to the outer leaflet of the IM by the ABC transporter, MsbA, LptA-F work in a similar 
mode to Lol, to deliver LPS to the OM. LptB, C, F and G form the IM and cytosolic bound 
proteins to detach LPS from the IM and deliver it to the periplasmic chaperone LptA. LptA 
then docks with the OM assembly site comprising of LptD and E (Ruiz et al., 2008). 
OMPs are largely transported across the IM via the Sec system. Once they reach the 

































Figure 1.7. Outer membrane biogenesis. This figure illustrates the cellular machineries necessary for 
the biogenesis of the major OM constituents; LPS, OMPs and Lipoprotein. LPS is transported from its 
site of synthesis in the cytoplasm to the outer membrane by the Lpt pathway. OMPs and Lipoproteins 
are all synthesised with an N-terminal signal sequence that directs transport across the inner membrane 
via the Sec apparatus. OMPs are then chaperoned to the OM via the major periplasmic chaperones 
(SurA, DegP and Skp) where they dock with the BAM complex for insertion into the OM in their 
native β-barrel structure. After transport across the IM and cleavage of their signal sequence, 
lipoproteins are transported to the inner leaflet of the OM via the Lol system. Note that the mechanism 
used for incorporation of phospholipids into the outer membrane remains uncharacterised. Figure 
adapted from (Silhavy et al., 2010).   
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insertion into the OM as a folded species. Studies of folded OMPs have identified structural 
conservation, thus the majority of OMPs possess an even number of antiparallel β-strands 
which assume a cylindrical β-barrel conformation (Wimley, 2003). These embedded proteins 
serve many functions vital to the bacterial cell, including signal transduction and solute and 
protein translocation (Koebnik et al., 2000). The insertion and/or folding of all β-barrel OMPs 
studied thus far is found to be dependent on the recently described β-barrel Assembly 
Machinery (BAM) complex (Doerrler and Raetz, 2005; Werner and Misra, 2005; Wu et al., 
2005) (Fig. 1.7). Initially identified as Omp85 from N. meningitidis (Voulhoux et al., 2003), 
BamA was thought to play a role in LPS biogenesis and phospholipid incorporation into the 
OM (Genevrois et al., 2003). However, it is now widely accepted that BamA has a pivotal 
role in OMP assembly and that its effects on phospholipid incorporation and LPS biogenesis 
is indirect. BamA is part of a super-family of proteins that include transporters found in the 
membranes of chloroplasts and mitochondria and in all Gram-negative bacteria (Paschen et 
al., 2003). BamA is comprised of two distinct structures; a C-terminal β-barrel that assumes a 
cylindrical pore in the OM with a diameter of approximately 2.5 nm (Robert et al., 2006) and 
a set of five POTRA domains that are anchored to the β-barrel and protrude into the periplasm 
(Sanchez-Pulido et al., 2003). High resolution structural studies have revealed unique folds 
and interactions of the POTRA domains from E. coli, demonstrating intervening flexible 
linkers which could generate a large amount of conformational freedom between the domains; 
thus conferring the ability to bind and create folding intermediates with the associated OMP 
substrates (Kim et al., 2007; Knowles et al., 2008). BamA is the central component of the 
BAM complex. BAM has now been well characterised as a hetero-oligomeric complex 
composed of five proteins; the integral β-barrel membrane protein, BamA, and four OM-
associated lipoproteins, BamB-E (Fig. 1.7) (Knowles et al., 2009). A functional role for 
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BamB-E in OMP assembly has been confirmed given that deletion of any one of these 
lipoproteins leads to reduced OMP profiles and cell death (Malinverni et al., 2006; Wu et al., 
2005). Furthermore, based on co-purification, binding and mutagenesis studies it has been 
demonstrated that BamC, D and E interact with BamA via its POTRA domain 5, whilst 
BamB interacts directly with BamA, independent of any other BAM components (Malinverni 
et al., 2006; Sklar et al., 2007a; Vuong et al., 2008). Although these lipoprotein components 
are crucial to the functional integrity of the complex (Charlson et al., 2006; Knowles et al., 
2011) (Sklar et al., 2007a) only BamA and BamD are universally essential for both bacterial 
cell viability and OMP biogenesis (Malinverni et al., 2006).  
1.4 Protein translocation across the cell envelope 
1.4.1 Inner membrane translocation 
Roughly 25-30% of bacterial proteins serve structural and functional roles in the cell 
envelope, or outside the bacterial cell (Driessen and Nouwen, 2008). Bacteria have therefore 
evolved dedicated systems for the efficient transport and/or insertion of proteins across or into 
the appropriate cell membrane. Extensive studies in this area have elucidated the presence of a 
protein translocation pathway, common to both Gram-positive and Gram-negative bacteria 
that mediate translocation of newly synthesised proteins, across the cytoplasmic membrane 
before they acquire their final folded structure (Breyton et al., 2002; Wickner et al., 1991). 
This system has been named the Sec pathway, where proteins destined for translocation 
across the cytoplasmic or IM converge on the Sec translocase. The Sec translocase comprises 
a range of functionally diverse proteins; the Sec translocon consists of the integral membrane 
proteins, SecY, SecE and SecG, which forms a multimeric membrane bound complex, 
creating a channel for the passage of polypeptides (Fig. 1.7) (Breyton et al., 2002). Complete 
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with the peripheral subunit, SecA, the Sec translocase machinery is responsible for driving the 
transport of proteins across the IM (de Gier and Luirink, 2001). Many essential membrane 
events, including IM translocation, are coupled with ATP hydrolysis to generate the energy 
required to drive these processes. Thus, these processes are all contingent on the proton 
motive force to drive ATP synthesis via the membrane-bound ATP synthase (Weber, 1991). 
Additional factors interact to form a sub-complex named SecDFYajC. This sub-complex has 
been suggested to play a diverse role in IM translocation with roles ranging from SecA 
functioning, release of translocated proteins and maintenance of the proton motive force 
across the membrane (de Gier and Luirink, 2001). Although most proteins do converge at the 
Sec translocase, the mode of targeting to this pathway differs. The SecB chaperone is 
involved in the targeting of proteins post translationally, where SecB binds the protein after it 
is released from the ribosome, keeping it in an unfolded state before delivering it to the 
SecYEG translocon (Valent et al., 1998).  In contrast, the signal recognition particle (SRP) 
pathway is employed for co-translational targeting of IM proteins (Froderberg et al., 2004). 
The SRP is composed of the Ffh protein and 4.5S RNA. It acts by binding the first 
transmembrane segment of the protein upon exposure from the ribosome. The binding of SRP 
with its IM receptor, FtsY, stimulates the dissociation of the protein from the SRP, such that 
the protein is translocated across the IM as it emerges from the ribosome (Froderberg et al., 
2004). Both targeting mechanisms depend on the presence of a signal sequence at the N-
terminus of the secreted proteins. Although variations in both sequence and length of these 
signal sequences have been observed, attributable functions, additional to targeting, remain  
contentious (Leyton et al., 2010; Szabady et al., 2005).  
An additional pathway for IM translocation was later discovered that, in contrast to the Sec 
translocon, governs the translocation of fully folded proteins (Santini et al., 1998). Proteins 
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exported by this Tat (twin-arginine transport) pathway are synthesised as precursors with N-
terminal signal peptides bearing conserved SRRXFLK twin-arginine motifs within their 
amino acid sequence (Cristobal et al., 1999). All precursors exhibiting this sequence are 
ultimately transported across the IM by the twin-arginine translocation apparatus (Sargent, 
2007).  
1.4.2 Outer membrane translocation  
The OM, along with the periplasm and IM, constitutes the Gram-negative bacterial cell 
envelope. Although their unifying structure lends protection to the contents of the cell, it also 
leaves the bacterium with a formidable obstacle for proteins that are destined for the external 
milieu. Therefore, bacteria have evolved many different secretion systems (Type 1–Type 6) 
for the translocation of proteins to the cell surface and extracellular space (Fig. 1.8), which 
can be categorised into systems that contain their own dedicated machinery for IM 
translocation or those that are dependent on the Sec apparatus.  
1.5 Secretion pathways of Gram-negative bacteria  
1.5.1 Sec-independent translocation 
1.5.1.1 Type 1 secretion 
Proteins targeted to the type 1 secretion system (T1SS) secretion system can be assigned to a 
range of distinct families; proteases, lipases, haemophores, S-layer proteins and repeats in 
toxin proteins (RTX). The latter of these families contains haemolysin A (HlyA), which best 
exemplifies the model of the Type 1 secretion system (TISS) (Gentschev et al., 2002). 
Secreted by uropathogenic E. coli (UPEC), HlyA is a virulence-associated protein owing to 

































Figure 1.8. Type 1, 2, 3, 4 and 6 Secretion systems of Gram-negative bacteria. This figure illustrates a 
simplified view of the molecular structures found in the protein secretion systems of Gram-negative 
bacteria. Depicted from left to right, the Type 1 secretion system is exemplified by the secretion of HlyA 
from E. coli. The Type 2 secretion system is exemplified by the secretion of pullulanase from K. oxytoca. 
The Type 3 secretion system is represented by the secretion of Yop proteins, by Y. pestis and the Type 4 
secretion system is exemplified by the VirB system in A. tumefaciens. Both the Type 3 and Type 4 
secretion systems have the ability to inject their associated effectors directly into the host cytoplasm and 
unique to the type IV system is the ability to traffic DNA directly into target host cells (Hayes et al., 2010). 
Little is known about the organisation, function and mechanism of the recently described Type 6 secretion 
system. However, the conserved T6SS proteins Hcp, Vgr and ClpV are found in many pathogenic bacteria 
and are thought to assemble as shown in the diagram to inject effectors directly into neighbouring bacteria 
(Hood et al., 2010; Kanamaru, 2009). Effector proteins delivered through the Type 6 machinery are yet to 
be fully characterised. CY; cytoplasm, IM; inner membrane, PE; periplasm, OM; outer membrane; PM; 
host cell plasma membrane. Figure adapted from (Filloux et al., 2008; Henderson et al., 2004).  
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granulocytes, monocytes and endothelial cells (Gentschev et al., 2002).  
The T1SS secretes HlyA, and similar proteins, in a Sec-independent manner, in the absence of 
any periplasmic intermediates. This is achieved by integration of an IM ATP binding cassette 
(ABC), a membrane fusion protein (MFP) and a pore-forming OMP. In the case of HlyA, 
these are represented as HlyB, HlyD and TolC (Tolerance to colicins) respectively. HlyA 
binds to the cytoplasmic side of the HlyB-D complex by virtue of its C-terminal secretion 
signal. This interaction stimulates the extension of HlyD to associate with the trimeric TolC 
located in the OM, which initiates a conformational change in TolC permitting the formation 
of a trans-periplasmic export channel (Koronakis et al., 2000). This channel then permits 
secretion of HlyA to the external milieu, therefore eliminating the necessity for any distinct 
periplasmic intermediates.  
1.5.1.2 Type 3 Secretion  
The Type 3 secretion system (T3SS) was first discovered to play a pivotal role in the secretion 
of Yersinia outer proteins (Yops) from Yersinia spp. (Michiels et al., 1990). Since its initial 
discovery, the T3SS machinery has been shown to be crucial for the pathogenesis of many 
bacterial species including E. coli, S. Typhimurium and S. flexneri (Cheng and Schneewind, 
2000). The T3SS is defined by the prototypical example of Yersinia spp. where the T3SS 
depends on the transcription of 24 genes. Eleven of these are conserved genes and encode 
proteins that span the double membrane envelope of Gram-negative bacteria forming a 
protein conducting channel that enables protein secretion in one step. At the base of this 
protein conducting channel is an ATPase, which is oriented towards the bacterial cytoplasm 
and is extremely similar to the flagellar ATPase, FliI (Imada et al., 2007). This machinery, the 
secretion substrates (yop genes) and the chaperones (syc genes) are encoded on a 70-kb 
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virulence plasmid. Contact with the host cells, for example macrophages, triggers Yersinia 
spp. to activate their T3SS and inject the Yop proteins directly into the host cell, hence, for 
this system, the term „contact dependent‟ was coined (Cheng and Schneewind, 2000). 
Similar to the T1SS, translocation of effector molecules via the T3SS navigates proteins 
across the IM in a Sec-independent fashion. Furthermore, these effector proteins are devoid of 
a recognisable signal sequence, as such the targeting mechanism by which proteins are 
directed to the T3SS still remains elusive but is thought to involve the first 20 amino acids 
(Mattei et al., 2011). As a recurring theme with substrates exported via secretion systems, the 
functions of Type 3 virulence effectors differ remarkably within and between microorganisms 
and include cytotoxins, tyrosine phosphatases and kinases (Hueck, 1998; Pallen et al., 2003). 
1.5.1.3 Type 6 secretion 
A relatively recently described secretion system is the Type 6 secretion system (T6SS) that, 
like others, constitute many proteins that assemble to form a transenvelope delivery apparatus. 
Interestingly, T6SS associated structures bear resemblance to bacteriophage structures such as 
the tail and syringe and, on this basis, the Type 6 assembled machinery is now thought of as 
an upside down bacteriophage (Kanamaru, 2009; Leiman et al., 2009). Thus far, the T6SS is 
thought to secrete two types of proteins; namely the Hcp and VgrG proteins. Hcp is a small 
protein thought to hexamerise, forming nanotubes that allow the delivery of other T6SS 
associated substrates (Ballister et al., 2008). A role for the VgrG proteins remains elusive, 
however VgrG proteins are thought to trimerise and puncture holes into bound membranes 
and allow passage of further T6SS substrates. Structural insights into the Hcp and VgrG 
proteins reveal similarities to bacteriophage tube and tail spike proteins, respectively (Leiman 
et al., 2009). Although there is still a paucity of information regarding the substrates and 
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targets of the T6SS, many investigations have suggested that opposed to simply delivering 
effector proteins, the T6SS may be involved in divergent processes such as biofilm formation, 
sensing the environment or responding to stress (Bernard et al., 2010). The most intriguing 
notion came from a recent study of P. aeruginosa, with the proposition that the T6SS is 
involved in the secretion of a bacterial toxin that kills neighbouring bacteria through targeting 
and hydrolysing peptidoglycan (Hood et al., 2010; Russell et al., 2011).  
1.5.1.4 Type 4 secretion system  
The first Type 4 secretion system (T4SS) identified was the VirB system of Agrobacterium 
tumefaciens. A. tumefaciens is a plant pathogen that causes crown gall disease in 
dicotyledonous plants (Escobar and Dandekar, 2003). The VirB T4SS translocation 
machinery consists of at least 12 different Vir proteins, some of which code for ATPases 
(VirB4, VirB11 and VirD4) and some of which code for proteins that form core complexes in 
the periplasm and/or membrane (VirB6, VirB7, VirB8, VirB9, and VirB10). These Vir 
proteins work co-ordinately to deliver T-DNA (transfer DNA which has oncogenic potential) 
directly into plant cells. The proteins VirD2 and VirE2 contain plant-active nuclear 
localisation signals (NLS) that allows targeting to the nucleus and subsequent integration of 
T-DNA into the plant cells genome (Yeo and Waksman, 2004). 
Although the majority of effector molecules transported by the T4SS are targeted directly into 
the host cell, pertussis toxin is secreted into the external milieu. The pertussis toxin is a 
member of the AB5 toxins whose action upon G proteins leads to the attenuation of the 
immune system (Burns, 2003). Furthermore, pertussis toxin, unlike other T4SS effector 
proteins, is synthesised with a signal sequence causing it to be directed and translocated 
across the IM via the Sec apparatus in an unfolded state before interacting with the T4SS 
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(Farizo et al., 2000). However, the mechanism behind translocation across the OM remains 
obscure.  
1.5.2 Sec-dependent translocation 
1.5.2.1 Type 2 secretion  
The Type 2 secretion system (T2SS) was initially identified by the study of the secretion of 
the starch-hydrolyzing lipoprotein pullulanase, from Klebsiella oxytoca. The model of the 
T2SS follows two well defined steps. The initial step, involving translocation across the IM, 
is mediated by the previously described Sec apparatus. Upon exposure to the periplasm, the 
signal peptide is removed and consequently the mature protein is released into the periplasmic 
space, ready to be secreted across the OM. Secretion across the OM employs a highly specific 
multiprotein complex, consisting of 12 to 15 proteins, mostly transcribed in a single operon 
(Sandkvist, 2001a). In E. coli, these have been designated GspA to GspO (Desvaux et al., 
2004). The proteins transcribed from the operon generate the accessory proteins responsible 
for assembling the multi-protein complex, the secreton (Planet et al., 2001; Sauvonnet et al., 
2000). The proteins in this complex are assigned very specific roles. Protein C defines the 
substrate for export, Protein D has been suggested to oligomerise, forming the OM channel, 
and Protein E has been shown to act as the kinase promoting the assembly of the pilin-like 
subunits proteins G to K (Planet et al., 2001). In unison, the activities of both the Sec 
apparatus and the multi-protein complex ensure the efficient translocation of these 
extracellular proteins. Since its initial description, the T2SS has been assigned to the secretion 
of a diverse array of proteins from a number of pathogenic bacteria, including cholera toxin 
from V. cholerae and exotoxin A, elastase and phospholipase C from P. aeruginosa 
(Sandkvist, 2001b).  
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1.5.2.2 Type 5 secretion: The Autotransporter pathway 
In comparison to the complexity of the specialised secretion systems outlined above, the 
molecular machinery and mode of secretion that constitutes the autotransporter (AT) pathway 
is remarkably simple. Pohlner et al. (1987) were the first to describe the primary structure and 
functional moieties of an AT through studies on the IgA1 protease of Neisseria gonorrhoeae. 
The term „Autotransporter‟ was coined through their observations that the AT contained a 
three-part architecture that was sufficient to drive secretion of the functional extracellular 
moiety, without the participation of dedicated accessory factors. This three part architecture is 
comprised of an N-terminal signal sequence that directs IM translocation via the Sec 
translocon, a central passenger domain that represents the secreted virulence determinant and 
a C-terminal domain that inserts into the OM in a β-barrel conformation, which is essential for 
translocation of the passenger domain to the cell surface. Since this initial description, several 
ATs, all of which exhibit structures reminiscent of the IgA1 protease, have been identified 
and now constitute the largest family of secreted proteins in Gram-negative bacteria (Fig. 1.9) 
(Dautin and Bernstein, 2007). Furthermore, the AT pathway has been sub-divided into three 
categories; the classical AT pathway (type Va), the two-partner secretion system (TPS or type 
Vb) and the trimeric AT adhesion system (TAA or type Vc) (Fig. 1.9). The two-partner 
secretion system differs from the classical AT pathway in that the signal peptide and  
„passenger‟ effector domain (TpsA) are synthesised as a separate polypeptide to the C-
terminal β-barrel domain (TpsB). Additionally, its C-terminal β-barrel bears most 
resemblance to the BamA superfamily of OMPs rather than the β-barrels found in the 
classical ATs, given that in addition to forming a pore in the OM, contains two 
periplasmically located POTRA domains (Fig. 1.9). The Tps pathway FHA/FhaC 
(filamentous hemaglutinin/filamentous hemaglutinin transporter) from B. pertussis represents 
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Figure 1.9. The autotransporter pathway. This figure illustrates the sub-families of the AT pathway; 
classical AT pathway (Va) is shown on the left, the trimeric AT adhesion system (Vc) is shown in the 
centre and the two-partner secretion system (Vb) is shown on the right. In the simplest form, the 
tripartite domain organisation is shown on the bottom; the N-terminal signal sequence (green) mediates 
inner membrane translocation via the Sec machinery, the passenger domain (blue) represents the 
effector protein and the C-terminal domain (red) forms a β-barrel in the OM necessary for passenger 
domain translocation to the cell surface. Shown are the periplasmic chaperones tha aid AT transit 
across the periplasm and deliver ATs to the depicted BAM complex. Figure adapted from (Henderson 
et al., 2004).  
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the model Tps pathway where FhaC constitutes the transporter domain allowing FHA, the 
main adhesin of the pathogen, passage to the cell surface (Delattre et al., 2010). The TAA 
family of ATs differ from the classical situation in that biogenesis and function depends on 
trimerisation (Cotter et al., 2006). Furthermore, functions of the TAAs are largely limited to 
adhesive activity given that they remain anchored to their OM bound β-barrel.  
1.6 Autotransporter biogenesis 
Despite exhaustive research into the area of AT biogenesis, the mode of secretion at a 
molecular level has not been firmly established, with an increasing number of studies alluding 
to the necessity for accessory factors to facilitate protein secretion (Ruiz-Perez et al., 2009). 
The biogenesis of ATs, with respect to how their three part architecture governs their 
translocation across the double membrane, is discussed below, with particular reference to 
recent literature surrounding regulation and interaction with accessory proteins. 
1.6.1 Autotransporter gene regulation 
In contrast to the vast amount of functional studies, the regulation of AT expression has 
received very little attention. The first report in 1996 was a study on the phase-variable OMP 
of E. coli, Antigen 43 (Ag43) (Owen et al., 1996). Since this initial description, many studies 
have focussed attention on the regulation of Ag43, elucidating the nature of its phase-
variability. Ag43 switches between an „on‟ or „off‟ phase through competitive interactions of 
OxyR and Dam-mediated methylation at the agn43 promoter. In addition to the core -35 and -
10 promoter elements, the agn43 promoter contains three GATC motifs, directly downstream 
of the +1 transcription start site and an OxyR binding site that overlaps the -10 element 
(Wallecha et al., 2002). Binding of OxyR to its recognition site represses transcription of 
agn43 by blocking access of RNA polymerase to the core promoter. Dam-mediated 
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methylation of the adenine base within the GATC motifs, acts as an anti-repressor of 
transcription by abrogating OxyR binding and thus alleviating OxyR-dependent repression 
(Haagmans and van der Woude, 2000; Waldron et al., 2002). Furthermore, methylation of the 
GATC motifs, independent of OxyR, is necessary for full activation of agn43, in an as yet 
uncharacterized mechanism (Wallecha et al., 2002). It is this interplay between Dam 
methylation and OxyR binding that sets agn43 expression as „on‟ or „off‟, respectively. 
However, the molecular basis of switching between the „on‟ or „off‟ phase still remains 
unclear. The only other relatively well characterised regulation of an AT concerns IcsA 
regulation. In S. flexneri, IcsA, is an essential virulence factor and is subject to control via a 
novel mechanism involving the first documented regulatory RNA, RnaG, from S. flexneri‟s 
virulence plasmid (Giangrossi et al., 2010). IcsA and RnaG are co-transcribed to generate 
both the IcsA mRNA and the small RNA (sRNA), RnaG. Subsequently, RnaG acts as a direct 
repressor of icsA transcription, primarily by targeting the 5' end of icsA messenger RNA and 
causing transcription termination resulting in an aborted icsA transcript of 100 nt (Giangrossi 
et al., 2010). Although the expression of agn43 and icsA are relatively well understood, the 
regulation of ATs on a broader scale has received very little attention, with most studies being 
restricted to phenomenological aspects of AT gene expression i.e. the change in accumulation 
of protein in various cellular compartments in response to environmental stimuli. 
1.6.2 Inner membrane translocation 
After transcription and translation of genes encoding ATs, the next step is translocation across 
the IM. The energy-driven translocation of ATs across the IM into the periplasm is mediated 
by the N-terminal signal sequence. All ATs are synthesised with a Sec-dependent signal 
sequence that exhibit a tripartite organisation; a positively charged N-domain, a hydrophobic 
H-domain and a C-domain which serves as the recognition site for signal peptidase (Hegde 
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and Bernstein, 2006). A subset of ATs possesses an unusually long signal sequence, now 
termed the extended signal peptide region (ESPR). The ESPR comprises an additional region 
comprising a charged and hydrophobic domain such that the ESPR organisation consists of 
five regions; N1 charged domain, H1 hydrophobic domain, N2, H2 and C-domain, whereby 
the primary structure of the N2, H2 and C-domains are reminiscent of the classical signal 
sequence seen in all Sec-dependent proteins. In contrast to the classical signal sequence, 
which demonstrates significant sequence variability, the ESPR is largely conserved (Desvaux 
et al., 2007). Given the conservation of the ESPR, a cohort of studies investigated the notion 
that the ESPR imparts additional functions upon IM translocation. Initial studies, based on the 
supposition that signal peptides have the capacity to direct surface proteins to specific 
subcellular locations, were deemed erroneous given that polar localisation of specific ATs is 
independent of the ESPR (Charles et al., 2001). Other studies suggested the ESPR might alter 
the mechanism of targeting to the Sec translocon; although these studies were subsequently 
discounted (Chevalier et al., 2004). Although roles for the ESPR still remain contentious, 
recent investigations have led to the putative model that the ESPR slows the translocation of 
ATs across the IM to prevent accumulation of misfolded species in the periplasm (Desvaux et 
al., 2007; Jong and Luirink, 2008; Peterson et al., 2006).  
1.6.3 Periplasmic transit 
Upon exposure to the periplasm, the signal sequence is cleaved by signal peptidase, at the 
recognition sequence contained within its C-domain (Henderson et al., 2004). Controversy 
has surrounded how ATs, in a largely unfolded state, avoid degradation by periplasmic 
proteases and remain in a structurally competent state for outer membrane (OM) 
translocation. Developments in our understanding of AT biogenesis came through 




Figure 1.10. Classical AT structure. Depicted in this figure, from top to bottom; X-ray 
crystallography structures of all solved AT passenger domains, shown in green; Hbp: E. coli 
Hemoglobin protease (PDB entry 1WXR) (Otto et al., 2005), Prn: B. pertussis Pertactin (PDB entry 
1DAB) (Emsley et al., 1996), VacA: H. pylori vacuolating toxin p55 fragment (PDB entry 2QV3) 
(Gangwer et al., 2007), and IgaP: H. influenzae immunoglobulin A1 protease (PDB entry 3H09) 
(Johnson et al., 2009). α-helical plugs within the β-barrel pore are shown in red. X-ray 
crystallography structures of all solved AT β-domains are shown in light blue; E. coli EspP (PDB 
entry 2QOM) (Barnard et al., 2007), N. meningitidis NalP (PDB entry 1UYN) (Oomen et al., 
2004), P. aeruginosa EstA (PDB entry 3KVN) (van den Berg, 2010), E. coli Hbp (PDB entry 



















lacking the periplasmic chaperones SurA, Skp and DegP (Purdy et al., 2007). These 
observations raised the question of whether there was a direct protein-protein interaction of 
ATs with these chaperones. Through both in vivo and in vitro techniques, later studies were 
able to demonstrate direct binding of SurA, Skp and DegP with the ATs EspP and Hbp (Ieva 
and Bernstein, 2009; Ruiz-Perez et al., 2009; Sauri et al., 2009), with the assumption that 
these interactions extend to many other ATs. Although these interactions have been 
established, the exact property that they confer on the participating ATs remains enigmatic. 
1.6.4 Outer membrane translocation 
1.6.4.1 Autotransporter β-domain incorporation into the OM; structure and function 
Assisted by the aforementioned periplasmic chaperones, ATs are delivered to the OM and 
dock with the BAM complex. Thereafter, passenger domain translocation to the cell surface is 
dependent on the BamA component of the BAM complex. Recent crystallography studies 
have elucidated the β-domain structures of many ATs (Fig. 1.10) including NalP, EspP, BrkA, 
Hbp and EstA (Barnard et al., 2007; Oomen et al., 2004; Tajima et al., 2010; van den Berg, 
2010; Zhai et al., 2011). Despite the sequence variation of the β-domains, the structures reveal 
a largely uniform architecture, where each β-domain, comprises twelve strands with 
interconnecting extracellular loops and periplasmic turns, adopts a β-barrel conformation 
within the OM (Fig. 1.10). An additional conserved structural feature is the presence of an α-
helix within the barrel lumen. A multitude of studies including antibiotic sensitivity studies, 
molecular dynamics and electrophysiological experiments deduced that the role of the α-helix, 
together with certain extracellular loops of the β-barrel, functions in both plugging the pore, 
such that the permeability barrier of the OM is not compromised, and maintaining the width 
of the β-barrel pore (Clantin et al., 2007; De et al., 2008; Khalid and Sansom, 2006). As well 
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as highlighting important structural features of AT β-domains, structural and mutagenesis 
studies have provided insight into the function of the β-domain in the context of passenger 
domain translocation, dismissing the notion that the β-domain may act as a passive pore, with 
only subtle functional roles such as targeting to the OM. For example, mutagenesis of 
residues within strand 6 of both the BrkA and Tsh β-barrels significantly reduced passenger 
domain translocation to the cell surface illustrating the importance of a conserved 
hydrophobic cavity within the region of these β-barrels (Yen et al., 2010; Zhai et al., 2011). 
Consequently, this area of research is currently elucidating the precise molecular interactions 
that govern passenger domain translocation and establishing that the β-barrel does play an 
active part in this process.  
1.6.4.2 Passenger domain translocation across the OM 
After insertion and the correct assembly of the AT β-barrel in the OM, the passenger domain 
must traverse the OM to reach its extracellular target. Until recently, four models of passenger 
domain translocation across the OM have been discussed. These were the „threading‟, 
„hairpin‟, „oligomeric‟ and the „OMP 85‟ (now referred to as BamA) models. The „threading‟ 
and the „oligomeric‟ models have essentially been discounted by a large body of evidence and 
will not be discussed further. 
1.6.4.2.1 Hairpin model 
The classical hairpin model favours secretion of largely unfolded ATs through the lumen of 
the monomeric β-barrel. This model rationalises that the passenger domain is translocated in a 
C to N-terminal fashion, through the formation of a hairpin-like structure at the passenger 
domain to β-domain interface termed the Autochaperone (AC) domain. Experimentally, the 
engineering of disulphide bonds within the passenger domain has verified this model by 
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detection of a translocation intermediate whereby the C-terminal portion of the AT is 
susceptible to proteases/antibodies at the cell surface, whilst the N-terminal portion remains 
periplasmically orientated (Renn and Clark, 2011). The initial appearance of the extremely 
stable AC domain at the bacterial cell surface serves a functional role by driving the folding 
of the subsequent β-helical passenger domain, prior to its release (Junker et al., 2009; Soprova 
et al., 2010). However, based on the solved dimensions of the β-barrel lumen where the 
ellipsoidal cross section extends from 1.9 nm to 2.7 nm at its narrowest and widest, 
respectively, there are size limitations that bring this hairpin model into question. Evidence 
whereby disulphide bonded or glycosylated regions of the passenger domain are efficiently 
translocated to the cell surface (Lindenthal and Elsinghorst, 1999; Sherlock et al., 2006; 
Skillman et al., 2005) highlighted the need for alternative models to explain the contradictions 
between these observed structures and the inherently narrow β-barrel pore.  
1.6.4.2.2 BamA model 
Due to the intrinsic problems of the hairpin model, a large body of evidence has now been 
generated to support an essential role of BamA, a part of the BAM complex, in AT secretion. 
Using various experimental strategies, the intimate association of ATs with BamA, and the 
necessity for a functional BamA for AT secretion, have been established (Jain and Goldberg, 
2007; Lehr et al., 2010; Ruiz-Perez et al., 2009; Sauri et al., 2009). Currently, these studies 
lack the molecular insights to substantiate a mechanism for AT biogenesis involving BamA. 
However, speculations based on these observations have theorised two predominant models. 
Firstly, a model integrating both the hairpin and BamA model proposes that the β-domain 
inserts into the pore of BamA whilst the β-barrel is held „open‟ by BamA allowing the 
passenger domain to be translocated to the exterior of the cell. However, size constraints 
relating to the size of the BamA pore again cast doubt on the plausibility of this model. In 
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another model, the formation of a β-barrel is suspended whilst the β-domain merely docks 
with BamA and is held in a loosely folded conformation whereby the passenger domain 
favours the BamA pore as a translocation conduit, after which the BAM complex would 
disassemble triggering sealing of the AT β-domain and its folding into a stable barrel (Ieva et 
al., 2011; Sauri et al., 2009). Evidently, significant advances in our understanding of AT 
biogenesis have been made since their initial description in 1987, calling into question the 
„auto‟ nature of their secretion. However, there is still a distinct lack of mechanistic detail 
regarding their OM translocation that future studies are still at liberty to resolve.  
1.6.5 Passenger domain structure 
Once the passenger domain has reached the outside of the bacterium, it has to fold into its 
native form in order to manifest its function. The passenger domain, which comprises the 
effector moiety of the AT polypeptide, often exceeds 100 kDa, although they do range from 
<20 to >400 kDa. Although there is no structural motif common to all ATs, crystal structures, 
bioinformatics, and biophysical analyses suggest that most passenger domains are variations 
on a common structural theme. Crystal structures solved for the Bordetella pertussis Pertactin 
(Emsley et al., 1996) and the Haemoglobin protease, Hbp (Otto et al., 2005) from E. coli 
show a characteristic right-handed β-helical stalk-like structure adjoined by loops of varying 
length and structure (Fig. 1.10). Intriguingly, the striking β-helical stalk of Pertactin and Hbp 
are two of only a dozen or so right-handed parallel β-helix protein structures solved; with the 
24 turns of right-handed β-helix noted in the Hbp structure, compared with 16 in Pertactin, 
being the longest parallel β-helix known to date. Furthermore, a conserved domain at the 
extreme C-terminus of the passenger domain, named the autochaperone (AC) domain, appears 
to be decisive for the correct folding of the β-helical passenger domain on the cell surface 
(Fig. 1.10) (Oliver et al., 2003; Velarde and Nataro, 2004). Consistent with the notion that 
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secretion proceeds in a C-to-N terminal direction, this model would assume that the AC 
domain appears on the cell surface first and initiates subsequent folding of the passenger 
domain. Additional studies have resolved the structures of the IgAP and VacA ATs, 
elucidating further structures that decorate the surface of the core β-helix. In the case of Hbp 
and IgAP, these structures constitute domains independent of the β-helical stem with distinct 
functional features. For example, Hbp, a member of the Serine Protease Autotransporters of 
the Enterobacteriaceae (SPATE) subfamily of ATs, has a large globular domain that is fixed 
at the N-terminal base of the β-helix where the signature serine protease motif lies (Domain 1) 
(Fig. 1.10). Sequence alignments of Hbp with the other known SPATEs (Pet, Sat, EspC, SepA 
and Pic) suggest high conservation within this region, with minor residue changes in and 
around the serine protease motif, assumed to confer substrate specificity on the functionally 
diverse SPATEs (Otto et al., 2005). Additional solved domains consist of Domain 2, which 
resides at the base of the β-helix on the opposing face to Domain  1 (Fig. 1.10) and is capable 
of independent movement and folding (Johnson et al., 2009). However, the revealed structure 
for EstA challenges this conservation where the characteristic β-helix is replaced by a large 
globular fold that is dominated by alpha-helices and loops (Fig. 1.10) (van den Berg, 2010).  
1.6.6 Extracellular release of the passenger domain 
Many ATs are released into the external environment following a proteolytic event, cleaving 
the passenger domain from its β-domain in the OM. However, there are exceptions whereby 
ATs remain attached to the β-domain (EstA) or are processed to remain in close association 
with their cognate β-barrels (Ag43) (Henderson et al., 2004). For those ATs that are cleaved, 
the mechanisms of AT proteolysis are exceptionally diverse. Dedicated OM proteases are 
often employed for passenger domain release. In the case of IcsA from Shigella, an integral 
OM protease, IcsP, is responsible for specific cleavage of IcsA (Shere et al., 1997). 
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Additionally, the AT, NalP, is responsible for the cleavage of associated ATs from N. 
meningitidis such as IgAP and App (van Ulsen et al., 2003). However, cleavage of many ATs 
is known to undergo auto-proteolysis, due to either endogenous serine protease activity 
(Hendrixson et al., 1997; Serruto et al., 2003) or an interaction independent of their serine 
protease, involving residues within the β-barrel lumen (Dautin et al., 2007; Dautin and 
Bernstein, 2011; Velarde and Nataro, 2004).   
1.7 Autotransporter function  
Given the prevalence and functional diversity of ATs, only the functions of a few ATs that are 
relevant to my work will be discussed. However, it is important to note that ATs encompass 
virulence factors that serve many diverse functions including cytotoxicity, enterotoxicity, 
invasion and adhesion. Work in our laboratory has focused mainly on the archetypal AT, 
Plasmid encoded toxin (Pet) from Enteroaggregative E. coli (EAEC) 042 and Antigen 43 
(Ag43), a phase-variable AT found in many E. coli strains. Ag43 is one of the most abundant 
phase-variable OMPs in E. coli. Its presence on the cell surface mediates auto-aggregation, 
however its function and the phase-variable nature of its expression is not clearly defined (van 
der Woude and Henderson, 2008). In light of the fact that exhaustive studies have not been 
able to specify a role for Ag43, it is thought that this AT may play a role in the persistence of 
E. coli, both as a pathogen and a commensal.  
1.7.1 Plasmid-encoded toxin  
Pet is a 104 kDa protein encoded on the 65-MDa adherence-related plasmid of the 
prototypical EAEC strain 042. EAEC 042 represents an emerging pathogen that causes enteric 
and food-borne infectious diseases. EAEC pathogenesis comprises four major features; 
abundant adherence to the intestinal mucosa, formation of a thick mucus-containing biofilm, 
47 
 
induction of mucosal inflammation and elaboration of enterotoxins and cytotoxins 
(Harrington et al., 2006). One of these toxins, Pet, is an archetypal SPATE which is cleaved 
at the bacterial cell surface and released into the extracellular milieu. To cause the 
characteristic toxic effects on eukaryotic cells, Pet must undergo endocytosis to reach its 
intracellular cytosolic target, Fodrin. Pet binds to the epithelial cell surface of the human 
intestinal mucosa, and is internalised by clathrin-coated vesicles (Navarro-Garcia et al., 
2007b). In a manner analogous to that of the well characterised AB5 toxins, such as Cholera 
and Diptheria toxin, Pet is the first non-AB5 toxin that exploits the vesicular trafficking 
pathways of the target cell in order to pass from the cell surface through the golgi apparatus 
and ER onto the cytosol (Navarro-Garcia et al., 2007a). Pet utilises its serine protease activity 
to cleave the cytoskeletal protein fodrin within the cytosol (Canizalez-Roman and Navarro-
Garcia, 2003), which consequently disrupts the organisation of the actin cytoskeleton leading 
to loss of actin stress fibers and release of focal contacts in HEp-2 and HT29/C1 cell 
monolayers (Navarro-Garcia et al., 1999). These cytotoxic effects lead to cell rounding and 
detachment from the substratum.  
1.8 Project aims 
The basis for this project began by the identification of novel factors involved in AT 
biogenesis, using a previously generated transposon library of EAEC 042 (Sheikh et al., 
2002) to screen for the secretion of the AT, Pet. This screen identified over 70 transposon 
mutants that resulted in reduced or abolished secretion of Pet. This project is an extension of 
this preliminary data and the specific aims are as follows;  
 1. To confirm a role for the factors identified by the initial transposon screen in the  
 biogenesis of Pet, using defined E. coli mutants.  
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 2. To establish a role for the factors in Pet biogenesis, initially by outlining the stage 
 that Pet biogenesis is affected. 
 3. To focus on a subset of the identified factors and gain insight into the mechanistic  
  details of how these factors affect Pet biogenesis. 
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Unless otherwise stated, culture medium components were purchased from Oxoid Limited 
and all chemicals were purchased from Sigma Aldrich. Thermus aquaticus (Taq) polymerase 
was supplied by Thermo Scientific. Phusion High Fidelity DNA polymerase, Calf alkaline 
phosphatase, T4 polynucleotide kinase and 100bp DNA ladder were purchased from New 
England Biolabs. T4 DNA ligase was supplied by Invitrogen. Unless otherwise specified, all 
enzymes were used according to manufacturer‟s instructions and used in the supplied buffers. 
dNTP mixes and Hyperladder I were purchased from Bioline. Oligonucleotides were 
purchased from either Alta Bioscience (University of Birmingham), or Eurogentec 
(Hampshire, UK). All radionucleotides were purchased from Perkin Elmer or MP 
Biomedicals and ribonucleotides and DNase I was supplied by Roche. E. coli RNA 
polymerase holoenzyme containing σ
70
 was purchased from Epicentre Technologies 
(Madison, WI). Purified CRP and Fis protein was kindly donated by David Lee and David 
Grainger (University of Birmingham).   
2.2 Bacterial strains and culture conditions 
2.2.1 Bacterial strains 
The bacterial strains used in this study are listed in Table 2.1. All strains were stored as 
glycerol stocks at -80°C.  
2.2.2 Bacterial culture conditions 
Bacteria were routinely maintained using nutrient broth as follows; Luria-Bertani (LB) 
medium contained 1% (w/v) tryptone, 0.5% (w/v) yeast extract and 1% (w/v) NaCl (pH 7.2). 
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Table 2.1 Strains used in this study 
Strain Relevant characteristic Source 









Diarrhoeagenic in volunteers; expresses 
AAF/II; biofilm positive; harbours pAA2. 
(Nataro et al., 
1995) 
Escherichia coli CFT073  Wild type Uropathogenic Escherichia coli 
(UPEC) isolate 




Wild type Uropathogenic Escherichia coli 




Wild type Uropathogenic Escherichia coli 




Wild type Uropathogenic Escherichia coli 
(UPEC) isolate, bamE::aph 
This study 





recA13, ara-14, leuB6, proA2, lacY1, 
galK2, rpsL20 (str
r
), xyl-5, mtl-1 
Promega 
HB101 bamB::aph HB101 derivative with Datsenko & Wanner 
replacement of designated gene with 
kanamycin resistance cassette, bamB::aph 
This study 
HB101 bamC::aph HB101 derivative with Datsenko & Wanner 
replacement of designated gene with 
kanamycin resistance cassette, bamC::aph 
This study 
HB101 bamE::aph HB101 derivative with Datsenko & Wanner 
replacement of designated gene with 
kanamycin resistance cassette, bamE::aph 
This study 
HB101 crp::aph HB101 derivative with Datsenko & Wanner 
replacement of designated gene with 
kanamycin resistance cassette, crp::aph 
This study 
HB101 degP::aph HB101 derivative with Datsenko & Wanner 
replacement of designated gene with 
kanamycin resistance cassette, degP::aph 
This study 
HB101 fis::aph HB101 derivative with Datsenko & Wanner 
replacement of designated gene with 
kanamycin resistance cassette, fis::aph 
This study 
HB101 ppiA::aph HB101 derivative with Datsenko & Wanner 
replacement of designated gene with 
kanamycin resistance cassette, ppiA::aph 
This study 
HB101 ppiD::aph HB101 derivative with Datsenko & Wanner 
replacement of designated gene with 
kanamycin resistance cassette, ppiD::aph 
This study 
HB101 skp::aph HB101 derivative with Datsenko & Wanner 
replacement of designated gene with 
kanamycin resistance cassette, skp::aph 
This study 
HB101 surA::aph HB101 derivative with Datsenko & Wanner 
replacement of designated gene with 





Table 2.1 Strains used in this study (continued) 





 rrnBT14 ∆lacZWJ16 hsdR514 
∆araBADAH33 ∆ rhaBADLD78                              
(Baba et al., 2006) 
BW25113 ackA::aph                   BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, ackA::aph                             
(Baba et al., 2006) 
BW25113 adiY::aph                   BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, adiY::aph                             
(Baba et al., 2006) 
BW25113 ais::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, ais::aph                     
(Baba et al., 2006) 
BW25113 bamB::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, bamB::aph                     
(Baba et al., 2006) 
BW25113 bamC::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, bamC::aph                     
(Baba et al., 2006) 
BW25113 bamE::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, bamE::aph                     
(Baba et al., 2006) 
BW25113 cadA ::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, cadA::aph                     
(Baba et al., 2006) 
BW25113 celB::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, celb::aph                     
(Baba et al., 2006) 
BW25113 clpB::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, clpB::aph                     
(Baba et al., 2006) 
BW25113 crp::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, crp::aph                     
(Baba et al., 2006) 
BW25113 crr::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, crr::aph                     
(Baba et al., 2006) 
BW25113 cspG::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, cspG::aph                     
(Baba et al., 2006) 
BW25113 cysK::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, cysK::aph                     
(Baba et al., 2006) 
BW25113 degP::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, degP::aph                     
(Baba et al., 2006) 
BW25113 dnaG::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, dnaG::aph                     




Table 2.1 Strains used in this study (continued) 
Strain Relevant characteristic Source 
BW25113 fis::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, fis::aph                     
(Baba et al., 2006) 
BW25113 fkpA::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, fkpA::aph                     
(Baba et al., 2006) 
BW25113 folX::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, folX::aph                     
(Baba et al., 2006) 
BW25113 lon::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, lon::aph                     
(Baba et al., 2006) 
BW25113 mhpC::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, mhpC::aph                     
(Baba et al., 2006) 
BW25113 nei::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, nei::aph                     
(Baba et al., 2006) 
BW25113 nuoF::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, nuoF::aph                     
(Baba et al., 2006) 
BW25113 pal::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, pal::aph                     
(Baba et al., 2006) 
BW25113 pitA::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, pitA::aph                     
(Baba et al., 2006) 
BW25113 ppiA::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, ppiA::aph                     
(Baba et al., 2006) 
BW25113 ppiD::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, ppiD::aph                     
(Baba et al., 2006) 
BW25113 pqiB::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, pqiB::aph                     
(Baba et al., 2006) 
BW25113 prmA::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, prmA::aph                     
(Baba et al., 2006) 
BW25113 proP::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, proP::aph                     
(Baba et al., 2006) 
BW25113 proW::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, proW::aph                     
(Baba et al., 2006) 
BW25113 rfaJ::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, rfaJ::aph                     




Table 2.1 Strains used in this study (continued) 
Strain Relevant characteristic Source 
BW25113 rlpA::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, rlpA::aph                     
(Baba et al., 2006) 
BW25113 skp::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, skp::aph                     
(Baba et al., 2006) 
BW25113 slyB::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, slyB::aph                     
(Baba et al., 2006) 
BW25113 surA::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, surA::aph                     
(Baba et al., 2006) 
BW25113 thiC::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, thiC::aph                     
(Baba et al., 2006) 
BW25113 uvrD::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, uvrD::aph                     
(Baba et al., 2006) 
BW25113 uxuR::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, uxuR::aph                     
(Baba et al., 2006) 
BW25113 yafO::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, yafO::aph                     
(Baba et al., 2006) 
BW25113 ybbB::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, ybbB::aph                     
(Baba et al., 2006) 
BW25113 ybeL::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, ybeL::aph                     
(Baba et al., 2006) 
BW25113 ybhC::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, ybhC::aph                     
(Baba et al., 2006) 
BW25113 ydiM::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, ydiM::aph                     
(Baba et al., 2006) 
BW25113 ydiN::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, ydiN::aph                     
(Baba et al., 2006) 
BW25113 yeiC::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, yeiC::aph                     
(Baba et al., 2006) 
BW25113 yeiL::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, yeiL::aph                     
(Baba et al., 2006) 
BW25113 yeiM::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, yeiM::aph                     




Table 2.1 Strains used in this study (continued) 
Strain Relevant characteristic Source 
BW25113 yfbV::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, yfbV::aph                     
(Baba et al., 2006) 
BW25113 yfcI::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, yfcI::aph                     
(Baba et al., 2006) 
BW25113 yfeK::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, yfeK::aph                     
(Baba et al., 2006) 
BW25113 ygeV::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, ygeV::aph                     
(Baba et al., 2006) 
BW25113 ygjI::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, ygjI::aph                     
(Baba et al., 2006) 
BW25113 yhiL::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, yhiL::aph                     
(Baba et al., 2006) 
BW25113 yhiN::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, yhiN::aph                     
(Baba et al., 2006) 
BW25113 yiaG::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, yiaG::aph                     
(Baba et al., 2006) 
BW25113 yihN::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, yihN::aph                     
(Baba et al., 2006) 
BW25113 yihR::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, yihR::aph                     
(Baba et al., 2006) 
BW25113 yjdL::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, yjdL::aph                     
(Baba et al., 2006) 
BW25113 yjiC::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, yjiC::aph                     
(Baba et al., 2006) 
BW25113 ykgG::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, ykgG::aph                     
(Baba et al., 2006) 
BW25113 ynbC::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, ynbC::aph                     
(Baba et al., 2006) 
BW25113 yohM::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, yohM::aph                     
(Baba et al., 2006) 
BW25113 yphF::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, yphF::aph                     





Table 2.1 Strains used in this study (continued). 
Strain Relevant characteristic Source 
BW25113 yqiH::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, yqiH::aph                     
(Baba et al., 2006) 
BW25113 yshA::aph                     BW25113 derivative with designated gene 
disrupted with a kanamycin resistance 
cassette, yshA::aph                     




solid LB medium included 1.5% (w/v) bacteriological agar (Agar No. 1). To screen for β-
galactosidase activity, 5% (w/v) MacConkey lactose agar was used. All media was autoclaved 
at 121°C for 20 min and allowed to cool to approximately 60°C, prior to use. When 
appropriate, media was supplemented with antibiotic(s) to a final concentration of 100 µg/ml 
ampicillin, 50 µg/ml kanamycin and 10 µg/ml tetracycline. Tetracycline was made up with 
100% methanol and all others were made up with sterile distilled water (SDW). All 
antibiotics were made at 1000 x their working concentration, filtered through a 0.2 µM pore 
and stored at -20°C, until required. Unless otherwise specified, liquid cultures were incubated 
at 37°C with shaking at 180 rpm for aerobic growth, or in a static 37°C incubator for 
anaerobic growth. Growth on agar plates was routinely done in a static incubator, overnight at 
37°C. Bacterial growth, in liquid cultures, was assessed by reading the optical density of 
samples at 600 nm (OD600) using an Ultra Spec 2100 spectrophotometer. 
2.3 Plasmids 
All plasmids used in this study are listed in Table 2.2. Plasmid maps are shown in Figure 2.1. 
2.4 DNA Manipulations 
2.4.1 Polymerase chain reaction (PCR) 
Standard PCR was carried out using Phusion High fidelity DNA polymerase (NEB) in the 
provided buffer, according to manufacturer‟s instructions. Between 1-5 ng of plasmid 
miniprep DNA or purified PCR product would be used as a template in a 50 µl reaction. 
Oligonucleotides were used at a final concentration of 0.5 µM and dNTP‟s were used at a 
final concentration of 200 µM each. Reactions were made up to 50 µl with SDW. Unless 
stated otherwise, thermal cycling was carried out as follows; 98°C/10 s, (98°C/10 s, X°C/30 s,  
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Table 2.2 Plasmids used in this study 
Plasmids Relevant characteristic Source 
pRW50 oriV, lacZYA, Tet
r
. Broad-host 
range, low-copy-number lacZ 
expression vector used for 
cloning EcoRI-HindIII 
promoter fragments. 
(Lodge et al., 1992) 
 
pCEFN1 3.9-kb PCR-derived fragment 
expressing Pet protein under 
the control of its native 




(Eslava et al., 1998) 





pSR pBR322 derivative containing 
transcription terminator, λoop.             
(Kolb et al., 1995) 
pDCRP pBR322 derivative carrying 
crp gene. 
(West et al., 1993) 
pDU9 Derivative of pDCRP with crp 
deleted. 
(Bell et al., 1990) 
pDCRP HL159 pDCRP derivative with 
defective AR1. 
(West et al., 1993) 
pDCRP KE101 pDCRP derivative with 
defective AR2. 
 





pDCRP derivative with 
defective AR1 and AR2. 
(Rhodius et al., 1997) 
pQuantagen(kx) phoA, p15A origin of 





pQMDSSpet Pet signal sequence cloned 
into pQUANTagen(kx) 
(Desvaux et al., 2007) 




(Datsenko and Wanner, 2000) 







(Ulett et al., 2007) 
pACYC184/pet PCR-derived fragment 
expressing Pet protein under 
the control of its native 
promoter cloned into 
pACYC184. 
















Figure 2.1. Plasmid maps. A. Map of the lac fusion vector, pRW50. EcoRI-HindIII fragments carrying the 
promoter of interest were cloned between the EcoRI and HindIII sites, contained within the multiple cloning site 
(MCS, a blue-filled box), to give EcoRI-promoter-HindIII::lac fusions, such that expression of the lac genes is 
under control of the cloned promoter. Also shown are the tetracycline resistance gene (tet
R
), the origin of 
replication (oriV), the plasmid replication genes trfA and trfB, and trpBA, which forms an operon with lacZYA. 
B. Map of pSR. EcoRI-HindIII promoter fragments are cloned upstream of the λ oop terminator and used for in 
vitro transcription reactions. Transcription initiates at the cloned promoter and terminates at the λ terminator, to 
produce a discrete transcript of a defined length.  Also shown are the RNA1 gene, which produces a control 
transcript during in vitro transcription, the bla gene, which encodes resitance to ampicillin (Amp
R
), and the 





































72°C/[1 min/kb]) x 30, 72°C/10 min. X refers to the annealing temperature. Annealing 
temperatures were used at 5°C‟s lower than that of the lowest given melting temperature of 
the primers used in the reaction. If not used immediately, PCR products were stored at -20°C. 
Colony PCR was used routinely to check for chromosomal insertions or deletions and to 
check for the presence of cloned inserts within plasmids. Template DNA was prepared by re-
suspending a colony in 30 µl of SDW and boiling at 100°C for 5 min. 2.5 µl of the sample 
was used in a total volume of 25 µl, made up with ReddyMix PCR (Thermo scientific).  
2.4.2 Gel electrophoresis of DNA 
All DNA samples above 500 bp were analysed using 0.8-1.5% agarose dissolved in 1x Tris-
acetate-EDTA (TAE) buffer (40 mM Tris, 20 mM acetic acid, 1 mM EDTA, pH 8.4). To stain 
the DNA, Syber green was added whilst the agarose was still molten, according to 
manufacturer‟s instructions. The gel was then poured onto a casting plate and left for 
approximately 10 min to set. When necessary, DNA samples were mixed in a 5:1 ratio with 6 
x DNA loading dye (2.5% Ficoll 400, 11 mM EDTA, 3.3 mM Tris-HCl, 0.017% SDS 0.015% 
Bromophenol Blue, pH 8.0). Gels were run in 1 x TAE at 80-120 V (constant voltage) for 40-
60 min, alongside Hyperladder I DNA marker (Bioline). Gels were visualised using a UV 
transilluminator with the gel-documentation system (Bio-Rad).  
All DNA samples below 1 kb were analysed using 7.5% polyacrylamide gels. All gels were 
made using clean 1.5 mm thick Bio-Rad Minigel glass plates. Polyacrylamide gels (7.5% 
polyacrylamide, 4% glycerol and 1 x TBE [90 mM Tris, 90 mM Boric acid, 2 mM EDTA, pH 
8.3]) were prepared using the appropriate amount of 30% (w/v) acrylamide, 0.8% (w/v) bis-
acrylamide stock solution (Protogel, National diagnostics) and polymerised using 0.01 
volumes of 10% (w/v) ammonium persulphate and 0.001 volumes TEMED (N,N,N′,N′-
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Tetramethylethylenediamine). DNA samples were mixed in a 5:1 ratio with 6 x DNA loading 
dye, as above. Gels were run in 1 x TBE at 130 V (constant voltage) alongside 100 bp DNA 
ladder (NEB), for approximately 2 h, then post-stained in 50 mL de-ionised H20 with the 
addition of 1 µl Sybr green (Applied Biosystems) and visualised using a UV transilluminator, 
as above. If gel bands were excised, they were either used immediately or stored at -20°C. 
To analyse samples from DNA footprinting and electrophoretic mobility shift assay (EMSA) 
reactions, denaturing 6% polyacrylamide gels were made in large glass plates using the 
SequaGel sequencing system, as described in the manufacturer‟s instructions. Gels were pre-
run in 1 x TBE buffer at 60 W (constant wattage) for approximately 1 h, prior to loading. 
Samples from footprinting reactions were in loading buffer and subjected to heating at 90°C 
for 2 min before loading. EMSA samples were loaded directly onto the gel in the absence of 
loading buffer, alongside a lane containing loading buffer, as a point of reference. Gels were 
run in 1 x TBE buffer at 60 W for 1-2.5 h, carefully removed from glass plates, then fixed for 
10 min in a 10% methanol/10% acetic acid solution.  Gels were placed on filter paper and 
dried under vacuum at 80°C for 30-40 min.  Dried gels were exposed to a Fuji Imaging 
Phosphor screen for 1 to 16 h, the phosphor screen was scanned using a Bio-Rad Molecular 
Imager FX and images were analysed using QuantityOne software (BioRad).    
2.4.3 Extraction and purification of DNA 
2.4.3.1 Extraction of plasmid DNA 
For small scale preparation, extraction of plasmid DNA from overnight cultures, 
supplemented with the appropriate antibiotic, was done using a QIAprep Spin Miniprep kit 
(QIAGEN), as per manufacturer‟s instructions. For cultures containing high copy number 
plasmids (10-30 copies per cell), 5 ml of culture was applied to one column, for cultures 
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containing low copy plasmids (1-5 copies per cell), 10 ml of culture was applied to one 
column. Plasmid DNA was eluted in 30-50 µl of provided elution buffer. 
For the large scale preparation of concentrated plasmid DNA, for in vitro assays, caesium 
chloride density gradient ultracentrifugation was used. To do this, 500 ml LB was 
supplemented with the appropriate antibiotic(s), inoculated with an overnight culture of a 
strain harbouring the required plasmid and incubated at 37°C with aeration until an OD650 = 
0.8-1.0 was reached. 50 mg chloramphenicol was then added to the culture to inhibit protein 
synthesis, whilst maintaining the ability of the bacterium to replicate plasmid DNA, and then 
incubated overnight. The following day, cells were harvested by centrifugation at 4,000 rpm 
for 30 min. The cell pellet was then re-suspended in 12 ml ice-cold TES buffer (50 mM NaCl, 
60 mM Tris, 5 mM EDTA, pH 8.0). 2 ml of ice-cold 250 mM EDTA and 3 ml cold TES 
buffer containing 10 mg/ml lysozyme was then added to the cell suspension and left to 
incubate on ice for 15 min. To lyse the cells, 2 ml 10% SDS was added, mixed and incubated 
on ice for a further 10 min. 5 ml ice cold 5 M sodium chloride was added to the solution, 
mixed and incubated on ice overnight. To remove cell debris, the cell lysate was centrifuged 
for 2 h at 20,000 rpm at 4°C. The supernatant was then decanted into a fresh tube and allowed 
to warm to room temperature. DNA was precipitated by adding 15 ml isopropanol, incubating 
for 15 min at room temperature, and centrifuging for 15 min at 15,000 rpm at 20°C.  The 
supernatant was then carefully discarded and the DNA pellet was dried under vacuum for 10 
min to remove excess isopropanol, and re-suspended in 5 ml TES buffer by vigorous 
vortexing. 5.16 g caesium chloride, 200 µl ethidium bromide (10 mg/ml, Biorad) and 5.16 ml 
DNA solution were mixed, vortexed and transferred to a 10 ml Beckman quick-seal 
centrifuge tube.  The tubes were sealed, using a soldering iron and then centrifuged for 22 h at 
50,000 rpm at 20°C.  After centrifugation, two ethidium bromide-stained bands were visible; 
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an upper band containing linear, chromosomal and nicked circular plasmid DNA, and a lower 
band containing closed circular plasmid DNA.  The lower band was removed by insertion of a 
needle and a syringe slightly below the band and suction until the band was extracted. The 
resulting solution was extracted five times with an equal volume of water-saturated butanol to 
remove ethidium bromide, then dialysed overnight at 4°C against 4 l TE buffer (10 mM Tris, 
0.5 mM EDTA, pH 8.0).  The DNA solution was then extracted using phenol/chloroform and 
ethanol precipitated, as described in sections 2.4.3.2 and 2.4.3.3, and re-suspended in 600 µl 
TE buffer. The purity of the plasmid DNA was checked by agarose gel electrophoresis, and 
the DNA concentration was measured using an Eppendorf Biophotomoter.    
2.4.3.2 Phenol/chloroform extraction of DNA 
For the removal of contaminating proteins from enzymatic reactions, DNA samples were 
mixed in an equal volume of phenol/chloroform, vortexed for 10 s and then centrifuged for 2 
min at 14,000 rpm to separate the aqueous and organic phase. The DNA-containing upper 
aqueous layer was then extracted carefully, without disturbing the interface between the two 
layers, and added to a fresh tube.  
2.4.3.3 Ethanol precipitation of DNA 
To precipitate DNA from solutions, 1/10 volume of 3 M sodium acetate (pH 5.2) and 2 
volumes of ice-cold 100% ethanol were added and the resulting solution was left to 
precipitate for 20 min at -20°C, or overnight at -80°C. The sample was then centrifuged at 
14,000 rpm for 15 min, the supernatant was discarded and the pellet was washed with 1 ml 
70% ice-cold ethanol. The sample was then centrifuged again at 14,000 rpm for 10 min, 
supernatant discarded and the pellet was vacuum dried for 10-15 min. The pellet was then re-
suspended in either SDW or DNA loading dye, where appropriate.  
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2.4.3.4 Purification of PCR products 
For purification of PCR products of 100 bp and more, a QIAquick PCR purification kit 
(QIAGEN) was used, according to manufacturer‟s instructions. PCR products were eluted 
from the column using 30-50 µl SDW, depending on concentration requirements.  
2.4.3.5 Electroelution of DNA fragments from polyacrylamide gels 
Excised gel bands, from polyacrylamide gels, were placed in 6.3 mm dialysis tubing with 200 
µl 0.1 x TBE and clipped at both sides, ensuring no air bubbles were present. The dialysis 
bags were then placed in an electroelution tank filled with 0.1 x TBE and ran at 40 mA 
(constant amps) for 40-50 min. The buffer contained within the dialysis tubing was removed 
and put into a fresh tube, the tubing was then rinsed with 200 µl SDW and this was added to 
the collected buffer to make a total volume of 400 µl. The DNA contained within the buffer 
was then extracted, purified and concentrated by phenol/chloroform extraction and ethanol 
precipitation as described in 2.4.3.2 and 2.4.3.3, respectively and finally re-suspended in 20-
25 µl SDW. 
2.4.4 Restriction digestion of DNA 
For cloning purposes, digestion of plasmid DNA was performed by adding 340 µl small-scale 
prepared plasmid DNA (section 2.4.3.1) to a total of 20 µl restriction enzyme (10 µl of each 
enzyme if double digestion needed), 40 µl of the appropriate 10 x restriction digest buffer as 
determined using the New England Biolabs double digest finder 
(http://www.neb.com/nebecomm/ DoubleDigestCalculator.asp) and 4 µl 100 x bovine serum 
albumin (BSA) where needed, giving a total reaction volume of 400 µl. For the preparation of 
DNA inserts, 10 µl purified PCR product was digested with a total of 6 µl of restriction 
enzymes (3µl of each enzyme for a double digest), 6 µl of the appropriate 10 x restriction 
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digest buffer and made up to a total reaction volume of 60 µl with SDW. All digests were 
incubated at 37°C for 3 h. For the preparation of plasmid DNA to be used in downstream 
cloning procedures, 4 µl calf alkaline phosphatase was added to the restriction digest mix 
after the 3 h incubation and incubated for a further 60 min at 37°C. This was done in order to 
remove terminal 5' phosphate groups, to prevent re-ligation of vector DNA.  Digested DNA 
was purified either by phenol/chloroform extraction and ethanol precipitation or electroelution 
from 7.5% polyacrylamide excised gel bands, as in section 2.4.  
2.4.5 DNA ligations 
For ligation of digested insert DNA into digested vector, 10 µl purified insert DNA was added 
to 5 µl purified vector DNA, with 1 µl T4 DNA ligase (Invitrogen) and 4 µl supplied 5 x 
ligase buffer, in a total reaction volume of 20 µl. Ligations were incubated for 3 h at room 
temperature and the total ligation mix was then transformed into RLG221 chemically 
competent cells by the heat shock method, as described in section 2.4.8.  
2.4.6 DNA sequencing 
For sequencing of plasmid DNA, 5 µl low-copy plasmid, or 3 µl high-copy DNA was added 
to 3 µl of the appropriate primer (1µM) and made up to 10 µl with SDW. The samples were 
then loaded onto a „Plasmid to profile‟ plate in Functional Genomics and Proteomics 
Laboratory, University of Birmingham and the sequencing results were ready for analysis the 
next day.  
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2.4.7 Cloning of promoter fragments  
2.4.7.1 Preparation of promoter fragments by PCR 
All the primers used for cloning and manipulation of promoter fragments in this study are 
listed in Table 2.3 and a list of all the promoter fragments are found in Table 2.4. In all cases, 
forward primers introduced a DNA site for the restriction enzyme of choice to bind and cut 
just upstream of the 5' upstream region of the desired promoter. The reverse primer 
introduced a DNA site for the restriction enzyme of choice to bind and cut just downstream of 
the 3' region of the promoter fragment. Once the promoter of interest had been amplified, it 
was treated as in section 2.4.7 for cloning into the appropriately digested vector. For more 
details on specific cloning strategies for cloning into pRW50 and pSR, please refer to sections 
3, 4 and 5, respectively.   
2.4.7.2 Introduction of point mutations into promoter fragments by mega primer PCR 
Point mutations were introduced into EcoRI-HindIII promoter fragments, by mega primer 
PCR. All primers used to introduce point mutations into promoter fragments are shown in 
Table 2.3.  
The PCR product was used as the „mega primer‟ in the second round of PCR in conjunction 
with the upstream primer, D10520, which anneals approximately 80 bp upstream of the 
EcoRI site in pRW50. The PCR product of the correct size was then excised from a 7.5% 
polyacrylamide gel, electroeluted and purified by phenol/chloroform extraction and ethanol 
precipitation, as described in section 2.4. The purified fragments were EcoRI-HindIII 




Table 2.3 Primers used in this study for amplification of EcoRI-HindIII fragments and for 
mutagenesis of promoter fragments 
Name Sequence (5'      3') Use 
Pet_F ggggaattcttccatgtgacatctcag Amplifies pet regulatory region, to create 
AER1 fragment with 5' EcoR1 site 
Pet_R gggaagcttgtattttattcatatattctctca
actcatttattg 
Amplifies pet regulatory region, to create 





Used in Mega primer PCR to introduce 





Used in Mega primer PCR to introduce 
mutations within Fis I binding site in AER1 
PetFISIIC ggaacctgataatgctcctaaataggagc
aaaaaaaaac 
Used in Mega primer PCR to introduce 
mutations within Fis II binding site in AER1 
Pet+1 cacacattaacaatagtagaactgttactttt
tacggg 
Used in Mega primer PCR to introduce one 
base pair insertion in AER1 fragment 
Pet-10 cattaacaatatagaactgttcctttttacgg
g 
Used in Mega primer PCR to introduce 




Used to introduce one helical turn in F35CC(-
40.5) promoter derivative 
F40CC(-40.5) ggagagctccatggggtacccggggatc Used to introduce half a helical turn in 




Used to introduce Fis binding site 35 bp 
upstream of CC(-40.5) promoter derivative 
F30CC(-40.5) ggagagctcccggggatcaggta Used to remove half a helical turn in F35CC(-
40.5) promoter derivative 
F25CC(-40.5) ggagagctcgatcaggtaaatg Used to remove one helical turn in F35CC(-
40.5) promoter derivative 
Sat_F ggggaattctgaacgatgttccatgcgaa
cag 
Amplifies sat regulatory region, to create 




Amplifies sat regulatory region, to create 
SAT fragment with 3' HindIII site 
SatCRPI catcattaatgacaacattgtgacatatttac
aatatag 
Used in Mega primer PCR to introduce 
mutations within CRP binding site in SAT 
SatFISI caacccaccatcaattaacgatgaattag Used in Mega primer PCR to introduce 
mutations within Fis binding site in SAT 
Sat-10 caatatagaactgttccttttagcaagctg Used in Mega primer PCR to introduce 




Used in Mega primer PCR to introduce 
one base pair insertion in SAT fragment 
D10520 ccctgcggtgcccctcaag Anneals upstream of EcoRI site in 
pRW50.Used for sequencing of inserts. 
D5431 acctgacgtctaagaaacc Anneals upstream of EcoRI site in pSR.Used 
for sequencing of inserts. 
Pet_1 ggggaattcgatggaagctcagatgga Used for nested deletion analysis to 
successively remove 25 bp from AER1 
a
Bases labelled „S‟ represent a G or a C. The G insertion in primer „Pet+1‟ is in bold font. 
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Table 2.3 Primers used in this study for amplification of EcoRI-HindIII fragments and for 
mutagenesis of promoter fragments (continued) 
Name Sequence (5'      3') Use 
Pet_2 ggggaattcatatgagcaaaaaaaaac Used for nested deletion analysis to 
successively remove 25 bp from AER1 
Pet_3 ggggaattcgattaatttatgatcaatc Used for nested deletion analysis to 
successively remove 25 bp from AER1 
Pet_4 ggggaattctggtttacatgacatcg Used for nested deletion analysis to 
successively remove 25 bp from AER1 
Pet_5 ggggaattctaacgagagcattgtcac Used for nested deletion analysis to 
successively remove 25 bp from AER1 
Pet_6 ggggaattcaacaatatagaactgttact Used for nested deletion analysis to 
successively remove 25 bp from AER1 
Pet_7 ggggaattccgggatattagtaacaaac Used for nested deletion analysis to 
successively remove 25 bp from AER1 
Pet_8 ggggaattcctaatggttttaattcttaatc Used for nested deletion analysis to 







Table 2.4 Promoter fragments used in this study 
Promoter 
fragments 
Relevant characteristic Source 
AER1 EcoRI-HindIII fragment carrying pet regulatory region This study 
AER1-crp1 Derivative of AER1 with a C to G and G to C 
substitution at positions -36 & -45, respectively 
This study 
AER1-fis1 Derivative of AER1 with a C to G and G to C 
substitution at positions -84 & -98, respectively 
This study 
AER1-fisII Derivative of AER1 with a T to G and G to C 
substitution at positions -119 & -126, respectively 
This study 
AER1-10 Derivative of AER1 with an A to C substitution at 
position -11 in the promoter -10 element 
This study 
      AER1+1 Derivative of AER1 with a G:C insertion between base  
pairs -21 and -22 
This study 
      Pet_1 Derivative of AER1 with 17 bp removed from the 5' end  This study 
      Pet_2 Derivative of AER1 with 53 bp removed from the 5' end This study 
      Pet_3 Derivative of AER1 with 77 bp removed from the 5' end This study 
      Pet_4 Derivative of AER1 with 101 bp removed from the 5' 
end 
This study 
      Pet_5 Derivative of AER1 with 124 bp removed from the 5' 
end 
This study 
      Pet_6 Derivative of AER1 with 147 bp removed from the 5' 
end 
This study 
      Pet_7 Derivative of AER1 with 173 bp removed from the 5' 
end 
This study 
      Pet_8 Derivative of AER1 with 197 bp removed from the 5' 
end 
This study 
CC(-41.5) Derivative of E.coli melR promoter with consensus CRP 
binding site centred at –41.5 
(Gaston et al., 
1990) 
CC(-40.5) CC(-41.5) with one base pair deleted between the DNA 
site for CRP and the  -10 element 
(West et al., 1993) 
CC (-39.5) CC(-41.5) with two base pairs deleted between  the 
DNA site for CRP and the  -10 element 
(West et al., 1993) 
FCC(-40.5) CC(-40.5) derivative with the Fis I site, from the AER1 
promoter fragment, inserted 35 base pairs upstream of 
the DNA site for CRP 
This study 
FCC(-39.5) CC(-39.5) derivative with the Fis I site from AER1 
promoter fragment inserted 35 base pairs upstream of 
the DNA site for CRP 
This study 
SAT EcoRI-HindIII fragment carrying sat regulatory region This study 
SAT-crp1 Derivative of SAT with a C to G and G to C substitution 
at positions -36 & -45, respectively 
This study 
SAT-fis1 Derivative of SAT with a C to G and G to C substitution 




Derivative of SAT with an A to C substitution at 
position -11 in the promoter -10 element 
This study 
SAT+1 Derivative of SAT with a G:C insertion between base  





2.4.8 Bacterial transformations of DNA 
2.4.8.1 Preparation of chemically competent bacterial cells 
To prepare highly competent cells, for transformation by the heat shock method, 100 ml LB 
broth was inoculated with 1 ml overnight culture of the required strain. The culture was then 
grown at 37°C with aeration until an OD600 of 0.4-0.6 was reached. The culture was then 
placed on ice for 10 min before spinning at 4,000 rpm at 4°C for 10 min. The supernatant was 
then discarded and the cell pellet was re-suspended in 30 ml sterile ice-cold TFB1 (30 mM 
KOAc, 100 mM RbCl, 10 mM CaCl2, 50 mM MnCl2, 15% glycerol) and incubated on ice for 
90 min. The cell suspension was then centrifuged at 4,000 rpm for 10 min, supernatant 
discarded and the cell pellet was re-suspended in 2 ml sterile ice-cold TFB2 (0.1 M CaCl2, 
15% glycerol). The cells were either used straight away or aliquoted into 100 µl batches and 
stored at -80°C for future use.  
2.4.8.2 Preparation of electro-competent bacterial cells  
To prepare competent cells for transformation by electroporation, cultures were prepared and 
harvested as above, centrifuged at 4,000 rpm for 10 min at 4°C, the supernatant was discarded 
and the cell pellet was washed three times with 30 ml sterile ice-cold 10% glycerol. On the 
final spin, the cell pellet was re-suspended in 1 ml 10% glycerol and either used straight away 
or aliquoted as above and stored at -80°C.  
2.4.8.3 Transformation by heat shock method 
50 µl chemically competent cells were mixed with 1-3 µl plasmid DNA and incubated on ice 
for 30 min.  Cells were then heat shocked at 42°C for 45 s and 0.5 ml LB medium was added 
to the heat shocked cells. These cells were then incubated at 37°C for 60 min with aeration. 
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Cells were then centrifuged at 4,000 rpm for 2 min, the pellet was re-suspended in 
approximately 100 µl of the supernatant, plated onto agar, supplemented with appropriate 
antibiotic(s), and incubated overnight at 37°C. 
2.4.8.4 Transformation by electroporation 
50 µl electro-competent cells were mixed with 1-3 µl plasmid DNA and added straight to an 
ice-cold 1 mm electroporation cuvette (Invitrogen). Cells were then electroporated at 1.8 kV 
using a gene pulser (BioRad). 1 ml LB medium was added straight to the electroporation 
cuvette and the solution was then transferred to a sterile tube and incubated at 37°C for 60 
min with aeration. Cells were then centrifuged as above and transformants were selected on 
solid LB media supplemented with the appropriate antibiotic(s).  
2.5 Screening KEIO collection mutants by PCR 
The KEIO collection is a library of defined, single-gene deletions of all non-essential genes in 
E. coli K-12. This collection of mutants was made by replacing chromosomal genes with a 1.5 
kb kanamycin resistance cassette flanked by FLP recognition target (FRT) sites (Baba et al., 
2006). Prior to use in this study, the veracity of the mutations were checked by colony PCR, 
as detailed in section 2.4.1. Primers that annealed to regions approximately 200 bp upstream 
and downstream of the first and last codon of the gene of interest, respectively, were used to 
analyse the size of the loci in question. All primers used for this screening are listed in 
Appendix 1. PCR products amplified from the candidate mutant and the parental strain, for 
comparison, were separated on a 1% agarose gel. In cases of a correct mutation, amplification 
of the candidate loci would result in a 1.5 kb PCR product, representing the size of the 
inserted kanamycin cassette, whereas amplification of the loci in the parental strain would 
result in a PCR product representing the size of the native gene.  In cases where the size of the 
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native gene equalled that of the kanamycin resistant cassette, the primers flanking the gene of 
interest were used in conjunction with primers that annealed to inside the kanamycin cassette, 
and the presence of the correct size PCR product from the candidate loci was taken as a 
positive result. Although mutants from the KEIO collection represent insertions of the 
kanamycin cassette into the target locus, for simplicity, mutants are denoted as „Δx‟, where x 
represents the gene name. Note that, the result of this screen indicated that the KEIO library is 
10-15% inaccurate and thus a thorough screening procedure is required to ensure the veracity 
of mutants before used for further work.  
2.6 Constructions of mutants using the λ-RED system 
For construction of mutants containing chromosomal insertions, a method based on the λ-red 
system was used (Datsenko and Wanner, 2000). Briefly, the allele containing a kanamycin 
insertion was amplified from the BW25113 strain of interest from the KEIO collection (Baba 
et al., 2006). The PCR product was amplified using the primers listed in the Appendix 1, 
which were designed to anneal approximately 200 bp upstream and downstream of the allele 
of interest, resulting in ~ 400 bp regions of homology to the chromosomal target. The PCR 
product was electroporated into the desired strain, containing the pKD46 plasmid which 
harbours the inducible red recombinase system (Datsenko and Wanner, 2000). Kanamycin 
resistant colonies were screened by two independent colony PCR‟s for verification of targeted 
chromosomal gene disruption. For screening of candidate colonies, primers listed in the 
Appendix 2 were used that annealed to the kanamycin cassette in conjunction with primers 
that annealed 100 bp upstream of the inserted locus. 
73 
 
2.7 Protein preparation, detection and analysis  
2.7.1 Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) 
All SDS-PAGE protein separation was carried out using 12.5% polyacrylamide gels, prepared 
using Bio-Rad Minigel glass frames of 1.5 mm thickness. Each resolving gel contained the 
appropriate amount of 30% (w/v) acrylamide, 0.8% (w/v) bis-acrylamide stock solution 
(ProtoGel, National Diagnostics), 375 mM Tris-HCl (pH 8.8) and 0.1% (w/v) SDS. 4% 
stacking gels were made with the appropriate amount of acrylamide solution above, 125 mM 
Tris-HCl (pH 6.8) and 0.1% (w/v) SDS. Polymerisation of the acrylamide was achieved by 
adding 0.01 volumes of 10% (w/v) ammonium persulphate and 0.001 volumes TEMED 
(N,N,N′,N′-Tetramethylethylenediamine) to the resolving and stacking gel. Protein samples 
were mixed in equal volumes of 2 x Laemmli stock solution (Invitrogen). The gels were 
electrophoresed in 1 x SDS-PAGE running buffer (25 mM Tris-HCl, 0.1% SDS, 190 mM 
glycine) at 120 V (constant voltage) for 1.5-2 h.  
2.7.2 Protein detection  
For detection of all separated proteins, 0.25% (w/v) Coomassie Blue-R250 stain (BDH 
Laboratory Supplies) was dissolved in 10% (v/v) glacial acetic acid and 50% (v/v) methanol. 
For staining, gels were placed in approximately 25 ml of Coomassie Blue and incubated with 
shaking at room temperature for 1 h. Gels were then placed in destain (10% glacial acetic 
acid, 50% methanol) for approximately 1 h or until proteins of interest were visible.  
Western immunoblotting was carried out for specific detection of proteins using purified 
antibodies, raised against the protein of interest. Once protein samples had been separated by 
SDS-PAGE, gels were placed in 1 x transfer buffer (25 mM Tris, 192 mM Glycine, 20% 
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Methanol) for 5 min. Nitrocellulose membrane (GE Healthcare) was soaked in 1 x TB for 5 
min and placed on top of the gel within a western blot apparatus from Bio-Rad, according to 
manufacturer‟s instructions.  Proteins were then transferred to the nitrocellulose membrane 
for 1 h at 100 V (constant voltage).  Following transfer, the membrane was placed in 1 x PBS 
(137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.47 mM KH2PO4, pH 7.4), 0.05% Tween-
20 for 5 min. The membrane was then placed in 25 ml blotting solution (5% semi skimmed 
milk powder, dissolved in 1 x PBS-0.05% Tween-20) and incubated at room temperature for 
1 h, with shaking. The membrane was then washed 3 times with 25 ml 1 x PBS, 0.05% 
Tween-20 for 10 min, then incubated with 25 ml primary antibody, at the required dilution, 
dissolved in 1 x PBS, 0.05% Tween-20 for 3.5 h at room temperature, with shaking. The 
membrane was then washed 3 times with 25 ml 1 x PBS, 0.05% Tween-20 for 10 min, then 
placed in secondary antibody (alkaline phosphatase-labelled goat anti-rabbit IgG antibodies 
[Sigma Aldrich, UK]), diluted 1:10,000 in 1 x PBS, 0.05% Tween-20. The membrane was 
then washed 3 times with 25 ml 1 x PBS, 0.05% Tween-20 for 10 min. Antigen–antibody 
reactions were visualized using 1 ml alkaline phosphatase substrate NBT/BCIP, supplied by 
Sigma Aldrich.  
2.7.3 Inner membrane translocation assay 
To determine the ability of the Pet signal sequence (Petss) to mediate translocation across the 
IM, the Petss was fused to alkaline phosphatase (PhoA) and the subsequent periplasmic PhoA 
activity was measured. To do this, the desired strains were transformed with the plasmids 
pQMDSSpet and pQuantagen(kx), containing PhoA with and without Pet signal sequence, 
respectively (Desvaux et al., 2007). To determine the level of translocation across the IM, 
liquid assays of PhoA activity were performed. Cultures were grown overnight at 37°C in LB 
broth, supplemented with ampicillin. The following day, 20 ml LB broth was inoculated with 
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the overnight cultures at a 1:100 dilution and incubated at 37°C till an OD600=3.0 was 
reached. IPTG was then added to a final concentration of 1 mM and the samples were 
incubated for a further 2 h at 37 °C. 1 ml volumes were then removed and the OD595 recorded. 
To assay PhoA activity, 1 ml volumes were pelleted and re-suspended in 800 µl SDW. Cells 
were permeabilised by adding 20 μL 0.1% sodium dodecyl sulphate (SDS) and 20 μL 
chloroform and vortexed for 1 min. To begin the reaction, 100 μL 10 mg/ml of para-
nitrophenolphosphate (dissolved in 1 M Tris-HCl, pH 9.0) was added, and incubated at 37°C 
until a straw-yellow colour had developed or 1 h had elapsed. The reaction was stopped by 
adding 100 μl 10 M NaOH. Specific activity was calculated according to the following 
formula: 1,000 x (A420/[reaction time (min) x volume of cells (ml) x A595]) 
2.7.4 Preparation of whole cell extracts 
To analyse proteins from whole cell extracts, whole-cell lysate of the desired strain was 
prepared by spinning down 1 ml of an overnight culture, de-canting the supernatant and re-
suspending the cell pellet in 100 µl Laemmli buffer before boiling the resulting solution for 5 
min at 90˚C. Samples were separated by SDS-PAGE and visualised using the desired 
technique. 
2.7.5 Preparation of supernatant proteins 
To prepare culture supernatant fractions, strains were grown overnight at 37°C in 5 ml LB 
broth, supplemented with the appropriate antibiotic. The following day, overnight cultures 
were added to 20 ml fresh LB medium at a 1:20 dilution. The new cultures were then 
incubated at 37°C, with shaking, and grown until OD600=1.0. Cultures were normalised, cells 
were pelleted by centrifugation and the resultant supernatants were filtered through a 0.22 m 
filter and the proteins in the supernatant were precipitated with 10% trichloroacetic acid (v/v). 
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Samples were incubated on ice for 1 h or at 4°C overnight, then centrifuged at 14,000 x g for 
45 min and washed with 100% methanol. The pellets were collected by centrifugation at 
14,000 x g for 15 min, dried, and re-suspended in 40-100 L 2 x Laemmli buffer (Invitrogen). 
Samples were separated by sodium dodecyl sulfate-polyacrylamide gel
 
electrophoresis (SDS-
PAGE) and visualised using the desired technique. 
2.7.6 Release of the α-domain of Ag43 and immunodetection. 
For the analysis of Ag43 biogenesis, harvested cells were heat treated to release Ag43 from 
the surface of the cell by breaking the non-covalent interactions between the alpha-domain of 
Ag43 and the OM. To do this, cells from overnight LB cultures were normalised, harvested 
by centrifugation, washed in 0.9% (w/v) NaCl, and re-suspended in 1 ml of heat release buffer 
(75 mM NaCl–0.5 mM Tris, pH 7.4). The alpha-domain of Ag43 was released from the 
surface of the cells by heating at 60°C for 3 min. The cells were immediately removed by 
centrifugation, and the resultant protein in the supernatant was precipitated overnight at 4°C 
with 10% (w/v) TCA. The pellet was washed with 1 ml of 100% methanol and dried. Samples 
were then subjected to SDS-PAGE followed by western immunoblotting for detection of 
Ag43, as described in sections 2.7.1 and 2.7.2, respectively. Primary antibody, kindly donated 
by Mark Schembri, was used at a 1:1000 dilution.  
2.7.7 Ag43 mediated cell-cell aggregation 
Overnight cultures (containing 10 ml LB broth supplemented with 0.2% L-arabinose) 
harbouring strains carrying the pC02 plasmid were normalised to the same OD600 and 
transferred to 15 ml sterile falcon tubes. Prior to initiating the experiment, all cultures were 
vigorously shaken for 5 s and left in a rack with the lid off. Every 20 minutes, 100 µl of each 
sample was taken from each tube, approximately 1 cm from the top, and added to a 96-well 
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polypropylene micro-titre plate. The OD600 was then measured using a Bio-systems plate 
reader (Amersham Biosciences, UK).  
2.8 In vivo promoter analysis 
2.8.1 β-galactosidase assays 
β-galactosidase assays were carried out in order to measure the activity of promoter fragments 
fused to the lacZ gene in pRW50, under various conditions and in different genetic 
backgrounds (Miller, 1972). 5 ml LB broth, supplemented with appropriate antibiotics, was 
inoculated with a freshly transformed colony, containing pRW50 with the promoter of 
interest, and incubated overnight at 37°C. The following day, 5 ml LB broth was inoculated 
with the overnight culture at a 1:100 dilution for measurements of β-galactosidase activity 
taken during aerobic growth or a 1:50 dilution for measurements taken during anaerobic 
growth. Once cells had reached the required OD650 = 0.2, for aerobic cultures and 0.5, for 
anaerobic cultures, they were immediately placed on ice and the exact OD650 reading was 
recorded. To lyse cells, 2 ml samples were added to 30 µl toluene and 30 µl 0.1% sodium 
deoxycholate and incubated for 30 min at 37°C, with aeration. For measurements of β-
galactosidase activity, 100 µl of cell lysate was added to 2 ml Z buffer (0.75 g/l KCl, 0.25 g/l  
MgSO4.7H2O, 8.53 g/l  Na2HPO4, 4.87 g/l NaH2PO4.2H20, pH 7.0). Note that, β-
mercaptoethanol was added to Z buffer prior to use (0.027 ml/l). The assay was initiated by 
the addition of 0.5 ml o-nitrophenyl-β-D-galactopyranoside (ONPG) solution, dissolved in Z 
buffer (3.92 g/l). Once the solution had changed from a clear colour to a straw yellow colour, 
or 1 h elapsed, 1 ml 1 M sodium carbonate was added to stop the reaction and the exact 
reaction time recorded. The absorbance at 420 nm of the resultant solution was measured and 
the calculation of β-galactosidase activity was calculated as follows: 
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                                                  1000 x 2.5 x 3.6 x OD420nm 
β-galactosidase activity =                                         nmol/min/mg bacterial mass 
                                OD650nm x 4.5 x t x v                                            
Where: 2.5 = factor for conversion of OD650 into bacterial mass, based on OD650 of 1.0 being 
         equivalent to 0.4 mg/ml bacteria (dry weight).  
            3.6 = final assay volume (ml) 
   1000/4.5 = factor for conversion of OD420 into nmol o-nitrophenyl (ONP), based on 1  
                     nmol ml
-1 
ONP having an OD420 of  0.0045 
    t = incubation time (min) 
               v = volume of lysate added (in ml)    
 
Each experiment was done in triplicate and the mean and standard deviation calculated 
accordingly.  
2.9 In vitro promoter analysis  
2.9.1 Electrophoretic mobility shift assay (EMSA) 
For preparation of promoter fragments to be used in EMSA, vectors containing cloned EcoRI-
HindIII promoter fragments were digested with EcoRI and HindIII and treated with calf 
intestinal phosphatase, as described in section 2.4.4. Promoter fragments were then purified 
and concentrated by electroelution from a 7.5% polyacrylamide gel, phenol/chloroform 
extraction and ethanol precipitation, as described in section 2.4. Promoter fragments were 
then end-labelled with [γ-
32
P]-ATP using T4 polynucleotide kinase (PNK), which catalyses 
the transfer of the γ-phosphate from ATP to 5' terminal hydroxyl groups in DNA. To do this, 





P]-ATP giving a total reaction volume of 20 µl. Samples were then incubated at 
37°C for 30 min. Unincorporated [γ-
32
P]-ATP was then removed by passing the sample down 
a Sephadex G-50 column. These columns were made by the addition of 400 µl 50% 
Sephadex-G50 suspension (5 g sephadex G-50 [Pharmacia Biotech] autoclaved in 100 ml TE 
buffer, washed three times in 150 ml TE buffer and finally suspended in 50 ml TE buffer) 
onto a Micro Bio-Spin column (Bio-Rad) and centrifugation at 3,500 rpm for 2 min. The 
column was then placed into a fresh collection tube, and the 20 µl labelling reaction was 
loaded carefully onto the column and centrifuged for a further 2 min at 3,500 rpm.  
For analysis of CRP and Fis binding to promoter fragments, purified CRP and Fis protein was 
used, which was kindly donated by David Lee and David Grainger and purified as described 
by (Ghosaini et al., 1988) and (Pan et al., 1996), respectively. CRP and Fis were diluted to 10 
x the desired final concentration in protein dilution mix (1 x HEPES buffer [10 x HEPES; 200 
mM HEPES (pH8.0), 50 mM MgCl2, 500 mM potassium glutamate, 10 mM dithiothreitol], 1 
mg/ml bovine serum albumin [BSA]). The total reaction volume was 10 µl, containing 1 x 
HEPES, 0.2 mM cAMP, 0.5 mg/ml BSA, 25 ng/µl herring sperm DNA, 0.2-0.4 [γ
 32
P]-
labelled EcoRI-HindIII promoter fragment, 5% glycerol. Samples were incubated for 30 min 
at 37°C and loaded directly onto a 6% polyacrylamide gel containing 0.2 mM cAMP, which 
had been pre-run at 166 V for 30-60 min. The total 10 µl reaction was loaded onto the gel 
alongside 2 µl of loading dye, as a point of reference. The samples were then separated by 
electrophoresis at 166 V for approximately 2 h in 0.5 x TBE. The gels were then removed 
from the glass plates and fixed in 10% methanol/10% glacial acetic acid for 10-20 min, placed 
onto filter paper and dried under vacuum for 20-30 min. The gels were then exposed to a Fuji 
Imaging Phosphor screen for 1-3 h or overnight. The phosphor screen was scanned using a 
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Bio-Rad Molecular Imager FX and images were analysed using QuantityOne software 
(BioRad).   
2.9.2 In vitro DNA footprinting 
2.9.2.1 Preparation of radio-labelled promoter fragments for footprinting 
AatII-HindIII promoter fragments were digested from large-scale prepared (section 2.4.3.1) 
pSR and used for DNA footprinting reactions. To ensure labelling of only one strand of the 
promoter fragment, approximately 100 µg of plasmid DNA was incubated with 8 µl HindIII 
and 12 µl of supplied buffer 2 (NEB) in a total reaction volume of 120 µl for 3 h at 37°C, then 
treated with 5 µl CIP for 1 h, to remove 5' hydroxyl groups. The digested plasmid was then 
purified by phenol/chloroform extraction and ethanol precipitation and the resulting 50 µl of 
purified DNA was digested with 8 µl AatII in a total of 80 µl 1 x buffer 4 (NEB). After 3 h 
digestion at 37°C, the reaction was loaded onto a 7.5% polyacrylamide and the AatII-HindIII 
digested fragment was purified by electroelution followed by phenol/chloroform extraction 
and ethanol precipitation. Finally, the fragments were re-suspended in 50 µl TE and checked 
for purity and concentration on a 7.5% polyacrylamide gel. The AatII-HindIII promoter 
fragments were then end-labelled with [γ
 32
P] on the HindIII end as described in section 2.9.1. 
2.9.2.2 Preparation of G+A ladder 
AatII-HindIII radio-labelled promoter fragments, as prepared above, were treated with formic 
acid followed by piperidine cleavage, to generate Maxam-Gilbert G+A ladders, for use in 
calibrating DNA footprinting gels. To do this, 3-4 µl labelled promoter fragments were made 
up to a final volume of 12 µl in SDW, mixed with 50 µl 100% formic acid and incubated at 
room temperature for 1.5 min. The reaction was stopped by the addition of 700 µl 100% ice-
cold ethanol and 200 µl 0.3 M sodium acetate (pH 7.0) and DNA was precipitated as in 
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section 2.4.3.3. The DNA pellet was re-suspended in 100 µl piperidine and this cleavage 
reaction was incubated at 90°C for 30 min. Samples were then ethanol precipitated and re-
suspended in 20 µl denaturing gel loading buffer (40% deionised formamide; 5 M urea, 5 mM 
sodium hydroxide, 1 mM EDTA, 0.025% bromophenol blue, 0.025% xylene cyanole FF). 
Prior to loading on a gel, the G+A ladder was heated at 90°C for 2 min and 0.5-2 µl loaded 
onto a footprinting gel.  
2.9.2.3 DNase I footprinting  
DNase I footprinting was carried out in order to map the positions of CRP and Fis binding at 
various promoters. For each reaction, 0.1-0.3 end-labelled AatII-HindIII promoter fragments 
were mixed with a final concentration of 0-400 nM CRP and 0-1600 nM Fis, as indicated, in a 
final volume of 20 µl containing 1 x HEPES buffer, 0.2 mM cAMP, 0.5 mg/ml BSA and 30 
µg/ml Herring sperm DNA. Proteins were diluted to 10 x required concentration in protein 
dilution mix (1 x HEPES, 1 mg/ml BSA), prior to addition to the reaction mixture. Samples 
were incubated at 37°C for 20 min, to allow proteins to bind DNA, prior to DNase I 
treatment. Following incubation, 2 µl of a 1:1320 dilution of DNase I (10 U/µl, Roche 
Applied Science) in SDW was added to each reaction and incubated at 37°C for 40 s. To stop 
the reaction, 200 µl of DNase I stop solution (0.3 M sodium acetate [pH 7.0], 10 mM EDTA) 
was added. DNA samples were purified and concentrated by phenol/chloroform extraction 
and ethanol precipitation as described in section 2.4 and re-suspended in 7 µl denaturing gel 
loading buffer. All samples were then heated to 90°C for 2 min, 3.5 µl was loaded onto a 
denaturing 6 % acrylamide sequencing gel alongside „G+A‟ ladder and separated by 
electrophoresis in 1 x TBE for approximately 1.5-2 h. Gels were then dried and analysed as 
described in section 2.9.1.  
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2.9.2.4 Potassium permanganate footprinting 
Potassium permanganate footprinting was carried out in order to examine open complex 
formation at various promoters. Potassium permanganate modifies unpaired thymine residues 
in single stranded regions of DNA as found in open complexes at transcription start sites. 
Subsequent treatment with piperidine cleaves the DNA backbone on the 3' side of the 
modified thymine residues. For each reaction, 0.2-0.4 µl end-labelled AatII-HindIII promoter 
fragments were mixed with a final concentration of 50 nM E. coli RNA polymerase (RNAP) 
σ
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 holoenzyme, 50 nM CRP and 0-1600 nM Fis, as indicated, in a total volume of 20 µl 1 x 
HEPES, 0.2 mM cAMP and 0.5 mg/ml BSA. Proteins were diluted to 10 x the required 
concentration in protein dilution mix (1 x HEPES, 1 mg/ml BSA), prior to addition to the 
reaction mixture. Samples were then incubated at 37°C for 30 min, to allow proteins to bind 
DNA. Following incubation, 1 µl of freshly prepared 200 mM potassium permanganate was 
added to the reaction, incubated for 4 min at 37°C and 50 µl potassium permanganate stop 
solution (3 M ammonium acetate, 0.1 mM EDTA, 1.5 M β-mercaptoethanol) was then added 
to stop the reaction. 150 µl SDW was added to the reactions to make the volume up to 200 µl 
and DNA was then purified by phenol/chloroform extraction and ethanol precipitation, with 
re-suspension of the final DNA pellet in 40 µl 1 M piperidine. Samples were incubated with 
piperidine for 90°C for 30 min, to allow cleavage of the DNA to occur. Again, following 
incubation, the DNA was purified by phenol/chloroform extraction and ethanol precipitation, 
with the final dried DNA pellet being re-suspended in denaturing gel loading buffer. 3.5 µl of 
each sample was then heated to 90°C for 2 min and loaded onto a 6% denaturing 
polyacrylamide sequencing gel alongside „G+A‟ ladder and separated by electrophoreses for 
approximately 1.5-2 h. Gels were then dried and analysed as described in section 2.9.1.  
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2.9.3 In vitro transcription assays 
Using purified RNAP, CRP and Fis, multiple-round in vitro transcription assays were 
performed, using caesium chloride preparations of pSR plasmid, carrying various EcoRI-
HindIII promoter fragments, as template. CRP, Fis and RNAP were diluted to 10 x the desired 
final concentration, as indicated, in protein dilution mix (1 x transcription buffer [10 x 
transcription buffer; 400 mM Tris-Cl [pH 7.9], 100 mM MgCl2, 500 mM KCl, 1mM DTT], 
1mg/ml BSA), and added to a final volume of 20 µl containing 1 x transcription buffer, 0.1 
mg/ml BSA, 500 µM ATP, 500 µM CTP, 500 µM GTP, 50 µM UTP, 5 µCi [
32
P]-UTP, 0.2 
mM cAMP and 80 nM pSR plasmid DNA, carrying the promoter of interest. All samples 
were incubated at 37°C for 30 min, prior to adding RNAP, to allow proteins to bind DNA. 
RNAP was then added at a final concentration of 50 nM and incubated at 37°C for 20 min 
before adding 10 µl denaturing loading buffer (40% deionised formamide, 5 M urea, 5 mM 
sodium hydroxide, 1 mM EDTA, 0.025% bromophenol blue, 0.025% xylene cyanole FF) to 
stop the reaction. 4 µl was loaded directly onto a 6% denaturing polyacrylamide gel, 
alongside „G+A‟ sequence ladder, as prepared above, and gels run in 1 x TBE for 
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The moniker “Autotransporter” was originally coined by Meyer and colleagues to describe 
the mechanism of IgA1 protease secretion from N. gonorrhoea (Pohlner et al., 1987) (Section 
1.6). These investigators proposed that the three domain architecture of IgA1 protease, and 
other ATs, was sufficient to mediate translocation of the functional protease to the exterior of 
the cell. Early on, this supposition was questioned as no rational explanation was provided for 
how these large proteins could be translocated across the cell envelope without degradation, 
how they might fold on the cell surface, how the passenger domain could be released from the 
cell or how some ATs with unusual signal sequences were targeted to the inner membrane 
(Henderson et al., 1998). As a result of these contentions, several groups sought accessory 
factors which might aid AT biogenesis. Jose et al. (1996) were the first to demonstrate that 
the ATs formed a periplasmic intermediate and as such it was hypothesised that the ATs 
might interact with periplasmic chaperones during transit through the periplasm (Henderson et 
al., 1998). In the intervening years, several groups have demonstrated that the periplasmic 
chaperones SurA, DegP and Skp play a role in AT biogenesis, functioning to protect ATs 
from degradation by periplasmic proteases and to maintain the ATs in a translocation 
competent state (Purdy et al., 2007) (see Section 1.6.3). Several of the periplasmic chaperones 
interact with the β-barrel Assembly Machinery (BAM) which is composed of five proteins 
termed BamA-E (Section 1.3.3). The necessity of BamA for AT biogenesis was first 
demonstrated by Tommassen and co-workers (Voulhoux et al., 2003), with later studies 
showing a direct interaction between BamA and ATs during AT biogenesis (Ieva and 
Bernstein, 2009; Ruiz-Perez et al., 2009; Sauri et al., 2009). In addition to the demonstration 
that several proteins are required for periplasmic transit and subsequent OM translocation of 
AT passenger domains, several studies identified a variety of proteases that are essential for 
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cleavage of ATs from their b-barrel translocators (Dautin and Bernstein, 2007). This 
accumulated body of evidence indicates that the AT pathway is more complex than initially 
suggested.  
On the basis of the controversial nature of AT biogenesis, our laboratory adopted a non-biased 
random-transposon-mutagenesis strategy to identify novel factors required for AT biogenesis. 
A bank of previously generated random-transposon mutants of Enteroaggregative E. coli 
strain 042 (EAEC 042) was screened for the secretion of Pet, an archetypal autotransporter 
(Sheikh et al., 2001). Western immunoblotting of supernatant fractions from ca. 11,000 
mutants (~ 2-fold coverage) and subsequent sequencing of the transposon insertions of those 
mutants deficient in Pet secretion, identified over 60 genes that were observed to have a 
significant reduction in Pet secretion and thus were taken for further study (Table 3.1). To 
determine how the gene products of these loci are integrated into the mechanism of Pet 
biogenesis, studies were undertaken to investigate the impact that loss of these genes had on 
Pet translocation across the cell envelope and on pet transcription. Note that this screen would 
not enable the identification of any essential genes that are required for Pet biogenesis. 
3.2 RESULTS 
3.2.1 Veracity of defined E. coli BW25113 K-12 mutants by PCR 
Using single primer PCR to identify the sites of transposon insertion in EAEC 042, which 
abolished Pet secretion, it was noted that ca. 15% of the mutants had more than one 
transposon insertion. Furthermore, it is well recognised that such mutagenesis strategies can 
result in second site mutations elsewhere in the genome that might obscure the true phenotype 
of the mutant. Based on these observations it was deemed necessary to utilise strains with 
defined mutations to investigate the impact that loss of the genes listed in Table 3.1 had on 
87 
 
Table 3.1 List of genes and gene functions used in this study 
Gene name Relevant function 
ackA Acetate kinase A and propionate kinase 2 
adiY DNA-binding transcriptional activator putative ARAC-type regulatory 
protein 
ais Conserved protein induced by aluminium 
bamB Outer membrane lipoprotein component of the BAM complex, involved 
in outer membrane protein incorporation into the outer membrane 
bamC Outer membrane lipoprotein component of the BAM complex, involved 
in outer membrane protein incorporation into the outer membrane 
bamE Outer membrane lipoprotein component of the BAM complex, involved 
in outer membrane protein incorporation into the outer membrane 
cadA Lysine decarboxylase 1 
celB Unkown function 
clpB Protein disaggregation chaperone heat shock protein 
crp DNA-binding transcriptional dual regulator, cyclic AMP receptor 
protein 
crr Glucose-specific enzyme IIA component of PTS 
cspG DNA-binding transcriptional regulator homolog of Salmonella cold 
shock protein 
cysK Cysteine synthase A, O-acetylserine sulfhydrolase A subunit 
degP Periplasmic chaperone/protease 
dnaG DNA biosynthesis; DNA primase 
fkpA FKBP-type peptidyl-prolyl cis-trans isomerase (rotamase) 
fis Site-specific DNA inversion stimulation factor; DNA-binding protein 
folX D-erythro-7,8-dihydroneopterin triphosphate 2'-epimerase 
lon DNA-binding, ATP-dependent protease La; heat shock K-protein 
mhpC 2-hydroxy-6-ketonona-2,4-dienedioic acid hydrolase 
nei Endonuclease VIII 




Table 3.1 List of genes and gene functions used in this study (continued) 
Gene name Relevant function 
pal Peptidoglycan-associated outer membrane lipoprotein 
pitA Phosphate transporter 
pqiB Paraquat-inducible protein B 
 prmA Ribosomal protein L11 methyltransferase 
 proP Proline/glycine betaine transporter 
 proW Glycine betaine transporter subunit high-affinity transport system for glycine 
betaine and proline; membrane component of ABC superfamily 
 rfaJ UDP-D glucose:(galactosyl)lipopolysaccharide glucosyltransferase 
 rlpA Minor lipoprotein 
 skp Periplasmic chaperone 
 slyB Putative outer membrane protein 
 surA Periplasmic chaperone (peptidyl-prolyl cis-trans isomerase) 
 thiC Thiamin (pyrimidine moiety) biosynthesis protein 
 uvrD DNA-dependent ATPase I and helicase II 
 uxuR DNA-binding transcriptional repressor regulator for uxu operon 
 yafO Predicted antitoxin of the YafO-YafN toxin-antitoxin system 
 ybbB tRNA 2-selenouridine synthase 
 ybeL Conserved protein putative alpha helical protein 
 ybhC Predicted pectinesterase putative pectinesterase 
 ydiM Predicted transporterputative transport system permease protein 
 ydiN Predicted transporter putative transport system permease protein 
 yeiC Predicted pseudouridine kinase 
yeiL DNA-binding transcriptional activator of stationary phase nitrogen survival 
stationary phase nitrogen starvation regulator 
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Table 3.1 List of genes and gene functions used in this study (continued) 
Gene name Relevant functin 
 yeiM NUP transporter 
 yfbV Conserved inner membrane protein 
 yfcI Putative transposase, YhgA-like 
 yfeK Unknown function 
 ygeV Predicted DNA-binding transcriptional regulator putative transcriptional 
regulator 
 ygjI Transmembrane amino acid transporter protein 
yhdG(dusB) tRNA-dihydrouridine synthase B 
 yhiL Unknown function 
 yhiN Predicted oxidoreductase with FAD/NAD(P)-binding domain 
 yiaG Helix-turn-helix XRE-family like proteins. Prokaryotic DNA binding 
proteins belonging to the xenobiotic response element family of 
transcriptional regulators 
 yihN Predicted transporter putative resistance protein 
 yihR Predicted aldose-1-epimerase 
 yjdL Predicted DNA-binding transcriptional regulator putative ARAC-type 
regulatory protein 
 yjiC Hypothetical protein 
 ykgG Uncharacterised ACR, YkgG family 
 ynbC Lysophospholipase 
 yohM Membrane protein conferring nickel and cobalt resistance 
 yphF Predicted sugar transporter subunit: periplasmic-binding component of ABC 
superfamily putative LACI-type transcriptional regulator 
 yqiH Predicted periplasmic pilin chaperone 
 yshA(ompL) 
 




AT biogenesis. It was decided to utilise mutants created in a laboratory strain of E. coli since 
it has consistently been demonstrated that the biogenesis of ATs is largely unaffected by 
expression in such strains. To achieve these ends we utilised the E. coli BW25113 KEIO 
mutant library. The KEIO library is a collection of in-frame, single-gene knockout mutants, 
with independently made duplicate copies where the gene of interest has been replaced with a 
cassette encoding kanamycin resistance (Baba et al., 2006). During the course of this project 
we noted inconsistent phenotypes attributable to strains apparently harbouring the same 
mutations.  As a result, all mutants required for this study were checked for their veracity. For 
each proposed mutant, six independent colonies were obtained after growth on LB-agar 
containing kanamycin. Each colony was screened by PCR as outlined in Chapter 2, section 
2.5, using primers shown in the Appendix, Table 1. Gel electrophoresis of the resulting 
products was used to confirm the presence or absence of the kanamycin cassette in the target 
gene. A representative agarose gel is shown in Figure 3.1. Mutants without a verifiable 
mutation were removed from further study. Those mutants with a verified genetic lesion were 
used for further study and their name and putative function are listed in Table 3.1. 
In addition, to the ~70 genes identified through the random mutagenesis approach we selected 
a number of additional mutants to screen. These additional mutants were based on previously 
known functional interactions between their gene products and the proteins encoded by the 
genes identified through transposons mutagenesis. Thus, as we had identified the periplasmic 
chaperones DegP and SurA through the transposons screening process, we added mutants 
lacking the genes encoding other known periplasmic chaperones i.e. Skp, PpiA, PpiD and 
FkpA. Similarly, we identified a mutation in bamB, so strains carrying mutations in bamC and 




Figure 3.1. Gel electrophoresis analysis of PCR products. This figure shows the products of a 
PCR reaction using primers that flanked loci of interest in the E. coli BW25113 strain (WT) 
and the indicated E. coli BW25113 mutant strains. The mutant strain was verified when the 
PCR product equalled that of the kanamycin cassette (~1500 bp) and was different to that of 
the native size gene in WT. In instances where the native size of the gene equalled that of the 
kanamycin cassette (as shown here by ΔybhC), the PCR was repeated using primers that 
annealed to the kanamycin cassette. PCR products were resolved on a 1% agarose gel, pre-
stained with Sybr-Green and visualised using a UV transilluminator. MW; molecular weight 





3.2.2 Impact of mutations on pet transcription 
We hypothesised that some of the loci identified through the transposon screen may be 
involved in the initial stage of Pet biogenesis i.e. transcription. In order to test this hypothesis, 
the well studied b-galactosidase assay was employed to measure pet promoter activity. Thus, 
the minimal region of the pet promoter required for Pet secretion (Desvaux et al., 2006), 
herein termed the AER1 fragment (Fig. 3.2), was amplified by PCR from the recombinant 
plasmid pCEFN1 (Chapter 2, Table 2.2) using primers Pet_F and Pet_R (Chapter 2, Table 
2.3). The fragment was cloned into the pRW50 low copy number lac expression vector, as 
described in Chapter 2, section 2.4.7. The resulting recombinant (AER1/pRW50) was 
transformed into the E. coli K-12 Δlac strain BW25113 and its isogenic derivatives 
harbouring the defined mutations listed in Table 3.1. Measurements of β-galactosidase 
activities in the different strains revealed four categories of mutants (Fig. 3.3). In 59 cases, 
transcription was unaffected e.g. ybbB. For 19 mutants, transcription from the pet promoter 
was increased e.g. surA. For 15 genes, transcription was decreased in the respective mutant, 
including the genes encoding the well-known transcriptional regulators Fis and CRP. Finally, 
in 20 instances the duplicate mutants gave discrepant results e.g. transcription from the pet 
promoter in the E. coli yjhR1 is indistinguishable from the wild-type strain E. coli 
BW25113, however transcription from E. coli yjhR2 is significantly increased when 
compared to wild-type. 
3.2.3 Creation of defined E. coli HB101 mutant strains. 
Having established that some mutants affected transcription, we wished to test whether loss of 
other genes would affect later stages of Pet biogenesis.  However, inconsistencies between the 
promoter activities in the independent copies of the E. coli BW25113 KEIO mutant library
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HindIII Pet  
 
(+1) 
Figure 3.2. Base sequence of the AER1 fragment containing the pet gene regulatory region. This figure shows the EcoR1-HindIII AER1 fragment, 
cloned into the promoter-less lac expression vector, pRW50. The Pet ATG start codon is underlined and indicated with a horizontal arrow. The 






























































































































































































































































Figure 3.3. pet promoter activities in defined E. coli mutant backgrounds. A-K. This figure 
illustrates measured β-galactosidase activities in E. coli BW25113 and mutant backgrounds 
containing pRW50 with the pet promoter fragment, AER1. Cells were grown aerobically in 
Luria–Bertani broth at 37°C and harvested during early log phase. β-galactosidase activities are 
expressed as a percentage of the activity of the pet promoter in the E. coli BW25113 wild type 
strain (WT). Each activity is the average of three independent experiments. The unpaired t-test 
was used to compare differences between the promoter activities of mutant backgrounds versus 




strain led us to believe that there may be gene duplications or undetected mutations present in 
some of these strains. Therefore, defined mutations were constructed in the lab strain E. coli 
HB101 by a method based on the λ-Red system (Chapter 2, section 2.6). However, given the 
large number of loci identified in the original transposon screen and time constraints, we 
selected only a defined set of mutants for use in the further studies. From the results of the 
transcription screen shown in Figure 3.3, and the original transposon screen, we selected 
mutants that we thought to be involved in pet transcription; CRP and Fis, mutants that may be 
involved in the transit of Pet across the periplasm; SurA, Skp, DegP, PpiA, PpiD, FkpA and 
mutants that may be involved in outer membrane insertion and/or translocation, which 
included mutants in the BAM complex, BamA - BamE. All mutants were screened by PCR to 
verify the mutation was correct.  
3.2.2 Inner and Outer membrane translocation assays.  
Having demonstrated that each of the HB101 mutants was correct, we sought to determine 
whether inner membrane translocation was affected in these mutant strains. To do this, a 
construct containing a previously constructed Pet-alkaline phosphatase (PhoA) reporter 
fusions (pQMDSSpet) was used (Desvaux et al., 2007). This reporter construct utilises an 
inducible promoter and a translational fusion of PhoA to the N-terminal portion of Pet that 
contains the native Pet signal sequence; thus the efficiency of the Pet signal sequence in 
directing inner membrane translocation is determined by the accumulation of active PhoA 
enzyme in the periplasm at a specified time post-induction. To assay for inner membrane 
translocation the E. coli HB101 mutants mentioned above were transformed with 
pQMDSSpet and the equivalent empty vector pQuantagen(kx) and the levels of PhoA activity 
were measured (Desvaux et al., 2007). The data in Figure 3.4 demonstrate that for all the 




Figure 3.4. Efficiency of the Pet signal sequence in mediating inner membrane 
translocation. This figure illustrates the specific activity of periplasmic PhoA expressed 
from the Pet signal sequence-PhoA fusion (pQMDSSpet) or PhoA in the absence of any 
signal sequence (pQUANTagen(kx), measured in the indicated mutant backgrounds. Each 
activity is the average from three independent experiments. The efficiency of the Pet signal 
sequence in mediating inner membrane translocation remains unaffected in the absence of 






















































inner membrane translocation was not compromised. In all cases, statistically insignificant 
PhoA activity was observed for strains harbouring pQuantagen(kx).   
Having established that the E. coli HB101 mutants described above lacked defects in inner 
membrane secretion we sought to confirm that there was a defect in secretion of Pet as 
indicated by the transposon mutagenesis experiments. Thus, each mutant was transformed 
with pCEFN1 and after growth to mid-log phase supernatants fractions were harvested, 
normalised for bacterial numbers and analysed by SDS-PAGE for the presence of Pet. 
Mutants defective for production of CRP and Fis show significantly diminished levels of Pet 
accumulating in the extracellular milieu (Figure 3.5). Similarly, degP and surA null mutants 
showed significant abrogation of Pet secretion. Notably, the fkpA, ppiA and ppiD mutants 
produced Pet at levels similar to the wild-type strain, an observation consistent with the fact 
these loci were not identified via the transposon mutagenesis strategy. Interestingly, the skp 
mutant revealed diminished levels of Pet production. The BAM complex mutants are 
considered below. 
3.2.4 Role of the BAM complex in AT biogenesis 
3.2.4.1 BamA and BamD are required for Pet biogenesis 
Given that SurA has recently been shown to deliver unfolded OMPs to the BAM complex 
(Hagan et al., 2010) and that there is a body of evidence supporting a role for BamA in the 
secretion of ATs, we sought to characterise the precise role of the other BAM components in 
AT biogenesis. To do this, we first examined the role of the essential BamA and BamD 
proteins in Pet biogenesis. Full-length Pet protein was expressed under the control of its 
native promoter in BamA (Lehr et al., 2010) and BamD (Malinverni et al., 2006) depletion 




Figure 3.5. Secretion of Pet in defined E. coli HB101 mutants. SDS-PAGE analysis of 
trichloroacetic acid-precipitated culture supernatant fractions harvested after the growth of 
E. coli HB101 and indicated mutants, containing pCEFN1 or empty vector (EV). A. Pet 
was detected by SDS-PAGE followed by western immunoblotting using a polyclonal rabbit 
antiserum generated toward the Pet passenger domain (Eslava et al., 1998). B. Pet was 
detected by SDS-PAGE followed by coomassie blue staining. The sizes of the molecular 











pACYC184/pet, respectively (Plasmid details listed in Chapter 2, Table 2..2). In the 
respective depletion strains, expression of bamA or bamD is under the control of the pBAD 
promoter, such that expression is induced in the presence of arabinose but repressed in its 
absence. After growth under both replete (with arabinose) and depletion (without arabinose) 
conditions, the culture supernatant fractions were harvested from the BamA and BamD 
depletion strains and supernatant proteins were TCA precipitated. Precipitated proteins were 
resolved by SDS-PAGE, and detected by Coomassie staining. Results in Figure 3.6 illustrate 
that when both BamA and BamD are depleted from the cells, secretion of Pet into the culture 
medium is severely diminished. These results confirm previous observations that BamA is 
required for AT biogenesis and demonstrate, for the first time, an essential role for BamD in 
AT biogenesis. 
3.2.4.2 BamB, BamC and BamE are not required for AT biogenesis. 
While BamA has been implicated in the biogenesis of all examined ATs (Jain and Goldberg, 
2007; Sauri et al., 2009) the roles of the non-essential components of the BAM complex 
(BamB, BamC, and BamE) have not yet been fully investigated. In order to determine the role 
of these accessory factors in AT biogenesis, bamB, bamC, and bamE deletion mutants were 
constructed in laboratory strain E. coli HB101 and wild-type UPEC strain CFT073 using the 
λ-Red system, described in Chapter 2, section 2.6 (Datsenko and Wanner, 2000). In each 
mutant, the absence of the relevant endogenous protein in whole-cell lysates was confirmed 
by Western immunoblotting (Fig. 3.7, A). Anti-BamE antibodies were previously described 
(Knowles et al., 2011); Anti-BamB and BamC antibodies were raised and purified as 
previously described (Rossiter et al., 2011b). For analysis of Pet biogenesis, E. coli HB101 
and its mutant derivatives were transformed with pCEFN1 and the empty vector, pSPORT1. 




Figure 3.6. BamA and BamD are required for Pet secretion. BamA and BamD are 
required for Pet secretion. Shown are Coomassie blue-stained SDS-PAGE of 
trichloroacetic acid-precipitated supernatant proteins and Western blot analysis of 
whole-cell extracts from cultures of BamA depletion strain E. coli JWD3 (A) and 
BamD depletion strain E. coli JCM290 (B). A. E. coli JWD3, carrying either the empty 
pSPORT1 vector (lanes 1 and 3) or pCEFN1 (lanes 2 and 4), was grown in LB medium 
containing 100 µg/ml ampicillin supplemented with either 0.2% L-arabinose (Ara) (+) 
or 0.2% D-fructose (-). B. E. coli JCM290, carrying either pACYC184/pet (lanes 2 and 
4) or the empty vector (lanes 1 and 3), was grown in LB medium containing 30 µg/ml 
chloramphenicol supplemented with either 0.05% L-arabinose (+) or 0.05% D-fructose 
(-). For both panels A and B, overnight cultures were diluted into a volume of 50 ml 
(OD600=0.025) and grown at 37°C with shaking for 3 h. Cultures were harvested, and 
supernatant proteins were precipitated with 10% trichloroacetic acid. BamA, BamD, 
and OmpF were detected using antiserum raised in a rabbit, and the α subunit of RNA 
polymerase (αRNAP) was detected using mouse monoclonal antibodies (Neoclone). 
Blots were developed using the ECL Plus Western blotting detection system (GE 
Healthcare). Like OmpF levels, under BamA and BamD depletion conditions, Pet levels 
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Figure 3.7. BamB, BamC and BamE are not required for the biogenesis of Pet or Ag43. 
SDS-PAGE followed by western immunoblotting blot was used to analyse Pet and Ag43 
biogenesis in ∆bamB, ∆bamC and ∆bamE cells. A. Construction of bamB, bamC, and 
bamE null mutations in E. coli HB101 and E. coli CFT073. Whole-cell lysate of each 
mutant was prepared by spinning down 1 ml of an overnight culture and re-suspending it in 
Laemmli buffer. Samples were separated by SDS-PAGE and western immunoblotted with 
antibodies raised to BamB, BamC, and BamE, confirming the absence of the relevant 
protein from each mutant. B. For analysis of Pet biogenesis, cells harbouring either 
pCEFN1 (Pet +) or pSPORT1 (Pet -) were grown to an OD600=1.0 and pelleted. The 
supernatant fractions were then filter sterilised and a final volume of 10% trichloroacetic 
acid was used to precipitate proteins. Pet was localised by SDS-PAGE followed by western 
immunoblotting. For analysis of Ag43 biogenesis, a heat release assay was performed on 
cells, transformed with a plasmid carrying the full length Ag43 under control of an 
arabinose induced promoter, as described in the text. The heat release assay is used to break 
the non-covalent interactions between Ag43 and the outer membrane, thereby releasing free 
Ag43, which is then TCA precipitated, as above. 
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section 2.7 and Pet was detected by Western immunoblotting using a polyclonal rabbit 
antiserum generated toward the Pet passenger domain (Eslava et al., 1998). Data in Figure 
3.7, B show that accumulation of Pet in the culture medium was unaffected by the absence of 
BamB, BamC, or BamE. To gain a more complete picture of Pet biogenesis, we also 
examined the production of the C-terminal β-barrel of Pet. In each case, the levels of the Pet 
β-barrel were unaffected by the absence of the BAM components, and the β-barrel remained 
heat modifiable (Rossiter et al., 2011b), indicating that it was inserted in the outer membrane 
in its native conformation. To ensure that these effects were not specific to Pet, we examined 
the influence of these mutations on another AT, namely, biofilm-promoting Ag43. E. coli 
HB101 and its knockout derivatives were transformed with agn43-containing plasmid pCO2, 
which contains full length Ag43 under the control of the pBAD promoter. After growth in 
both the presence and absence of arabinose expression levels were monitored using the 
previously described heat release assay which detects Ag43 release from the bacterial cell 
surface. The resulting samples were analyzed by SDS-PAGE and Western immunoblotting 
with anti-Ag43 antibodies (Fig. 3.7, B). The levels of Ag43 were unaffected, indicating that 
BamB, BamC, and BamE are not required for the translocation of Ag43 to the exterior of the 
cell. These observations were confirmed for production of the Sat AT cytotoxin in the wild-
type strain and mutant versions of UPEC CFT073 (data not shown). While secretion is 
unaffected, it remains possible that folding of the passenger domain is abnormal. To test this 
hypothesis, we quantified the functional activity of Pet and Ag43 as a direct indicator of 
protein folding. An azocasein assay was used to test the function of Pet as described in 
(Rossiter et al., 2011b). In all of the mutants, the enzymatic activity of Pet was 
indistinguishable from those of the wild-type, indicating that BamB, BamC, and BamE are 























Figure 3.8. BamB, BamC, and BamE are not required for folding of Ag43 passenger 
domains. If the Ag43 passenger domain does not fold correctly, it will not be able to 
perform its extracellular function of mediating cell-cell aggregation. To determine if BamB, 
BamC, or BamE influences the folding of the Ag43 on the cell surface, the ability of Ag43 
to mediate cell-cell aggregation was quantified in wild-type E. coli HB101 and mutant 
derivatives. No difference in the rate of sedimentation between the mutants and the parent 
strain was observed. In contrast, the E. coli HB101 strain lacking the gene encoding Ag43 
(Δagn43) did not aggregate at all. These data indicate that Ag43 is not aberrantly folded. 
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cell aggregation assay was performed as described in Chapter 2, section 2.7.7. Data in Figure 
3.8 shows that the ability of Ag43 to mediate cell-cell aggregation remains unaffected in the 
absence of BamB, BamC and BamE also indicating these lesions do not affect folding of 
passenger domains.  
3.3 DISCUSSION  
Whilst the initial transposon screen of EAEC 042 carries with it a large margin of error, the 
subsequent screen of defined mutations in E. coli K-12 has led to the identification of novel 
factors involved in AT biogenesis. From the study of pet promoter activity in these mutants it 
was found that two of the well characterised „global‟ transcription factors of E. coli, CRP and 
Fis, are required for transcription activation of pet (Fig. 3.3, A and H). Crr and CyaA are 
intimately involved in the synthesis of cAMP, which mediates the allosteric activation of 
CRP. Thus the crr and cyaA strains are likely to be deficient in cAMP production and thus 
cause an indirect effect on pet transcription due a lack of active CRP. However, at this stage it 
is a possibility that the deletion of CRP and Fis causes a pleiotropic phenotype, which 
indirectly causes a reduction in pet promoter activity. Further work to confirm a role for CRP 
and Fis in pet transcription is investigated in detail in Chapter 4. Additionally, a significant 
reduction in pet promoter activity was seen in the BW25113 ΔuvrD strain. Given that uvrD 
encodes for a DNA helicase involved in nucleotide excision repair, it is difficult to envisage a 
direct involvement for UvrD in pet transcription and it is more likely that this has an effect on 
the reporter plasmid pRW50, such as replication (Bruand and Ehrlich, 2000). Unexpected 
changes in pet transcription were seen in the mutants encoding for the periplasmic 
chaperones, SurA, Skp, DegP and FkpA (Fig. 3.3, J and K). In the strains, which carry 
mutations in SurA and Skp and also the TolQ and Pal mutants, which are components of the 
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cell envelope spanning Tol-Pal complex, pet transcription is significantly increased (Fig. 3.3, 
B and E). A common phenotype observed in all of these strains is perturbations to the cell 
envelope. An elaborate response to cell envelope stress is mediated by the CPX system, which 
is a two component system that is able to sense outer membrane stress and mediate a specific 
transcriptional response. It has been suggested that the CPX system up-regulates proteases, 
folding catalysts and even virulence factors to aid survival in adverse conditions (Dorel et al., 
2006; Raivio et al., 1999). Thus, it may be a plausible explanation that pet expression is up-
regulated by the CPX system in response to cell envelope perturbation. In contrast, pet 
promoter activity in the strains carrying mutations in other periplasmic chaperones, DegP and 
FkpA, was significantly reduced. Discerning a precise reason for this reduction in pet 
promoter activity is unclear, yet it is likely that, again, the phenotype associated with DegP 
and FkpA null mutants triggers an envelope stress response that indirectly affects pet 
expression.  
In accordance with previous studies, we have highlighted a role for SurA and DegP in Pet 
secretion (Fig. 3.5, B). Our data suggest that SurA plays a role in the periplasmic transit of Pet 
and/or delivery of Pet to the BAM complex, given that both transcription and inner membrane 
translocation are not significantly reduced, whereas secretion is severely diminished. An 
extension of this study came with a collaborative effort to establish direct protein-protein 
interactions between these proteins using a variety of techniques including Surface Plasmon 
Resonance. Interactions of DegP and SurA with the homologous AT EspP, from 
enterohaemorrhagic E. coli O157:H7 were observed, where a putative aromatic-polar-
aromatic (aro-x-aro) motif was identified within the EspP β-domain as a candidate binding 
site for these chaperones (Ruiz-Perez et al., 2009). Although, in our hands, we did not see an 
effect of a skp null mutant on Pet biogenesis, our observations were consistent with that seen 
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for EspP such that a surA and a degP null mutant caused a reduction in Pet secretion. 
However, further studies are required to elucidate both specific binding sites and roles for 
these periplasmic chaperones in AT biogenesis. 
Ruiz-Perez and co-workers (2009) were the first to demonstrate a direct interaction of BamA 
with an AT. Our results confirm that BamA is required for Pet biogenesis. However, this 
study has highlighted the additional requirement of BamD for AT biogenesis. This 
observation is consistent with all previous studies which have demonstrated the essential 
nature of BamD in OMP assembly and reinforce the concept that BamA and BamD work in 
concert (Hagan et al., 2010; Malinverni et al., 2006). Previous investigations have 
demonstrated that different OMPs are assembled into the outer membrane via different routes. 
Thus, porins such as OmpF and LamB, as well as the omptin family member OmpT, have 
severe biogenic defects in the absence of BamB, whilst, in contrast, levels of TolC increase in 
a BamB mutant (Charlson et al., 2006; Hagan et al., 2010). Similarly, TolC levels are 
unaffected by loss of BamE whereas biogenesis of porins is marginally affected (Charlson et 
al., 2006; Sklar et al., 2007a; Volokhina et al., 2009). We conclude from our data that, like 
TolC, the AT biogenesis pathway does not require the non-essential lipoproteins BamB, 
BamC, and BamE. However, in contrast to TolC, AT levels do not increase in the absence of 
BamB. These studies suggest that there are at least two distinct pathways for OMP assembly 
in E. coli, one which is dependent on BamB, BamC, and BamE (the porins) and one which is 
independent of these other factors (the ATs and TolC), both of which converge on the core of 
the BAM complex formed by the BamA and BamD subunits.  
Although these studies have made a significant contribution to our understanding of OM 
translocation by ATs, there is large potential to uncover the involvement of further proteins 
that are needed for AT biogenesis. On the basis of the preliminary transposon screen and our 
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transcriptional data outlined in Figure 3.3, further work could be initiated to investigate the 
role for genes encoding proteins such as PitA, TolQ or Pal in Pet secretion, which may re-
















Regulation of the pet promoter by 








Extensive studies on the regulation of bacterial gene expression have elucidated many models 
of transcription initiation (see Chapter 1, section 1.2.7). These models highlight the 
mechanisms used by transcription factors to control the distribution of RNA polymerase 
between promoters. Although many promoters are regulated by relatively simple mechanisms, 
additional complexity is often observed when multiple transcription factors converge on a 
single promoter see Chapter 1, section 1.2.8. Co-regulation of a promoter by two or more 
transcription factors allows responses to a multitude of environmental cues and thus restricts 
virulence gene expression to a particular growth phase or niche. Many virulence genes, or 
pathogenicity islands, are regulated by „local‟ transcription factors, as exemplified by the 
regulation of the Salmonella pathogenicity island 1 (SPI-1) by the transcription factor, InvF 
(Darwin and Miller, 1999). However, the involvement of „global‟ regulators, such as CRP and 
Fis, in the regulation of virulence gene expression is becoming more apparent (See Chapter 1, 
section 1.2.4.2 and 1.2.6.1). As outlined in Chapter 1, section 1.2.4.1 and 1.2.6, CRP and Fis 
modulate transcription initiation via highly distinct mechanisms. At promoters where CRP 
activates transcription, the 16 bp DNA site for CRP is usually located 21 bps upstream from 
the promoter -10 hexamer element, and activation is dependent upon direct interactions 
between two surface exposed determinants, activating region 1 (AR1) and activating region 2 
(AR2) that interact with the C- and N-terminal domains of the RNA polymerase α subunit 
(αCTD and αNTD), respectively (Rhodius et al., 1997). In contrast to the rigidity of CRP-
dependent regulation, the mechanisms observed for Fis-dependent modulation are rather 
promiscuous. In order to extend our initial observations that show pet promoter activity is 
dependent on CRP and Fis in vivo (Chapter 3, section 3.2.1), we have used a combination of 
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 in vitro and in vivo techniques to elucidate the mechanism of transcription initiation, 
focussing attention on this largely elusive area of AT gene regulation.  
4.2 Results 
4.2.1 Bioinformatic analyses of the pet promoter  
The construct AER1/pRW50 outlined in Chapter 3, Figure 3.1 was the starting point for this 
work and formed the basis for all in vivo analyses. On the basis that the E. coli BW25113 
strains harbouring null mutations in either the crp or fis genes significantly reduced pet 
promoter activity, the pet regulatory region sequence was inspected to identify possible DNA 
sites for CRP and Fis, and the promoter -10 element. Using bioinformatic approaches and 
subsequent manual inspection of the nucleotide sequences upstream of the determined 
translational start site, we identified 5′-TACTTT-3′ as the likely -10 hexamer element, a 
single DNA site for CRP centred at position -40.5, and tandem DNA sites for Fis, located 
upstream, centred at positions -91 (Fis I) and -122 (Fis II) (Fig. 4.1). The validity of these 
predictions was confirmed as described below.  
4.2.2 Nested deletion analysis 
To investigate the regulatory elements important for modulating the expression of pet, a 
nested deletion analysis of the AER1 fragment in pRW50 was done by sequentially deleting 
25 bps of the pet regulatory region generating 8 reporter constructs labelled Pet_1 to Pet_8 
(Fig. 4.2, A). The primers used for this deletion analysis are shown in Chapter 2, Table 2.3 
and the regions that they correspond to in the AER1 fragment are highlighted in bold (Fig. 
4.2, A). β-galactosidase activities were determined for the resulting constructs under aerobic 
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Figure 4.1. Base sequence of the AER1 fragment containing the pet gene regulatory region. The Pet ATG start codon is underlined and 
indicated with a horizontal arrow. The predicted transcript start site is labelled +1. Both the +1 start site and the -10 element are highlighted in 
bold and underlined. Predicted DNA sites for CRP and Fis and the promoter -10 hexamer element are aligned with consensus binding 
sequences, shown in bold type. The predicted CRP site is indicated with red shaded arrows, the two predicted Fis sites are indicated with blue 
shaded blocks, and the centre of each site is numbered with respect to the transcript start. Vertical arrows indicate mutations in different targets 









































Figure 4.2. Nested deletion analysis of the pet promoter. A. A series of primers were designed, successively 
deleting 25 bp of the 272 bp region upstream of the +1 transcriptional start sitein the AER1 promoter fragment. 
These primers are named Pet_1 – Pet_8 and the sequence that they anneal to in the AER1 fragment are indicated 
in bold. The resulting linear fragments were cloned into pRW50 generating a series of reporter constructs Pet_1-
8. B. This figure illustrates the β-galactosidase activity of each construct, given as a percentage of the original 
AER1 reporter construct.  The unpaired t-test was used to compare differences between the activities of strains 
carrying each deleted construct versus that of the original AER1 construct, both in the BW25113 parental strain.  


























presence of a mild repressor between the Pet_1 - Pet_2 constructs and the presence of 
activators between Pet_3 - Pet_4 and Pet_5 - Pet_6, which are consistent with the regulatory 
elements identified in Figure 4.1.  
4.2.3 CRP and Fis act synergistically to activate the pet promoter 
As CRP and Fis had a demonstrable role in regulating pet transcription in vivo (Chapter 3 
section 3.2.1), a multi-round transcription assay was used to investigate the action of CRP and 
Fis at the pet promoter in vitro. For this assay, the AER1 fragment was cloned into plasmid 
pSR (AER1/pSR), placing the pet promoter upstream of the strong factor-independent 
bacteriophage λ oop terminator. Thus, RNA polymerase that initiates transcription at the pet 
promoter runs to the oop terminator and generates a discrete transcript that is detected by gel 
electrophoresis. Figure 4.3, A shows an analysis of transcripts made after incubation of 
AER1/pSR with purified RNA polymerase holoenzyme containing σ
70
, in the presence of 
CRP and Fis. Initiation at the pet promoter generates a 182-base transcript that corresponds to 
a location 77 bps upstream of the pet translation initiation ATG that we denote position +1 
(Fig. 4.1). Results in Figure 4.3, A demonstrates that optimal activity of the pet promoter 
requires both CRP and Fis. In the absence of Fis, CRP activates transcription poorly, whilst 
no pet transcript is observed in the absence of CRP. Note that in this experiment, the rna1 
transcript, encoded by the pSR vector, was used as an internal control. This experiment shows 
that pet promoter activity is CRP-dependent but that maximum activity requires Fis to act 
synergistically with CRP. In a complementary experiment, potassium permanganate 
footprinting was used to measure CRP- and Fis- dependent open complex formation at the pet 
promoter. Recall that single-stranded DNA, generated by DNA duplex unwinding during 





Figure 4.3. Transcription activation at the pet promoter. A. The figure shows an autoradiograph 
of a gel used to analyse transcripts made in vitro after plasmid AER1/pSR was incubated with 
RNA polymerase holoenzyme (50 nM) and 400 nM CRP/200 nM cAMP and 200 nM Fis, as 
indicated. The transcript generated from the pet promoter and the control rna1 transcripts are 
indicated by arrows. The activity of the pet promoter is optimal when both CRP and Fis are 
present. B. Open complex formation at the pet regulatory region. The figure shows the results of 
in vitro potassium permanganate footprinting using the AER1 AatII-HindIII fragment, end-
labelled on the template strand and incubated with a final concentration of 50 nM RNA 
polymerase holoenzyme (Pol), in the presence or absence of CRP and Fis. Fis concentrations 
were: lanes 1–3, no protein; lane 4, 100 nM; lane 5, 400 nM; lane 6, 800 nM; lane 7, 1600 nM. 
CRP concentrations were: lanes 1–2, no protein; lanes 3–7, 50 nM. The gel was calibrated using a 
Maxam–Gilbert „G + A‟ sequencing reaction, and is numbered with respect to the pet transcript 
start site. Open complex formation is present in the presence of Fis, CRP and Pol. Note that, Fis 
alone is unable to promote open complex formation at the pet promoter (data not shown). 
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be detected by gel electrophoresis (Browning et al., 2009; Sasse-Dwight and Gralla, 1988). 
Incubation of the AER1 fragment, with purified Fis, CRP and RNA polymerase holoenzyme, 
causes unwinding of the pet promoter at position -11 (Fig. 4.3, B). This unwinding is 
dependent on CRP and enhanced by Fis, which is consistent with the in vitro transcription 
assay (Fig. 4.3, A). Note that the unwinding is suppressed at higher concentrations of Fis. 
4.2.4 Mutational analysis of the pet promoter 
Given that CRP and Fis affect pet promoter activity both in vitro and in vivo, site-directed 
mutagenesis was used to confirm the predictions for the DNA sites for CRP and Fis and the 
assignment of the pet promoter -10 element. Derivatives of the AER1 fragment were 
constructed carrying mutations in the different targets, as illustrated in Figure 4.1. Each 
mutant derivative was cloned into pRW50, the resultant recombinants were transformed into 
E. coli BW25113, and the activity of each promoter was deduced from the measurement of β-
galactosidase expression. Using these constructs we demonstrated that pet promoter activity is 
greatly decreased by mutations in the -10 element or the DNA site for CRP (Fig. 4.4). 
Similarly, mutation of the Fis I target at position -91 led to a substantial decrease, consistent 
with the suggestion that pet promoter activity is co-dependent on both Fis and CRP. In 
contrast, mutation of the upstream Fis II target caused an increase in promoter activity, 
suggesting that upstream-bound Fis may be inhibitory (Fig. 4.4).  
4.2.5 CRP and Fis binding at the pet promoter 
An electrophoretic mobility shift assay was used to investigate direct binding of CRP and Fis 
to the AER1 promoter fragment and its mutant derivatives, AER1-crp, AER1-fisI and AER1-
fisII, carrying mutated DNA sites for CRP, Fis I and Fis II, as shown in Figure 4.1. Results in 

























Figure 4.4. Mutational analysis of the pet promoter. The figure illustrates measured β-
galactosidase activities in E. coli BW25113, containing a set of pRW50 constructs 
carrying the pet promoter (AER1) and mutant derivatives. The AER1 mutant derivatives 
were as follows; AER1, starting pet promoter; AER1-10, pet promoter with mutated -10 
element; AER1-crp, pet promoter with mutated DNA site for CRP; AER1-fisI, pet 
promoter with mutated Fis I site; AER1-fisII, pet promoter with mutated FIS II site (Fig. 
4.1). The sites of these regulatory elements are shown in a basic sketch of the AER1 
promoter above. Promoter activity is diminished when the -10 element, CRP and Fis I 
sites are mutated. Promoter activity is increased when the Fis II site is mutated. Cells were 
grown aerobically in Luria–Bertani broth at 37°C and harvested during early log phase. β-
galactosidase activities are expressed as a percentage of the activity with the starting pet 
promoter. Each activity is the average of three independent experiments.  










formation of a single shifted species, consistent with a single DNA site for CRP, whilst no 
shift is seen with the AER1-crp fragment. In contrast, incubation of the labelled AER1 
fragment with purified Fis results in the formation of two shifted species, consistent with two 
DNA sites for Fis (Fig. 4.5, A). Comparison of the shifted species found with AER1 
derivatives carrying mutations in either the Fis I site at position -91 or the Fis II site at 
position -122 (Fig. 4.5, A and B) shows that Fis has a higher affinity for the Fis I site than for 
the Fis II site.  
DNase I footprinting was used to define the DNA sites for CRP and Fis binding. Incubation 
of the AER1 promoter fragment with CRP resulted in a clear region of protection which maps 
to around the -40 region (Fig. 4.6, A). As expected, incubation with Fis resulted in two 
regions of protection which map to around -121, representing Fis II site and -91, representing 
Fis I site (Fig. 4.6, A). Furthermore, CRP and Fis bind to the pet promoter independently of 
each other, when comparing results shown in Figure 4.6A and B, the pattern of protection in 
the DNase I footprinting assay is not affected, demonstrating Fis does not alter the binding 
capacity of CRP.  
4.2.6 CRP acts by a class II mechanism at the pet promoter 
Given the location of the CRP site (centred between bps -40 and -41) we predicted that the pet 
promoter region is a class II CRP-dependent promoter. Transcription activation at class II 
promoters is dependent upon direct interactions between two activating regions (AR1 & AR2) 
on CRP with the αCTD and αNTD of RNA polymerase, respectively (Rhodius et al., 1997; 
West et al., 1993). To test this prediction, we assayed for pet promoter activity using our 
reporter construct in our crp strain with plasmids harbouring either native CRP or mutant 






Figure 4.5. CRP and Fis binding at the pet promoter. A. Labelled EcoR1-HindIII promoter 
fragments (AER1, AER1-fisI or AER1-crp) were incubated with increasing concentrations 
of purified Fis or CRP protein and subjected to analysis by EMSA. Fis concentrations were: 
lanes 1, 6 and 11–18, no protein; lanes 2 and 7, 100 nM; lanes 3 and 8, 200 nM; lanes 4 and 
9, 400 nM; lanes 5 and 10, 800 nM. CRP concentrations were: lanes 1–10, 11 and 15, no 
protein; lanes 12 and 16, 50 nM; lanes 13 and 17, 100 nM; lanes 14 and 18, 200 nM. cAMP 
was included in both the binding reactions and the gel at a final concentration of 200 nM. 
The positions of the electrophoretically retarded nucleoprotein complexes are indicated by 
arrows. B. Labelled promoter fragments (AER1 or AER1-fisII) were incubated with 
increasing concentrations of purified Fis and subjected to analysis by EMSA. Fis 
concentrations were: lanes 1 and 5, no protein; lanes 2 and 6, 200 nM; lanes 3 and 7, 400 
nM; lanes 4 and 8, 800 nM. The position of free DNA and nucleoprotein complexes are 






Figure 4.6. DNase I footprint analysis of the pet promoter. A. End-labelled pet AatII-HindIII 
fragment, on the HindIII end, was incubated with purified CRP or Fis and subjected to DNase I 
footprint analysis. Fis concentrations were: lanes 1–7, no protein; lane 8, 100 nM; lane 9, 200 
nM; lane 10, 400 nM; lane 11, 800 nM; lane 12, 1600 nM. CRP concentrations were: lanes 1 
and 7–12, no protein; lane 2, 25 nM; lane 3, 50 nM; lane 4, 100 nM; lane 5, 200 nM; lane 6, 
400 nM. Gels were calibrated using „G + A‟ sequencing reactions (indicated by GA). The 
position of the predicted DNA sites for CRP and Fis are indicated with shaded boxes adjacent 
to the gel and correspond with regions of protection. B. End-labelled pet AatII-HindIII 
fragment was incubated with purified CRP and/or Fis and subjected to DNase I footprint 
analysis. Fis concentrations were: lanes 1–5, no protein; lane 6, 200 nM; lane 7, 400 nM; lane 
8, 800 nM; lane 9, 1600 nM. CRP concentrations were: lane 1, no protein; lane 2, 50 nM; lane 
3, 100 nM; lane 4, 200 nM; lane 5–9, 400 nM. The position of the predicted DNA sites for 
CRP and Fis are indicated adjacent to the gel and correspond with regions of protection. Note 
that the dense bands within the CRP bidning site most likely represent areas of hypersensitivity 
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illustrated in Figure 4.7 indicate that the CRP mutants HL159 and KE101, harbouring 
defective AR1 or AR2 regions, respectively, had a five-fold decrease in transcription levels in 
comparison to the plasmid carrying the native CRP. Furthermore, the CRP mutant HL159 
KE101, containing both defective AR1 and AR2 regions simultaneously, had a ten-fold 
decrease in transcription levels. 
4.2.7 Fis-dependence of the pet promoter is due to non-optimal positioning of CRP.  
At most class II CRP-dependent promoters, the DNA site for CRP is located 21 bps upstream 
from the -10 hexamer element (Rhodius et al., 1997), whilst the spacing is 20 bps at the pet 
promoter (Fig. 4.1). Since location is known to be critical for CRP-dependent activation 
(Gaston et al., 1990; West et al., 1993), we reasoned that the dependence on Fis for pet 
promoter activity might be due to the location of the DNA binding site for CRP. To address 
this, a derivative of the AER1 fragment, AER1+1, was constructed with a single G:C bp 
inserted between position -21 and -22 (Fig. 4.1), and the dependence of the resulting mutant 
pet promoter on CRP and Fis was investigated using lac fusions in vivo and in vitro 
transcription assays. Results illustrated in Figure 4.8 show that, as expected, the activity of the 
pet promoter in the AER1 fragment is co-dependent on both CRP and Fis. In contrast, whilst 
the mutant pet promoter in the AER1+1 fragment is clearly CRP-dependent, the co-
dependence on Fis is lost, both in vivo and in vitro (Fig. 4.8, A and B). 
4.2.8 Co-dependence of promoter activity on CRP and Fis can be generated in a semi-
synthetic system  
Our data show that the dependence of the wild-type pet promoter on Fis is a consequence of 
the non-optimal positioning of the DNA site for CRP. To investigate whether this is a 










































Figure 4.7. β-galactosidase activities of the construct AER1/pRW50 measured in 
the E. coli BW25113 ∆crp strain harbouring plasmids with the native CRP, or its 
mutant derivatives. Plasmids contained in the E. coli BW25113 strain included the 
pDU9, empty vector; pDCRP, native CRP; pDCRP HL159, CRP with a defective 
AR1 region; pDCRP KE101, CRP with a defective AR2 region; pDCRP HL159 
KE101, CRP with defective AR1 and AR2 regions. E. coli BW25113 AER1 was 
included as a positive control. β-galactosidase activities are expressed as a 




































Figure 4.8. Optimal spacing between core elements at the pet promoter relieves Fis-dependent CRP 
activation. A. The figure shows β-galactosidase activities measured in E. coli BW25113, E. coli 
BW25113 fis and E. coli BW25113 crp cells carrying pRW50 containing the pet promoter (AER1) or the 
pet promoter derivative with a one base pair insertion (AER1+1). Cells were grown aerobically in Luria–
Bertani broth and measurements were taken at early log phase. For each promoter, activities are expressed 
as a percentage of the activity measured in E. coli BW25113 cells and each value derives from three 
independent experiments. B. In vitro transcription of the pet promoter (AER1) versus the pet derivative 
with a one base pair insertion (AER1+1). A multi-round in vitro transcription assay was performed in the 
presence of 50 nM RNA polymerase holoenzyme with 400 nM CRP and 200 nM Fis, as indicated. The 
transcript generated by the pet promoter and the control rna1 transcript are indicated by arrows. 
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synthetic class II CRP-dependent promoter that carries a single consensus DNA site for CRP 
upstream of a -10 hexamer element (5'-CATAAT-3'), shown in Figure 4.9 (Gaston et al., 
1990). It was previously found that CRP-dependent activation is greatly reduced in two 
derivative promoters CC(-40.5) and CC(-39.5) that carry one and two bp deletions between 
the DNA site for CRP and the -10 hexamer element (West et al., 1993). Hence, we 
constructed the F35CC(-40.5) and F35CC(-39.5) promoters that carry a single DNA site for Fis 
located 35 bps upstream of the DNA site for CRP, which mimics the organisation of the pet 
promoter (Fig. 4.9, B). Each of the promoter fragments was cloned into pRW50 and promoter 
activities were measured. Results illustrated in Figure 4.9, C confirm the CRP dependence of 
each of the promoters and show that, as expected, CRP-dependent transcription is optimal at 
the CC(-41.5) promoter and greatly reduced at the CC(-40.5) and CC(-39.5) promoters. CRP-
dependent activation at CC(-40.5) is restored by the introduction of an upstream DNA site for 
Fis in the F35CC(-40.5) promoter, while the upstream DNA site for Fis has little effect at the 
F35CC(-39.5) promoter. As the organisation of the -10 hexamers and DNA sites for CRP and 
Fis at the F35CC(-40.5) promoter and pet promoter are identical, we conclude that co-
dependence on Fis and CRP is a property of the promoter architecture rather than a peculiarity 
of the pet promoter.  
In order to examine the effect of the distance between the upstream Fis and CRP binding sites 
at the F35CC(-40.5) promoter, the location of the engineered Fis site was altered by increasing 
or decreasing the space between them, such that the Fis  binding site is on the same side or 
opposite side of the DNA helix (Fig. 4.10, A). This is denoted as FnCC(-40.5) where „n‟ 
represents the distance between the DNA sites for CRP and Fis binding. These promoter 
fragments were cloned into pRW50, the resulting recombinants were transformed into E. coli 
BW25113, and the activity of each promoter was deduced from measurement of β-
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Figure 4.9. Non-optimal spacing at the semi-synthetic CC(-41.5) promoter affects CRP-
dependent activity, which can be compensated by the insertion of an upstream Fis site. 
A. DNA sequence of the CC(-41.5) promoter fragment. The DNA site for CRP is indicated 
by shaded horizontal inverted arrows and the -10 hexamer element is underlined. The 
crosses (x) denote bases that are deleted in the CC(-40.5) and CC(-39.5) derivatives. B. 
DNA sequence upstream of the CRP site at the F35CC(-40.5) and F35CC(-39.5) 
promoters. C. The figure shows β-galactosidase activities measured in E. coli BW25113 or 
E. coli BW25113 crp cells carrying pRW50 containing the CC(-41.5) promoter or the 
CC(-40.5), CC(-39.5), F35CC(-40.5) and F35CC(-39.5) derivatives. Cells were grown 
aerobically in Luria–Bertani broth and measurements were taken at early log phase. β-
galactosidase activities are expressed as percentages of the measured activity with the CC(-




galactosidase expression. Results in Figure 4.10, B demonstrate that promoter constructs 
F40CC(-40.5) and F30CC(-40.5), dramatically reduced promoter activity. However, the 
deletion of one helical turn, F25CC(-40.5), significantly increased promoter activity. In 
contrast, the insertion of one helical turn, F45CC(-40.5), did not increase promoter activity 
(Rossiter et al., 2011a).  
4.3 Discussion 
The principal finding from this work is that expression of Pet from EAEC strain 042 is co-
dependent on Fis and CRP. Fis and CRP are well characterised global transcription factors 
that regulate hundreds of promoters in E. coli. It is well known that CRP activates 
transcription at many target promoters by binding to a single target that overlaps the promoter 
-35 element and that activation requires CRP to make two direct contacts with RNA 
polymerase via two activating regions (AR1 and AR2) (Rhodius et al., 1997). Data in Figure 
4.7 confirm that both AR1 and AR2 are essential for CRP-dependent activation at the pet 
promoter. Previous studies (Gaston et al., 1990) have shown the importance of positioning of 
the DNA site for CRP, whereby optimal activation results when it is located 21 bps upstream 
from the promoter -10 hexamer element (at position -41.5). Our experiments show that the 
spacing is 20 bps at the pet promoter and that this is the reason why a co-activator is required. 
It is known that upstream bound transcription factors can co-activate together with CRP by 
making a direct contact with the RNA polymerase αCTD (Belyaeva et al., 1998; McLeod et 
al., 2000). Furthermore, the strict geometry of bound regulatory proteins is well recognized as 
being an important tool for the efficiency of bacterial promoters, whereby the DNA binding 
sites are arranged in helical register (Gaston et al., 1990; Pul et al., 2008; Ushida and Aiba, 






















Figure 4.10. Helical phasing is crucial for Fis-dependent CRP activation. A. Base sequence of 
the FCC(-40.5) promoter derivatives where the Fis binding site has been inserted at various 
position upstream of the CRP binding site. Promoter names are given in the fashion of FnCC(-
40.5), whereby „n‟ equals the number of bases between the Fis and CRP binding sites. B. The 
figure shows β-galactosidase activities measured in E. coli BW25113 carrying the CC(-40.5) 
promoter and the FnCC(-40.5) promoter derivatives in pRW50. Cells were grown aerobically in 
Luria–Bertani broth and measurements were taken at early log phase. β-galactosidase activities are 
expressed as a percentage of the measured activity of the F35CC(-40.5) promoter. Each value is the 




demonstrate the importance of helical phasing in Fis-dependent CRP activation, i.e. that Fis 
and CRP binding to the same face of the helix is essential for transcriptional activation in 
vivo; the finding that Fis and CRP bind to the same helical face is consistent with the idea that 
Fis makes a direct interaction with RNA polymerase αCTD and enhances transcription. Our 
experiments with the semi-synthetic CC(-41.5), CC(-40.5) and CC(-39.5) promoters (Fig. 4.9) 
argue that the promoter co-dependence on CRP and Fis is created by the non-optimal 
positioning of the DNA site for CRP rather than specific sequence features of the pet 
promoter. Individually, Fis and CRP have been implicated in the modulation of many 
virulence genes in pathogens (Akhter et al., 2008; Muller et al., 2009; Ó'Cróinín et al., 2006; 
Steen et al., 2010) but, to our knowledge, this is the first example of a virulence gene that is 
co-regulated by both together. Levels of Fis in E. coli vary from very high to very low 
according to growth conditions and it is these fluctuations that set Fis activity (Mallik et al., 
2006; Morin et al., 2010). Thus, highest levels of Fis are found in rapidly growing cells, while 
Fis is undetectable in non-growing cells. In contrast, CRP activity is controlled by both its 
expression and the level of the cyclic AMP second messenger (Grainger and Busby, 2008). In 
E. coli, CRP and cyclic AMP levels are known to be raised as cell growth slows, and hence, 
the Fis and CRP activities are controlled by completely different environmental cues. The 
result of this is likely to be that the expression of Pet in a mammalian host is restricted to 
certain phases of growth or certain niches. One particular study, detailing Pet secretion 
through the growth curve of EAEC 042, demonstrated that Pet secretion spikes early in 
exponential phase and, thereafter, gradually accumulates (Betancourt-Sanchez and Navarro-
Garcia, 2009). This is consistent with our findings that Pet expression is co-regulated by CRP 
and Fis, suggesting that the growth-phase dependent regulation of Fis expression promotes 
Pet secretion early on in EAEC 042 growth. Furthermore, Fis is now well documented as a 
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key player in the pathogenesis of EAEC 042, as its activities are critical for the expression of 
the EAEC 042 specific AAF I/II fimbriae, the central virulence transcription factor AggR and 
the formation of biofilms (Morin et al., 2010; Sheikh et al., 2001). It is rather unusual that Fis 
plays a large role in pathogenesis of EAEC 042, given that expression of fimbriae and 
formation of biofilms is classically associated with sessile growth, where Fis expression is 
low (Morin et al., 2010). However, one may envisage a system whereby early Pet secretion, 
promoted by Fis and CRP, primes the intestine for colonization by cleaving fodrin and 
rounding the intestinal epithelial cells (Henderson et al., 1999), making the epithelial layer 
interface more accessible for bacterial adhesion thus, contributing to the establishment of a 
biofilm. Finally, when looking at the distribution of autotransporters, Pet is confined to EAEC 
042. However, functionally similar autotransporters, SigA (Al-Hasani et al., 2009) and Sat 
(Guyer et al., 2000) are found in Shigella spp. and uropathogenic E. coli (UPEC) respectively. 
Interestingly, bioinformatics search patterns suggest that similar promoter architecture, with 
respect to non-optimal spacing between a CRP binding site and the -10 hexamer element, is 
apparent in other virulence determinants such as putative type III and type VI secretion 
system proteins from EAEC 042 and also SigA and Sat. However, an upstream Fis site within 
these promoters is less evident (Fig. 4.11). This suggests the presence of a novel mechanism 
whereby CRP placed at a non-optimal position benefits the bacterium by allowing integration 
of signals, by other transcription factors, to rescue CRP from a non-optimal position and 
thereby promotes transcription in precise phases of growth/environmental conditions. 
Therefore, we envisage that through extensive bioinformatic and experimental techniques, we 
may establish CRP placed at a non-optimal position as a novel mode of virulence gene 
regulation, applicable to many Gram-negative pathogens.  
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Figure 4.11. Identification of other virulence gene promoters, from Shigella spp., UPEC and EAEC, containing similar promoter architecture to pet. 
The putative Type VI secretion system protein is designated EC042-0229. DNA sequences shown in this figure have been retrieved from the open source 
database Xbase (Chaudhuri et al., 2008).  
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Although we were able to re-capitulate the mechanism of co-dependence on CRP and Fis at 
the pet promoter in the semi-synthetically derived CC series of promoters (Chapter 4, section 
4.2.8), it is still unclear whether this mechanism is restricted to the pet promoter or whether 
many different naturally occurring promoters employ this strategy. An additional question is 
raised as to whether the integration of upstream bound factors, other than Fis, can rescue CRP 
from a non-optimal position. This notion could be tested at the various promoters identified in 
Chapter 4, Figure 4.11, where similar promoter architecture is apparent with respect to CRP 
placed at a non-optimal position, but lack an upstream binding site for Fis. However, for this 
work we have focussed on just one of the promoters identified, which regulates the secreted 
autotransporter (Sat) gene, encoding a cytotoxin from uropathogenic E. coli (UPEC) CFT073. 
UPEC is the major causative organism of urinary tract infections (UTIs). UTI manifests itself 
as two clinically recognised conditions; cystitis is the infection of the urethra and bladder, 
whereas a more severe complication is known as acute pyelonephritis, where the infection 
ascends to the kidneys (Nielubowicz and Mobley, 2010). UPEC have evolved their 
characteristic fimbriae (P and type 1 fimbriae) in order to circumvent the obstacles associated 
with the strong urine flow of the urinary tract (Lane and Mobley, 2007). Uropathogens may 
also damage their host through the elaboration of toxins. One of these toxins, Sat, was 
identified from 68% of strains associated with acute pyelonephritis (Guyer et al., 2000) and 
shares significant homology to Pet, containing the typical tripartite architecture and 
characteristics of all AT proteins. Sat is also functionally related to Pet in that it internalises 
and causes cytotoxic effects on bladder and kidney epithelial cells (Guyer et al., 2002). 
Although ATs encompass a wide array of divergent functions, some ATs evidently display 
functional similarities and, in the case of the IgA1 proteases and SPATEs, are evolutionary 
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related (Henderson et al., 2004). Therefore, it could be envisaged that at least some ATs 
display conserved regulatory mechanisms. In this chapter, the focus will be to study the 
regulation of sat, thus shedding light on the pathogenesis of UPEC, and additionally assess 
whether the gene encoding this cytotoxin is regulated by CRP and Fis in a manner similar to 
pet.   
5.2 Results 
5.2.1 sat gene regulatory region 
Bioinformatic analyses suggested that the sat promoter possessed a similar regulatory 
organisation to pet. Manual inspection of the nucleotide sequence confirmed the presence of 
putative DNA sites for CRP and Fis with similar spacing observed for pet. Given the 
conservation of the DNA sites for Fis and CRP binding between the pet and sat promoters, we 
hypothesised that sat was regulated in a similar manner, with CRP and Fis being the key 
activators of transcription initiation. In order to study the regulation of sat, we first cloned an 
EcoRI-HindIII fragment (SAT; Fig. 5.1), which contained the sat gene regulatory region, into 
the pRW50 low copy number lac expression vector to create a fusion of the sat gene promoter 
to the lacZ gene. To confirm a role for the transcription factors CRP and Fis in vivo, the 
resulting recombinant (SAT/pRW50) was transformed into the E. coli K-12 Δlac strain 
BW25113, and derivatives with disrupted crp or fis genes. Measurements of β-galactosidase 
expression in the different strains showed that sat promoter activity in the crp and fis mutants 
was 15% and 60% of the activity in the E. coli BW25113 parental strain, respectively (Fig. 
5.2, A). Surprisingly, sat promoter activity differs significantly from pet promoter activity in 
the fis knockout strain (60% and 25%, respectively). Surprisingly, the promoter activity of sat 
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Figure 5.1. Nucleotide sequence of the SAT fragment containing the sat gene regulatory region. The predicted Sat ATG start codon is underlined 
and indicated with a horizontal arrow. The predicted transcript start site is labelled +1. Both the +1 start site and the -10 element are highlighted in bold 
and underlined. Predicted DNA sites for CRP and Fis and the promoter -10 hexamer element are aligned with consensus binding sequences, shown in 
bold type. The predicted CRP site is indicated with red shaded arrows, the predicted Fis sites are indicated with blue shaded blocks, and the centre of 







































Figure 5.2. Promoter activities of pet vs sat. A. This figure illustrates β-galactosidase activities measured 
in E. coli BW25113 crp and fis cells carrying pRW50 containing the SAT promoter. B. The figure shows β-
galactosidase activities measured in E. coli BW25113, containing the pet (AER1) and sat (SAT) promoters 
in pRW50. Cells were grown aerobically in Luria–Bertani broth at 37°C and harvested during early log 
phase. β-galactosidase activities are expressed as a percentage of the activity with the sat promoter. Each 
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differences in promoter sequences between the pet and sat around the transcript start site (Fig. 
4.11). 
5.2.2 Mutational analysis of the sat promoter 
The experiments detailed above confirm a role for CRP and Fis in the regulation of the sat 
promoter. In order to validate the assignment of the CRP and Fis binding sites and the -10 
hexamer element identified in Figure 5.1, site-directed mutagenesis was used to target 
nucleotides within these sites (as detailed in Chapter 2, section 2.4.7.2) and the mutant 
EcoR1-HindIII SAT promoter derivatives were cloned into pRW50. The resultant 
recombinants were transformed into E. coli BW25113 and the promoter activity of each 
mutant derivative was deduced from β-galactosidase measurements. The data in Figure 5.3 
demonstrate that sat promoter activity is significantly reduced by mutations in the -10 element 
and the CRP and Fis binding sites, suggesting that the sat promoter, like pet, is co-dependent 
on CRP and Fis for optimal activity.  
5.2.3 CRP and Fis binding at the sat promoter 
Having established that mutation of the predicted CRP and Fis binding sites have a 
demonstrable role in sat regulation in vivo, an electrophoretic mobility shift assay (EMSA) 
was used to investigate the binding of CRP and Fis at the sat promoter. The EcoR1-HindIII 
fragments carrying the SAT promoter and its mutant derivatives, SAT-fis and SAT-crp, were 
cloned into pSR, as described in Chapter 2, section 2.4.7. The resultant recombinants were 
digested and labelled in order to generate fragments suitable for EMSA‟s. Results in Figure 
5.4 show that incubation of labelled SAT fragment with Fis results in the formation of two 
shifted species, suggestive of two Fis binding sites within the sat promoter. Incubation of 




































Figure 5.3. Mutational analysis of the sat promoter. The figure illustrates measured β-
galactosidase activities in E. coli BW25113, containing a set of pRW50 constructs carrying 
the sat promoter (SAT) and mutant derivatives. The SAT mutant derivatives were as follows; 
SAT, starting sat promoter; SAT-fis, sat promoter with mutated Fis site; SAT-crp, sat 
promoter with mutated DNA site for CRP; SAT-10, sat promoter with mutated -10 element 
(Fig. 5.1). Promoter activity is diminished when the Fis, CRP and-10 element are mutated. 
Cells were grown aerobically in Luria–Bertani broth at 37°C and harvested during early log 
phase. β-galactosidase activities are expressed as a percentage of the activity with the starting 
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Figure 5.4. CRP and Fis binding at the sat promoter. Labelled EcoR1-HindIII promoter 
fragments (SAT, SAT-fis or SAT-crp) were incubated with increasing concentrations of 
purified Fis or CRP protein and subjected to analysis by EMSA. Fis concentrations were: 
lanes 1, 5 and 9-16, no protein; lanes 2 and 6, 100 nM; lanes 3 and 7, 200 nM; lanes 4 and 
8, 400 nM. CRP concentrations were: lanes 1–9 and 13, no protein; lanes 10 and 14, 50 nM; 
lanes 11 and 15, 100 nM; lanes 12 and 16, 200 nM. The positions of the electrophoretically 
retarded nucleoprotein complexes are indicated by arrows. Note that the low intensity bands 
present in lanes 5-8 are due to inefficient labelling of the SAT-fis promoter fragment. The 
high molecular weight species in lanes 6-8 most likely represent Fis binding to a second 






the Fis site identified at position -91 in the sat promoter is correct. However, the second Fis 
binding site within the sat promoter remains uncharacterised. Incubation of the labelled SAT 
fragment with CRP results in the formation of a single shifted species consistent with one 
CRP binding site. The lack of this single shifted species when labelled SAT-crp fragment is 
incubated with CRP confirms that CRP binds to the predicted site at -40.5 (Fig. 5.1).  
5.2.4 Fis dependence of the sat promoter is due to non-optimal positioning of CRP  
Consistent with the pet promoter, the sat promoter has the key features to create co-
dependence on both CRP and Fis for transcription initiation; the non-optimal position of the 
CRP binding site at -40.5 which generates the atypical spacing of 20 bp between the CRP site 
and the -10 hexamer element, and the upstream Fis binding site at -91. As inferred from the 
pet promoter in Chapter 4, the co-dependence on Fis for full transcription activation of pet can 
be lost by the insertion of one bp between the CRP binding site and the -10 hexamer element 
(Chapter 4, Fig 4.8). Following this observation, we re-capitulated this mechanism in a semi-
synthetic system (Chapter 4, Fig. 4.9). Therefore, on the basis of bioinformatic searches for 
similar promoter architectures (Chapter 4, Fig. 4.11), we reasoned that this co-dependence 
could be an evolutionary conserved mechanism apparent in naturally occurring promoters. To 
test this, we inserted one bp between the CRP binding site and the -10 hexamer element in the 
sat promoter (Fig. 5.1) and the dependence of the SAT+1 promoter derivative on CRP and Fis 
was measured using lac fusions in vivo and an in vitro transcription assay. Results in Figure 
5.5 clearly demonstrate that, as expected, the sat promoter in the SAT fragment is co-
dependent on CRP and Fis, however the mutant promoter derivative, SAT+1 loses its 
dependence on Fis both in vivo and in vitro, given that full transcription activation is seen in 
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Figure 5.5. Optimal spacing between core elements at the sat promoter relieves Fis-dependent CRP 
activation. A. The figure shows β-galactosidase activities measured in E. coli BW25113, E. coli 
BW25113 fis and E. coli BW25113 crp cells carrying pRW50 containing the sat promoter (SAT) or the 
sat promoter derivative with a one base pair insertion (SAT+1). Cells were grown aerobically in Luria–
Bertani broth and measurements were taken at early log phase. Activities are expressed as a percentage 
of the starting SAT promoter activity measured in E. coli BW25113 cells and each value derives from 
three independent experiments. Note that there is a significant increase in SAT+1 promoter activity in 
E. coli BW25113 cells. B. In vitro transcription of the sat promoter (SAT) versus the sat derivative with 
a one base pair insertion (SAT+1). A multi-round in vitro transcription assay was performed in the 
presence of 50 nM RNA polymerase holoenzyme with 400 nM CRP and 200 nM Fis, as indicated. The 
transcript generated by the sat promoter and the control rna1 transcript are indicated by arrows. Note 
that the unevenness of rna1 levels across the gel may be due to limitng RNAp in the presence of the 
SAT promoter with CRP and/or Fis, such that CRP mediates specific recruitment of RNAp to the SAT 







5.3 Discussion   
There are two key findings from this work; firstly that the Sat toxin from UPEC CFT073 is 
co-regulated by CRP and Fis. Secondly, that the mechanism of co-dependence on CRP and 
Fis is analogous to that described at the pet promoter (Chapter 4), whereby the non-optimal 
positioning of CRP at -40.5 creates co-dependence on upstream bound Fis for full 
transcription activation. Although this work presents significant findings that this mechanism 
of co-dependence is evident at two naturally occurring promoters, the homology between Pet 
and Sat (~90% identical) dictates that this is likely to be the case. However, a feasible 
extension of these studies would be to study promoters that are distantly related from pet and 
sat, to see if CRP misplacement could render other promoters co-dependent on an upstream 
bound factor, other than Fis. Experiments recently undertaken in our laboratory indicates that 
replacement of the upstream Fis binding site with an IHF binding site allows for IHF to bind 
upstream of the non-optimally placed CRP and partially restore promoter activity in the CC-
40.5 promoter of the CC promoter derivatives used in Chapter 4, section 4.2.8. This result 
validates our model suggesting that non-optimally placed CRP may be a strategy to integrate 
additional upstream bound TFs, other than Fis, for optimal transcription. This model could be 
investigated further by the study of the promoters identified in Chapter 4, Figure 4.11.  
To date, studies have revealed mechanistically distinct gene regulation of ATs (Giangrossi et 
al., 2010; van der Woude and Henderson, 2008) (Reviewed in Chapter 1, section 1.6.1). This 
work is the first to describe conservation in the transcriptional regulation of ATs, indicative 
that this mode of regulation is physiologically significant to both EAEC 042 and UPEC 
CFT073 pathogenesis, in the intestine and urinary tract, respectively. However, given that 
these pathogens inhabit remarkably different niches, the clinical significance of this regulation 
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must be applicable in both settings. As noted in Chapter 4, Fis is a key player in the 
pathogenesis of EAEC 042, given its demonstrable role in the regulation of pet and EAEC 
specialised fimbriae. This intimate link between pet and fimbrial regulation is mimicked in 
UPEC CFT073, where sat and its Type 1 fimbriae are regulated by CRP (Muller et al., 2009). 
Therefore, further work is needed in the host organism to establish whether additional 
regulatory mechanisms exist to achieve the systematic expression of fimbriae and toxins that 






















The findings from this work have provided insights into two broad aspects of microbial 
biology; namely AT biogenesis and gene regulation. The details of these findings and the 
impact that they have on our current understanding of these fundamental processes are 
discussed below.  
Autotransporter biogenesis 
In recent years, a large number of studies have highlighted the requirement of novel accessory 
factors in AT biogenesis, challenging the initial supposition that ATs contain all the 
functional elements necessary for their translocation across the cell envelope. The work 
described in Chapter 3 builds on these data by the identification of factors involved in Pet 
biogenesis. Although many of the factors idenitified await further investigation, our work 
focusses on a subset of these factors and addresses the questions surrounding periplasmic 
transit and OM translocation of ATs. The supposition that the periplasmic transit of ATs was 
self-contained was first questioned with the study of IcsA from S. flexneri in 2002. This study 
demonstrated, for the first time, that ATs were accessible to periplasmic chaperones and that 
IcsA surface presentation was dependent on the periplasmic chaperone, DegP (Purdy et al., 
2002). Since this initial description, many reports have detailed the involvement of additional 
periplasmic enzymes in AT biogenesis, including SurA, Skp and FkpA (Purdy et al., 2007; 
Ruiz-Perez et al., 2010; Veiga et al., 2004). Our results demonstrate that DegP and SurA are 
required for Pet secretion and initiated work that provided evidence of putative motifs within 
ATs that represent binding targets for the chaperones (Ruiz-Perez et al., 2009). 
Given that these chaperones DegP, SurA and Skp are intimately involved in the delivery of 
OMPs to the BAM complex (Hagan et al., 2010), we investigated the role of the BAM 
complex, in the insertion and/or translocation of ATs into or across the OM. Previous studies 
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have established a role for the pore-forming component of the complex, BamA, in biogenesis 
of all examined ATs (Jain and Goldberg, 2007). However, our studies were the first to 
characterise the role of the other BAM components and demonstrated that BamD, as well as 
BamA, are essential for the secretion of Pet, whereas the non-essential components BamB, C 
and E are not required for either secretion or folding of Pet and Ag43 on the cell surface 
(Rossiter et al., 2011b). Further work is required to identify the exact molecular mechanism of 
their interactions to address whether the BAM complex is solely required for OM insertion of 
the AT β-barrel, therefore allowing passenger domain translocation through the cognate β-
barrel, or whether BamA is the preferred β-barrel pore for passenger domain translocation to 
the cell surface. Studies on „stalled‟ translocation intermediates (Renn and Clark, 2011) or 
experiments using the recently developed genetically incorporated in vivo cross-linker tool  
could help to discern a precise role for the periplasmic chaperones and the BAM complex in 
AT biogenesis (Zhang et al., 2011).    
The identification of an increasing number of accessory factors generates more questions 
regarding their precise molecular involvement in AT biogenesis, highlighting the gaps in our 
understanding of this secretion system. Thus, the answers to some questions still remain 
contentious; how exactly is AT gene expression regulated? What are the environmental 
signals that trigger gene expression within the host organism? What are the precise molecular 
interactions that govern AT translocation across the periplasm by periplasmic chaperones? 
How are the cognate β-barrels inserted into the OM? Do passenger domains pass through their 
own β-barrel or are they translocated through the BamA β-barrel? As time constraints 
prevented further investigations into the role of the additional factors identified from the 
transposon screen of EAEC 042, future studies focusing on their role in AT biogenesis could 
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help to answer these questions and build on the paradigm shift towards a  much more complex 
mechanism of AT secretion than initially suggested.  
Global regulators CRP and Fis 
The work outlined in Chapter 4 and 5 details the regulation of the pet and sat promoter by 
CRP and Fis. The two key findings from this work are; a) that the regulation of at least two 
functionally similar ATs occurs by a conserved activation mechanism and; b) the way in 
which non-optimal positioning of CRP generates co-dependence on upstream bound Fis 
contradicts the typical mechanism seen at all Class II CRP-dependent promoters studied to 
date (Zheng et al., 2004). 
CRP and Fis are perhaps the most well studied bacterial TFs and their role in the modulation 
of over 200 promoters has earned them the title of „global‟ regulators. However, in most 
instances their effect is seen at promoters that control the expression of metabolic and 
housekeeping genes, yet in this post-genomic era and with the development of extensive 
bioinformatics tools, the role of CRP and Fis in the regulation of virulence determinants is 
becoming ever more prevalent. The observation that pet and sat, genes encoding cytotoxins 
from the two distinct pathogens, Enteroaggregative E. coli (EAEC) and Uropathogenic E. coli 
(UPEC), share a conserved activation mechanism raises the idea that this regulation must 
confer some physiological advantage in the infection of their host organism. Fis is regulated 
in a growth-phase dependent manner, such that the highest levels of Fis are found in rapidly 
growing cells, while Fis is undetectable in non-growing cells (Mallik et al., 2006; Morin et 
al., 2010). In contrast, CRP activity is controlled by both its expression and the level of the 
cyclic AMP second messenger (Grainger and Busby, 2008), thus in E. coli, CRP levels are 
known to be raised as cell growth slows. Given that both pet and sat are regulated by CRP 
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and Fis, the result of this is likely to be that the expression in a mammalian host is restricted 
to certain phases of growth or certain niches. A feasible role for Fis may become relevant to 
the expression of Pet in the host intestine. Passage through the stomach and proximal small 
intestine will expose EAEC to favourable conditions high in nutrients causing bacteria to 
grow exponentially. This will consequently trigger the activities of Fis and stimulate 
expression of both EAECs characteristic AAF Fimbriae (Sheikh et al., 2001) and Pet. The 
role of CRP may be to sustain the expression of these toxins once Fis levels are depleted at 
stationary phase of growth. Further work is required to substantiate the role of CRP and Fis in 
the natural setting, and to highlight any additional levels of regulation that are pathogen-
specific. For example, recent observations have highlighted a possible role for AggR (the 
master virulence regulator of EAEC) on pet expression, given that a putative AggR binding 
site was found to map within the Fis site I of the AER1 fragment. Thus, this level of 
regulation could not occur in the E. coli K-12 strain used in these studies.  
A study that investigated the CRP regulon, identified many new targets for CRP and found 
that most of these targets were activated by the simple Class II mechanism (Zheng et al., 
2004). In chapter 4, using well characterised CRP mutants, we showed that the pet promoter 
is also Class II activated but that it is organised in an atypical manner. All Class II activated 
promoters contain a single DNA site for CRP centred at -41.5, however at the pet promoter 
the site is centred at -40.5 and our experiments show that this non-optimal spacing creates 
dependence on upstream bound Fis for full activation of pet. An extension of these 
observations detailed in Chapter 5, show that this non-optimal positioning of CRP also occurs 
at the sat promoter. Therefore, it is possible that the non-optimal positioning of CRP could be 
a mechanism seen at many other promoters, which awaits investigation by future studies. 
However, recent studies communicated in our laboratory show that the replacement of the Fis 
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binding site with an IHF binding site can rescue CRP from its non-optimal position and 
partially restore promoter activity. Thus, this hints that IHF and Fis are working in a similar 
fashion to rescue misplaced CRP, perhaps by bending DNA. However, further work is needed 
to elucidate the precise mechanism that upstream bound Fis uses to co-activate the pet 
promoter. More specifically, investigations should initially determine whether the ability of 
Fis to interact directly with RNA polymerase or its propensity to bend DNA is the underlying 
mechanism causing this co-dependence.  
In conclusion, our investigations have revealed novel factors that are involved in the secretion 
of autotransporters by Gram-negative pathogens. However, future studies are still obliged to 
resolve the precise molecular interactions that underpin AT biogenesis, particularly 
concerning their translocation across the OM. Furthermore, with the progression of high-
throughput technologies, our work highlights the importance of studying single gene 
promoters to uncover new ways in which TFs operate, which will ultimately re-define the 




Table 1. Primers used for the screening and amplification of loci from the E.coli BW25113 
chromosome, and for generation of mutants by a method based on the λ-red system. 
Name Sequence (5'      3') Use 
ackA_F ggtgtcatcatgcgctacgc Upstream primer for amplification of named 
chromosomal loci. 
ackA_R cagccgacgctggttccgg Downstream primer for amplification of named 
chromosomal loci. 
adiY_F gcgcggccccaccccgcgct Upstream primer for amplification of named 
chromosomal loci. 
adiY_R ccgggttatcgctgatgccg Downstream primer for amplification of named 
chromosomal loci. 
ais_F gaggcattttgccgacatcg Upstream primer for amplification of named 
chromosomal loci. 
ais_R cgttacgtttgaaaggtcttc Downstream primer for amplification of named 
chromosomal loci. 
cadA_F ccacaccgcgtctaacgcac Upstream primer for amplification of named 
chromosomal loci. 
cadA_R cgcgcgcggctgtgagggtg Downstream primer for amplification of named 
chromosomal loci. 
celB_F gtgcttaaggctgcggttgc Upstream primer for amplification of named 
chromosomal loci. 
celB_R gcttccgtttgcgtatcggg Downstream primer for amplification of named 
chromosomal loci. 
clpB_F cgtcgcgacaagaccaccgg Upstream primer for amplification of named 
chromosomal loci. 
clpB_R gggagttattccggcctgac Downstream primer for amplification of named 
chromosomal loci. 
crp_F ggacgtcacattaccgtgcag Upstream primer for amplification of named 
chromosomal loci. 
crp_R gataaatcagtctgcgccac Downstream primer for amplification of named 
chromosomal loci. 
crr_F cgacaacggacgagttaatg Upstream primer for amplification of named 
chromosomal loci. 
crr_R gctacacccagcagcatgag Downstream primer for amplification of named 
chromosomal loci. 
cspG_F gagtctctctcctgaacac Upstream primer for amplification of named 
chromosomal loci. 
cspG_R catcgaatgccgatgtgcgg Downstream primer for amplification of named 
chromosomal loci. 
cysK_F ccgcatattctctgagcggg Upstream primer for amplification of named 
chromosomal loci. 
cysK_R gcgaaagtttgaagcaggcc Downstream primer for amplification of named 
chromosomal loci. 
degP_F ggaacttcaggctataaaac Upstream primer for amplification of named 
chromosomal loci. 







Table 1. Primers used for the screening and amplification of loci from the E.coli BW25113 
and for generation of mutants by a method based on the λ-red system (continued). 
Name Sequence (5'      3') Use 
dnaG_F ggctcgcgaaaacgcacgcc Upstream primer for amplification of named 
chromosomal loci. 
dnaG_R cggctgtcgggggcttcccg Downstream primer for amplification of named 
chromosomal loci. 
fis_F gccagcgaacagctggaggc Upstream primer for amplification of named 
chromosomal loci. 
fis_R cctgttctcatggtcactcc Downstream primer for amplification of named 
chromosomal loci. 
fkpA_F gacaacgctttatagtaccc Upstream primer for amplification of named 
chromosomal loci. 
fkpA_R ctaaattaatacagcggagg Downstream primer for amplification of named 
chromosomal loci. 
folX_F gttcgcgccctgccaccggg Upstream primer for amplification of named 
chromosomal loci. 
folX_R caaacgcggaatcaaatggc Downstream primer for amplification of named 
chromosomal loci. 
lon_F cccatatactgacgtacatg Upstream primer for amplification of named 
chromosomal loci. 
lon_R cccgaattagcctgccagccc Downstream primer for amplification of named 
chromosomal loci. 
mhpC_F gcaactggcgtagcgaaggg Upstream primer for amplification of named 
chromosomal loci. 
mhpC_R gcaatcgcttcgccctgctc Downstream primer for amplification of named 
chromosomal loci. 
nei_F cgctctgcatttgccgaaaagg Upstream primer for amplification of named 
chromosomal loci. 
nei_R ccgatatggcgctcattatggc Downstream primer for amplification of named 
chromosomal loci. 
nlpB_F gggcatgtaaggaactg Upstream primer for amplification of named 
chromosomal loci. 
nlpB_R ctaaaatcgcgttttcctgc Downstream primer for amplification of named 
chromosomal loci. 
nuoF_F gctgctgccaacttgctgcc Upstream primer for amplification of named 
chromosomal loci. 
nuoF_R gtctacatgaattgtagcca Downstream primer for amplification of named 
chromosomal loci. 
pal_F cagatgggcgtttcaaagcg Upstream primer for amplification of named 
chromosomal loci. 
pal_R cctgagcaaaagcggcccag Downstream primer for amplification of named 
chromosomal loci. 
pitA_F gagtgaaatccatacagggg Upstream primer for amplification of named 
chromosomal loci. 






Table 1. Primers used for the screening and amplification of loci from the E.coli BW25113 
and for generation of mutants by a method based on the λ-red system (continued) 
Name Sequence (5'      3') Use 
pqiB_F gctatgacgtttgacccgcg Upstream primer for amplification of named 
chromosomal loci. 
pqiB_R gcatccggccagccacagtg Downstream primer for amplification of named 
chromosomal loci. 
prmA_F ggaaaccgtttcggtacatc Upstream primer for amplification of named 
chromosomal loci. 
prmA_R gcaaatttgcgtaaataatc Downstream primer for amplification of named 
chromosomal loci. 
proP_F cccttttgcggccgtcgcgc Upstream primer for amplification of named 
chromosomal loci. 
proP_R ggagagtatgcgcgtcagag Downstream primer for amplification of named 
chromosomal loci. 
proW_F cgtggtcgacgaggaccaacag Upstream primer for amplification of named 
chromosomal loci. 
proW_R cagtaatgcctttgcccggc Downstream primer for amplification of named 
chromosomal loci. 
rfaJ_F gatatagcgcaaaacatatgc Upstream primer for amplification of named 
chromosomal loci. 
rfaJ_R cggtaaaaacaaccaagtc Downstream primer for amplification of named 
chromosomal loci. 
rlpA_F gtgctgatggctgggttcg Upstream primer for amplification of named 
chromosomal loci. 
rlpA_R ccctactatagcaaatgcac Downstream primer for amplification of named 
chromosomal loci. 
skp_F ggaatgtagtggtagtgtag Upstream primer for amplification of named 
chromosomal loci. 
skp_R ccggtgatgacgatatcgcc Downstream primer for amplification of named 
chromosomal loci. 
slyB_F ggattcacatatgccatatac Upstream primer for amplification of named 
chromosomal loci. 
slyB_R ctggagcaactgattacgctc Downstream primer for amplification of named 
chromosomal loci. 
smpA_F ggagcgagtggtttaccg Upstream primer for amplification of named 
chromosomal loci. 
smpA_R ccctctcattgccgatccg Downstream primer for amplification of named 
chromosomal loci. 
surA_F gcggtatatgacaacgcaatc Upstream primer for amplification of named 
chromosomal loci. 
surA_R gcggagggtgagcggcaaac Downstream primer for amplification of named 
chromosomal loci. 
thiC_F cggcgatcgtctcttgcttc Upstream primer for amplification of named 
chromosomal loci. 






Table 1. Primers used for the screening and amplification of loci from the E.coli BW25113 
and for generation of mutants by a method based on the λ-red system (continued). 
Name Sequence (5'      3') Use 
uvrD_F cccggttggcatctctgacc Upstream primer for amplification of named 
chromosomal loci. 
uvrD_R cctatccggcctacatgacg Downstream primer for amplification of named 
chromosomal loci. 
uxuR_F cgttgtaggccggataaggc Upstream primer for amplification of named 
chromosomal loci. 
uxuR_R ccaggaagaatgagtactaac Downstream primer for amplification of named 
chromosomal loci. 
yafO_F cgcttccgtccaagtgctgc Upstream primer for amplification of named 
chromosomal loci. 
yafO_R ccgctctaatgaaaatagcg Downstream primer for amplification of named 
chromosomal loci. 
ybbB_F ggcgcaaatttggcagcggc Upstream primer for amplification of named 
chromosomal loci. 
ybbB_R ccggtaactctcaacctttc Downstream primer for amplification of named 
chromosomal loci. 
ybeL_F cgcatagcatagcccaaacg Upstream primer for amplification of named 
chromosomal loci. 
ybeL_R cggggaatttcattcggccc Downstream primer for amplification of named 
chromosomal loci. 
ybhC_F gcaatgccatctggtatcac Upstream primer for amplification of named 
chromosomal loci. 
ybhC_R cgaaccgtaggccggataag Downstream primer for amplification of named 
chromosomal loci. 
yeiC_F gagcctgctcaaatctgccc Upstream primer for amplification of named 
chromosomal loci. 
yeiC_R gattccagcgccacaaccgg Downstream primer for amplification of named 
chromosomal loci. 
yeiL_F gaccgggccgatgattgaatc Upstream primer for amplification of named 
chromosomal loci. 
yeiL_R gcttgcatccggcaatcgc Downstream primer for amplification of named 
chromosomal loci. 
yeiM_F gcgggttaatttctgacggg Upstream primer for amplification of named 
chromosomal loci. 
yeiM_R cggagaataaattctccggg Downstream primer for amplification of named 
chromosomal loci. 
yfbV_F cccgctgagttgtgaatttg Upstream primer for amplification of named 
chromosomal loci. 
yfbV_R gtaacgttcagcatttgccg Downstream primer for amplification of named 
chromosomal loci. 
yfcI_F ctgcctgctgcattgggtg Upstream primer for amplification of named 
chromosomal loci. 






Table 1. Primers used for the screening and amplification of loci from the E.coli BW25113 
and for generation of mutants by a method based on the λ-red system (continued). 
Name Sequence (5'      3') Use 
yfeK_F gtaatccaaccgaaactttac Upstream primer for amplification of named 
chromosomal loci. 
yfeK_R gccatagttgacagctaaac Downstream primer for amplification of named 
chromosomal loci. 
yfgL_F gcgcgtagtgcatgggaagc Upstream primer for amplification of named 
chromosomal loci. 
yfgL_R caacgcacgctatattcgcg Downstream primer for amplification of named 
chromosomal loci. 
ygeV_F gatctgtgaaccatcaacgtc Upstream primer for amplification of named 
chromosomal loci. 
ygeV_R cacggggtatcagatgattg Downstream primer for amplification of named 
chromosomal loci. 
ygjI_F ggttctcaaagtcaccatcg Upstream primer for amplification of named 
chromosomal loci. 
ygjI_R ggcagaaactattttccctc Downstream primer for amplification of named 
chromosomal loci. 
yhiL_F caattatcttccagggaggg Upstream primer for amplification of named 
chromosomal loci. 
yhiL_R catatacaggtgtgggtttc Downstream primer for amplification of named 
chromosomal loci. 
yhiN_F ctttcgcggcgcgggcaaag Upstream primer for amplification of named 
chromosomal loci. 
yhiN_R caatcacctttccatccacc Downstream primer for amplification of named 
chromosomal loci. 
yiaG_F gaatcgaatcatagccagag Upstream primer for amplification of named 
chromosomal loci. 
yiaG_R cacgcattggcgggtgatgc Downstream primer for amplification of named 
chromosomal loci. 
yihN_F gaatggtcggtatcttattg Upstream primer for amplification of named 
chromosomal loci. 
yihN_R gcggcgtaaacgccttatcc Downstream primer for amplification of named 
chromosomal loci. 
yihR_F cctaaccctctccccaaagg Upstream primer for amplification of named 
chromosomal loci. 
yihR_R ctttagcgagtgaaatgttc Downstream primer for amplification of named 
chromosomal loci. 
yjdL_F ggctgatggccgctataccg Upstream primer for amplification of named 
chromosomal loci. 
yjdL_R ggtacactgtattatctgcc Downstream primer for amplification of named 
chromosomal loci. 
yjiC_F cctaccctttaatatcaccg Upstream primer for amplification of named 
chromosomal loci. 






Table 1. Primers used for the screening and amplification of loci from the E.coli BW25113 
and for generation of mutants by a method based on the λ-red system (continued). 
Name Sequence (5'      3') Use 
ykgG_F ggccggtgctcatgcggcaagc Upstream primer for amplification of named 
chromosomal loci. 
ykgG_R gcataaccatgacggaacgggg Downstream primer for amplification of named 
chromosomal loci. 
ynbC_F gcggcgatgtcgtgatgtcag Upstream primer for amplification of named 
chromosomal loci. 
ynbC_R gtgaagaagaaaaacggggc Downstream primer for amplification of named 
chromosomal loci. 
yohM_F ctactggggggtagtatcagg Upstream primer for amplification of named 
chromosomal loci. 
yohM_R ccttagcgagcagagagtcag Downstream primer for amplification of named 
chromosomal loci. 
yphF_F gacggcgattaatccggcttg Upstream primer for amplification of named 
chromosomal loci. 
yphF_R cacttttgctaccgggactg Downstream primer for amplification of named 
chromosomal loci. 
yqiH_F caacttaaccaccggaacgg Upstream primer for amplification of named 
chromosomal loci. 
yqiH_R cattgcccatgcaggtaatg Downstream primer for amplification of named 
chromosomal loci. 
yshA_F caatagccgctatttccatc Upstream primer for amplification of named 
chromosomal loci. 
yshA_R ccgtatcaaccgtaggccgg Downstream primer for amplification of named 
chromosomal loci. 
kan_F cctgcaaagtaaactggatg Primer that anneals to the internal of the kanamycin 
cassette on the top strand 
kan_R catgctcttcgtgcagatca Primer that anneals to the internal of the kanamycin 














Table 2 Primers used for the screening of candidate kanamycin resistant colonies after 
chromosomal disruption of target genes in E. coli HB101 using the λ-red system. 
Primer Sequence (5'      3') Use 
surA_seq gccgactctatgttaggtg Primer anneals approximately 100 bp upstream of the 
loci used to disrupt target chromosomal gene. Used in 
conjunction with a downstream primer that anneals to 
the kanamycin cassette.  
degP_seq cgcgcttattccacaaactc Primer anneals approximately 100 bp upstream of the 
loci used to disrupt target chromosomal gene. Used in 
conjunction with a downstream primer that anneals to 
the kanamycin cassette. 
skp_seq ccgtatgtctgcgggtatcg Primer anneals approximately 100 bp upstream of the 
loci used to disrupt target chromosomal gene. Used in 
conjunction with a downstream primer that anneals to 
the kanamycin cassette. 
ppiA_seq ccagtcagtgcgtaggagag Primer anneals approximately 100 bp upstream of the 
loci used to disrupt target chromosomal gene. Used in 
conjunction with a downstream primer that anneals to 
the kanamycin cassette. 
ppiD_seq gcttccgtaactgaatctctg Primer anneals approximately 100 bp upstream of the 
loci used to disrupt target chromosomal gene. Used in 
conjunction with a downstream primer that anneals to 
the kanamycin cassette. 
bamB_seq gccgcccagttacaacaggg Primer anneals approximately 100 bp upstream of the 
loci used to disrupt target chromosomal gene. Used in 
conjunction with a downstream primer that anneals to 
the kanamycin cassette. 
bamC_seq gcgatgatgcgagcgcgctg Primer anneals approximately 100 bp upstream of the 
loci used to disrupt target chromosomal gene. Used in 
conjunction with a downstream primer that anneals to 
the kanamycin cassette. 
bamE_seq gccacaagtcgcgggatgtg Primer anneals approximately 100 bp upstream of the 
loci used to disrupt target chromosomal gene. Used in 
conjunction with a downstream primer that anneals to 
the kanamycin cassette. 
crp_seq cccttcgacccacttcactcg Primer anneals approximately 100 bp upstream of the 
loci used to disrupt target chromosomal gene. Used in 
conjunction with a downstream primer that anneals to 
the kanamycin cassette. 
fis_seq gctttgcgcgcacgttcggg Primer anneals approximately 100 bp upstream of the 
loci used to disrupt target chromosomal gene. Used in 
conjunction with a downstream primer that anneals to 
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